Index	Cancer	Signature	Type	HR	Low CI95	Up CI95	p-value	Number_Event	N/A_number	Likelihood_ratio_test	Wald_test	Score_test	zph	concordance
	ACC	AR	(continuous)	0.775067022	0.643298294	0.933826336	0.007360291	79/28	13(14.13%)	0.003483034	0.007360291	0.005440488	0.837808332	0.663923182
	ACC	AR	H (vs L)	0.420163079	0.184808026	0.955245383	0.03852474	40/20--39/8	13(14.13%)	0.029810665	0.03852474	0.032847009	0.830892978	0.600823045
	ACC	ESR1	(continuous)	1.089308523	0.878272116	1.351054003	0.436225774	79/28	13(14.13%)	0.436854545	0.436225774	0.435405212	0.859315732	0.53909465
	ACC	ESR1	H (vs L)	1.059228464	0.504220518	2.225147331	0.879239068	40/14--39/14	13(14.13%)	0.879246893	0.879239068	0.879222729	0.144308375	0.478395062
	ACC	ESR2	(continuous)	0.808953903	0.655369066	0.998531136	0.048421804	79/28	13(14.13%)	0.049502242	0.048421804	0.045234098	0.35061894	0.594993141
	ACC	ESR2	H (vs L)	0.541558027	0.252395346	1.162006756	0.115372433	40/17--39/11	13(14.13%)	0.110253792	0.115372433	0.109969076	0.724872767	0.571673525
	ACC	PGR	(continuous)	1.027682634	0.836074779	1.263202316	0.795348981	79/28	13(14.13%)	0.792135629	0.795348981	0.795307431	0.107181875	0.604252401
	ACC	PGR	H (vs L)	2.642799397	1.189677392	5.870825738	0.017011446	40/9--39/19	13(14.13%)	0.013026997	0.017011446	0.013219971	0.303360158	0.599451303
1	ACC	weiss_score_overall	(continuous)	1.264737256	1.043656224	1.532650589	0.016581658	69/28	23(25%)	0.014153621	0.016581658	0.014334899	0.016978075	0.585803432
1	ACC	mitoses_per_50_hpf	(continuous)	1.021758625	1.010521254	1.03312096	0.000136247	61/24	31(33.7%)	0.000820443	0.000136247	2.07E-05	0.171704779	0.703214696
	ACC	age_at_initial_pathologic_diagnosis	(continuous)	1.013516912	0.992817268	1.034648131	0.202214049	92/34	0(0%)	0.200457131	0.202214049	0.200811782	0.804475396	0.561792453
	ACC	gender	MALE (vs FEMALE)	0.84859844	0.413528965	1.741399933	0.654437274	32/11--60/23	0(0%)	0.651459797	0.654437274	0.654075376	0.884256975	0.517688679
	ACC	pathologic_stage_v2	StageIII/IV (vs StageI/II)	8.009918439	3.539214237	18.12797675	5.95E-07	37/24--53/9	2(2.17%)	5.49E-08	5.95E-07	1.05E-08	0.325161745	0.745208845
	ACC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	33.77671967	7.756320622	147.088658	2.75E-06	45/30--45/2	2(2.17%)	1.32E-12	2.75E-06	9.37E-12	0.706156852	0.77077001
	ACC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	13.16366238	4.900626108	35.35915686	3.18E-07	25/17--54/7	13(14.13%)	1.99E-08	3.18E-07	2.55E-10	0.919980168	0.769461078
	ACC	residual_tumor	R1 (vs R0)	7.627293482	2.528404079	23.00882455	0.000310327	7/5--64/14	NA	NA	NA	NA	0.431020622	NA
	ACC	residual_tumor	R2 (vs R0)	12.46695073	5.301959889	29.31460512	7.30E-09	12/11--64/14	NA	NA	NA	NA	0.580271256	NA
	ACC	residual_tumor	RX (vs R0)	3.379818201	0.967345887	11.80877619	0.05639753	6/3--64/14	NA	NA	NA	NA	0.086249178	NA
	ACC	residual_tumor	Global	NA	NA	NA	NA	NA	3(3.26%)	2.63E-07	1.08E-07	3.80E-11	0.196696788	0.752113376
	ACC	new_tumor_event	Yes (vs No)	4.054764661	1.882826196	8.732147708	0.000347984	44/25--48/9	0(0%)	0.000116024	0.000347984	0.000112195	0.833865841	0.66509434
	ACC	number_of_lymphnodes_positive_by_he	Yes (vs No)	2.364197859	0.911274481	6.133642091	0.076902097	8/5--84/29	0(0%)	0.109642611	0.076902097	0.06820791	0.428407634	0.555188679
	ACC	clinical_status_within_3_mths_surgery	Disease (vs No_evidence)	9.002843266	4.410304388	18.37768547	1.58E-09	20/18--72/16	0(0%)	6.99E-09	1.58E-09	7.73E-13	0.893623762	0.721933962
1	ACC	ct_scan_preop_results.1	Involvement (vs Normal)	3.50849747	1.660608975	7.412674914	0.001005729	24/15--53/13	15(16.3%)	0.00120425	0.001005729	0.000462278	0.280655222	0.667232022
	ACC	history_adrenal_hormone_excess	None (vs Yes)	0.499472934	0.2330442	1.070497407	0.074291101	38/9--54/25	0(0%)	0.061410509	0.074291101	0.06864553	0.26658036	0.560613208
	ACC	invasion_of_tumor_capsule	Absent (vs Present)	0.380816286	0.174014855	0.833383123	0.015688213	35/9--48/22	9(9.78%)	0.011111612	0.015688213	0.012242682	0.09758868	0.639905549
1	ACC	Mitotic_Rate_._5.50_HPF	Absent (vs Present)	0.391217204	0.174305577	0.878060836	0.022892522	32/8--48/24	12(13.04%)	0.015383812	0.022892522	0.018562579	0.203439307	0.585653753
	ACC	necrosis	Absent (vs Present)	0.381967807	0.133993239	1.088856469	0.07175189	20/4--67/29	5(5.43%)	0.043025115	0.07175189	0.061458831	0.174615225	0.555960437
1	ACC	sinusoid_invasion	Present (vs Absent)	2.128865783	0.971691604	4.66410279	0.058998929	29/15--39/11	24(26.09%)	0.057039427	0.058998929	0.053431761	0.124430097	0.562874251
	ACC	weiss_venous_invasion	Present (vs Absent)	3.186834788	1.506840513	6.73987451	0.002422462	36/19--43/12	13(14.13%)	0.001997354	0.002422462	0.001489744	0.850561533	0.642156863
	BLCA	AR	(continuous)	0.982049632	0.923937633	1.043816645	0.560552809	407/178	5(1.21%)	0.559454959	0.560552809	0.560480171	0.006975698	0.537087496
	BLCA	AR	H (vs L)	0.971144111	0.723328013	1.303863349	0.845554542	204/91--203/87	5(1.21%)	0.845540998	0.845554542	0.845549174	0.00124795	0.53062484
	BLCA	ESR1	(continuous)	1.02861513	0.95207132	1.111312844	0.474551832	407/178	5(1.21%)	0.475261282	0.474551832	0.47451374	0.517714155	0.51065465
	BLCA	ESR1	H (vs L)	1.166030103	0.867521902	1.567252882	0.308649503	204/80--203/98	5(1.21%)	0.307633395	0.308649503	0.308177669	0.202447692	0.509478563
	BLCA	ESR2	(continuous)	0.883247909	0.770780651	1.012125652	0.074014477	407/178	5(1.21%)	0.072085058	0.074014477	0.07395054	0.405032897	0.532289993
	BLCA	ESR2	H (vs L)	0.757938931	0.563855406	1.018827552	0.066302218	204/98--203/80	5(1.21%)	0.065463737	0.066302218	0.065445153	0.273253713	0.543480286
	BLCA	PGR	(continuous)	1.115536282	1.015945661	1.224889523	0.021932879	407/178	5(1.21%)	0.022690196	0.021932879	0.021886455	0.060890415	0.536318964
	BLCA	PGR	H (vs L)	1.417159209	1.053928975	1.905574541	0.021021011	205/79--202/99	5(1.21%)	0.020510803	0.021021011	0.020383763	0.351802048	0.5348867
1	BLCA	BMI	(continuous)	0.993441148	0.966874428	1.020737839	0.634208182	361/153	51(12.38%)	0.63050777	0.634208182	0.634276435	0.629734344	0.510043456
	BLCA	tobacco_smoking_history	(continuous)	1.0453368	0.922455888	1.184586753	0.487105539	398/175	14(3.4%)	0.487526615	0.487105539	0.486985578	0.304785893	0.525047168
	BLCA	age_at_initial_pathologic_diagnosis	(continuous)	1.031469259	1.016002639	1.047171328	5.83E-05	411/180	1(0.24%)	3.90E-05	5.83E-05	5.34E-05	0.050673676	0.601052943
	BLCA	race	ASIAN (vs WHITE)	0.621738497	0.316476793	1.221444248	0.167781557	44/9--327/152	NA	NA	NA	NA	0.03256885	NA
	BLCA	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	1.254371469	0.711495125	2.211466709	0.43340138	23/13--327/152	NA	NA	NA	NA	0.657729904	NA
	BLCA	race	Global	NA	NA	NA	NA	NA	19(4.61%)	0.229005382	0.262372888	0.255944768	0.09743239	0.530146841
	BLCA	gender	FEMALE (vs MALE)	1.117713128	0.808016182	1.546110912	0.501429957	108/51--304/130	1(0.24%)	0.504924325	0.501429957	0.501210032	0.563747306	0.514941326
	BLCA	pathologic_stage_v2	StageI/II (vs StageIII/IV)	0.447355989	0.309042518	0.647572321	2.02E-05	133/35--277/145	3(0.73%)	4.43E-06	2.02E-05	1.20E-05	0.34816219	0.58422506
	BLCA	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	5.781134504	4.051567948	8.249032617	0	165/124--222/43	26(6.31%)	0	0	0	0.039548993	0.681734197
2	BLCA	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	4.651801469	2.688957979	8.047450753	3.86E-08	23/17--234/57	NA	NA	NA	NA	0.8187725	NA
2	BLCA	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	3.559724241	2.087859061	6.069201176	3.10E-06	30/18--234/57	NA	NA	NA	NA	0.539551692	NA
2	BLCA	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	6.395690812	4.330158745	9.446503782	0	68/54--234/57	NA	NA	NA	NA	0.817262024	NA
2	BLCA	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	57(13.83%)	0	0	0	0.879131625	0.702924124
3	BLCA	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	5.125227312	3.634706443	7.226981164	0	121/89--234/57	57(13.83%)	0	0	0	0.791829166	0.692777918
	BLCA	new_tumor_event	Yes (vs No)	1.832175105	1.36678232	2.456035293	5.13E-05	144/93--268/88	1(0.24%)	5.60E-05	5.13E-05	3.94E-05	0.000112299	0.543527699
	BLCA	pharmaceutical_tx_adjuvant	YES (vs NO)	0.665612035	0.453796838	0.976294553	0.037277042	77/32--335/149	1(0.24%)	0.029856021	0.037277042	0.035997106	0.171049664	0.541253525
	BLCA	number_of_lymphnodes_positive_by_he	Yes (vs None)	2.032508462	1.511818036	2.732531661	2.64E-06	120/78--292/103	1(0.24%)	4.74E-06	2.64E-06	1.62E-06	0.465538789	0.574570181
	BLCA	histologic_subtype	Papillary (vs Non-Papillary)	0.675275154	0.475653554	0.95867366	0.028090883	133/42--274/135	6(1.46%)	0.023281992	0.028090883	0.02710404	0.4663448	0.545559129
	BLCA	lymphovascular_invasion	YES (vs NO)	1.795298696	1.337272166	2.410203016	9.86E-05	153/82--259/99	1(0.24%)	0.000127476	9.86E-05	7.85E-05	0.631439169	0.573501319
	BLCA	extracapsular_extension	YES (vs NO)	1.419218641	0.997817973	2.01858616	0.051437575	73/41--339/140	1(0.24%)	0.059520561	0.051437575	0.050262454	0.161262337	0.518398072
	BRCA	AR	(continuous)	1.023020208	0.959475144	1.090773797	0.486681523	1094/151	3(0.27%)	0.481961922	0.486681523	0.486540948	0.00026884	0.464057115
	BRCA	AR	H (vs L)	1.056342717	0.766549983	1.455691032	0.737608449	548/77--546/74	3(0.27%)	0.737659655	0.737608449	0.737577523	0.034758939	0.471911928
	BRCA	ESR1	(continuous)	0.997951363	0.947665155	1.050905922	0.938035532	1094/151	3(0.27%)	0.938110726	0.938035532	0.938035198	0.015652377	0.536542959
	BRCA	ESR1	H (vs L)	1.157314359	0.840584455	1.593387216	0.370503434	548/74--546/77	3(0.27%)	0.370477368	0.370503434	0.370083136	0.291811125	0.492591396
	BRCA	ESR2	(continuous)	0.773668792	0.646918498	0.925253183	0.004939204	1094/151	3(0.27%)	0.004876224	0.004939204	0.005025271	0.66389921	0.573024372
	BRCA	ESR2	H (vs L)	0.642982904	0.463800969	0.891388854	0.008053777	552/91--542/60	3(0.27%)	0.007380136	0.008053777	0.00755965	0.972995933	0.556853151
	BRCA	PGR	(continuous)	0.961001736	0.917754416	1.006286999	0.090418237	1094/151	3(0.27%)	0.092446309	0.090418237	0.089768203	0.008770116	0.592488306
	BRCA	PGR	H (vs L)	0.750689021	0.544930438	1.034139344	0.07933317	548/79--546/72	3(0.27%)	0.079171601	0.07933317	0.078326619	0.004920516	0.581810069
	BRCA	age_at_initial_pathologic_diagnosis	(continuous)	1.032682833	1.020075616	1.045445864	2.87E-07	1096/151	1(0.09%)	3.14E-07	2.87E-07	2.24E-07	0.700603547	0.635736137
	BRCA	gender	MALE (vs FEMALE)	0.841827499	0.117528358	6.02980892	0.863909966	12/1--1085/150	1(0.09%)	0.860008259	0.863909966	0.863743446	0.671390281	0.498039939
	BRCA	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.573865767	0.910408832	2.720814389	0.104399094	621/65--183/16	NA	NA	NA	NA	0.305105006	NA
	BRCA	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	3.015843877	1.700465524	5.348720196	0.000159366	249/44--183/16	NA	NA	NA	NA	0.00253504	NA
	BRCA	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	13.00744482	6.416348659	26.36914385	1.12E-12	20/15--183/16	NA	NA	NA	NA	0.037498356	NA
	BRCA	ajcc_pathologic_tumor_stage	Stage_X (vs Stage_I)	4.187727144	1.710457182	10.25284866	0.001719147	13/7--183/16	NA	NA	NA	NA	0.029026523	NA
	BRCA	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	12(1.09%)	5.27E-11	1.65E-14	0	0.003008098	0.693722267
	BRCA	pathologic_stage_v2	StageIII/IV (vs StageI/II)	2.648561783	1.892892876	3.705904124	1.32E-08	269/59--804/81	NA	NA	NA	NA	0.000348274	NA
	BRCA	pathologic_stage_v2	Stage_X (vs StageI/II)	2.970724011	1.360707075	6.485746504	0.006273832	13/7--804/81	NA	NA	NA	NA	0.057566107	NA
	BRCA	pathologic_stage_v2	Global	NA	NA	NA	NA	NA	12(1.09%)	6.91E-08	2.06E-08	4.67E-09	0.000727299	0.663075745
	BRCA	histological_type	Infiltrating_Lobular_Carcinoma (vs Infiltrating_Ductal_Carcinoma)	0.846999027	0.538995165	1.331008881	0.471486397	203/23--784/106	NA	NA	NA	NA	0.930106602	NA
	BRCA	histological_type	Other_specify (vs Infiltrating_Ductal_Carcinoma)	1.276856495	0.661626936	2.464171906	0.466250004	46/10--784/106	NA	NA	NA	NA	0.354456178	NA
	BRCA	histological_type	Mixed_Histology_(please_specify) (vs Infiltrating_Ductal_Carcinoma)	1.02135518	0.448171526	2.327605262	0.959900604	30/6--784/106	NA	NA	NA	NA	0.503591711	NA
	BRCA	histological_type	Mucinous_Carcinoma (vs Infiltrating_Ductal_Carcinoma)	4.079650819	1.28149783	12.98757627	0.017323394	17/3--784/106	NA	NA	NA	NA	0.73133509	NA
	BRCA	histological_type	Metaplastic_Carcinoma (vs Infiltrating_Ductal_Carcinoma)	2.357963647	0.327483883	16.97791202	0.394408646	9/1--784/106	NA	NA	NA	NA	0.855862379	NA
	BRCA	histological_type	Medullary_Carcinoma (vs Infiltrating_Ductal_Carcinoma)	1.06538655	0.261399885	4.34219204	0.929596143	6/2--784/106	NA	NA	NA	NA	0.028798837	NA
	BRCA	histological_type	Infiltrating_Carcinoma_NOS (vs Infiltrating_Ductal_Carcinoma)	1.02E-05	0	Inf	0.995891408	1/0--784/106	NA	NA	NA	NA	0.99963864	NA
	BRCA	histological_type	Global	NA	NA	NA	NA	NA	2(0.18%)	0.576343614	0.361870655	0.266622358	0.488465838	0.521665564
	BRCA	menopause_status	Pre (vs Post)	0.456905363	0.275127304	0.758785143	0.002473551	229/18--705/91	NA	NA	NA	NA	0.29753229	NA
	BRCA	menopause_status	Peri (vs Post)	0.178340652	0.024840623	1.280378016	0.086488454	39/1--705/91	NA	NA	NA	NA	0.453827055	NA
	BRCA	menopause_status	Indeterminate (vs Post)	0.666856654	0.362137679	1.227979918	0.193363791	34/15--705/91	NA	NA	NA	NA	0.090190466	NA
	BRCA	menopause_status	Global	NA	NA	NA	NA	NA	91(8.3%)	0.001503579	0.005939323	0.003590033	0.171846257	0.585485987
	BRCA	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	10.93158784	7.653983443	15.61273468	0	126/83--935/49	37(3.37%)	0	0	0	0.005554886	0.784288339
	BRCA	margin_status	Positive (vs Negative)	1.980990721	1.203619017	3.260437217	0.007166936	79/19--920/89	NA	NA	NA	NA	0.072833381	NA
	BRCA	margin_status	Close (vs Negative)	1.904431	0.830123676	4.369056731	0.128383008	31/6--920/89	NA	NA	NA	NA	0.830465037	NA
	BRCA	margin_status	Global	NA	NA	NA	NA	NA	68(6.2%)	0.021386025	0.012562802	0.010630557	0.200055842	0.534975922
	BRCA	new_tumor_event_type	Distant_Metastasis (vs No)	5.346471344	3.750043861	7.622512401	0	64/46--995/95	NA	NA	NA	NA	0.096301392	NA
	BRCA	new_tumor_event_type	New_Primary_Tumor (vs No)	0.678508678	0.246841166	1.865061787	0.452169253	19/4--995/95	NA	NA	NA	NA	0.143607824	NA
	BRCA	new_tumor_event_type	Locoregional_Disease (vs No)	1.939703064	0.780583566	4.820045081	0.153700228	10/5--995/95	NA	NA	NA	NA	0.683106538	NA
	BRCA	new_tumor_event_type	Locoregional_Recurrence (vs No)	0.785079322	0.109331685	5.637428356	0.809890699	9/1--995/95	NA	NA	NA	NA	0.663967276	NA
	BRCA	new_tumor_event_type	Global	NA	NA	NA	NA	NA	1(0.09%)	2.10E-14	0	0	0.345091237	0.63277683
	BRCA	new_tumor_event_dx_days_to	Yes (vs No)	3.14129467	2.250813841	4.384073007	1.70E-11	113/60--984/91	1(0.09%)	2.05E-10	1.70E-11	1.66E-12	0.012423888	0.626058817
	BRCA	number_of_lymphnodes_positive_by_he	Yes (vs None)	1.60419281	1.162222471	2.214235772	0.004050389	473/86--624/65	1(0.09%)	0.003821405	0.004050389	0.003720215	0.341239188	0.564927977
	BRCA	surgical_procedure_first	Other (vs Modified_Radical_Mastectomy)	0.707100474	0.470526108	1.062621332	0.095375553	272/39--322/58	NA	NA	NA	NA	0.14118208	NA
	BRCA	surgical_procedure_first	Lumpectomy (vs Modified_Radical_Mastectomy)	0.563738595	0.348626063	0.911581884	0.019413082	247/24--322/58	NA	NA	NA	NA	0.270853814	NA
	BRCA	surgical_procedure_first	Simple_Mastectomy (vs Modified_Radical_Mastectomy)	0.53877929	0.314963387	0.921640847	0.02395357	200/18--322/58	NA	NA	NA	NA	0.929807904	NA
	BRCA	surgical_procedure_first	Global	NA	NA	NA	NA	NA	57(5.2%)	0.037224118	0.036155576	0.033294975	0.380797047	0.572100802
	BRCA	micromet_detection_by_ihc	YES (vs NO)	0.409012645	0.240947997	0.694304773	0.000928624	263/18--467/66	367(33.45%)	0.000393749	0.000928624	0.000630666	0.969553268	0.603892076
	BRCA	er_status_by_ihc	Negative (vs Positive)	1.36109381	0.944332842	1.961783257	0.098355745	238/41--808/100	52(4.74%)	0.106114787	0.098355745	0.097069221	0.012015109	0.561508721
	BRCA	pr_status_by_ihc	Negative (vs Positive)	1.334549908	0.95237854	1.870079368	0.093637354	344/56--699/86	55(5.01%)	0.097517294	0.093637354	0.092518286	0.000921224	0.57960271
	BRCA	her2_status_by_ihc	Positive (vs Negative)	1.643131037	1.008597291	2.676865809	0.046114601	164/23--564/57	369(33.64%)	0.05461368	0.046114601	0.04396028	0.306722136	0.561043377
	CESC	AR	(continuous)	1.042854209	0.931958968	1.166945046	0.464463961	304/71	3(0.98%)	0.469940213	0.464463961	0.46415763	0.082047593	0.482044573
	CESC	AR	H (vs L)	1.063014386	0.667409977	1.693111617	0.796933898	152/35--152/36	3(0.98%)	0.796920878	0.796933898	0.796903073	0.085041665	0.48375891
	CESC	ESR1	(continuous)	0.982349547	0.878712233	1.09821008	0.754233582	304/71	3(0.98%)	0.754178296	0.754233582	0.754228206	0.33186833	0.52278264
	CESC	ESR1	H (vs L)	0.95803178	0.601420718	1.526094569	0.856770467	152/36--152/35	3(0.98%)	0.856761579	0.856770467	0.856759661	0.880536923	0.509519083
	CESC	ESR2	(continuous)	0.848583061	0.656332589	1.097146817	0.210340153	304/71	3(0.98%)	0.203720753	0.210340153	0.211476684	0.757433778	0.547054047
	CESC	ESR2	H (vs L)	0.727810791	0.455413945	1.163136423	0.184110242	153/38--151/33	3(0.98%)	0.183348254	0.184110242	0.182322078	0.859187584	0.539655328
	CESC	PGR	(continuous)	0.93312556	0.840930078	1.035428905	0.192223243	304/71	3(0.98%)	0.185266213	0.192223243	0.192218101	0.37199183	0.579761797
	CESC	PGR	H (vs L)	0.662776223	0.412477389	1.064960972	0.089157513	153/42--151/29	3(0.98%)	0.086265019	0.089157513	0.08694881	0.044148662	0.582649102
	CESC	BMI	(continuous)	0.952253852	0.910819291	0.995573334	0.03112883	262/52	45(14.66%)	0.024274343	0.03112883	0.031339748	0.753645291	0.598963372
	CESC	age_at_initial_pathologic_diagnosis	(continuous)	1.016860619	0.999272521	1.034758283	0.060351851	307/71	0(0%)	0.062968722	0.060351851	0.059697112	0.819235627	0.559015953
	CESC	BMI_category	Over (vs Normal)	0.480094338	0.23114355	0.997175017	0.049119877	75/10--99/26	NA	NA	NA	NA	0.239438102	NA
	CESC	BMI_category	Obesity (vs Normal)	0.645043368	0.345771064	1.203342298	0.168162133	88/16--99/26	NA	NA	NA	NA	0.874157851	NA
	CESC	BMI_category	Global	NA	NA	NA	NA	NA	45(14.66%)	0.100774287	0.10634332	0.098781926	0.425218679	0.565583967
	CESC	clinical_stage	Stage_II (vs Stage_I)	0.807604996	0.410257197	1.589797414	0.536336965	70/11--163/36	NA	NA	NA	NA	0.342514745	NA
	CESC	clinical_stage	Stage_III (vs Stage_I)	1.241052066	0.615433886	2.502641251	0.546189788	46/10--163/36	NA	NA	NA	NA	0.37775378	NA
	CESC	clinical_stage	Stage_IV (vs Stage_I)	4.447563211	2.393038074	8.265985707	2.37E-06	21/14--163/36	NA	NA	NA	NA	0.089690121	NA
	CESC	clinical_stage	Global	NA	NA	NA	NA	NA	7(2.28%)	0.000229696	9.90E-06	7.85E-07	0.345599972	0.615844203
	CESC	clinical_stage_v2	StageIII/IV (vs StageI/II)	2.259777538	1.380683119	3.698599957	0.001181893	67/24--233/47	7(2.28%)	0.002107401	0.001181893	0.000858929	0.114816273	0.604168567
	CESC	histological_grade	G2 (vs G1)	1.883739333	0.452234029	7.846543269	0.384363208	136/37--18/2	NA	NA	NA	NA	0.657060044	NA
	CESC	histological_grade	G3 (vs G1)	1.602603519	0.375909216	6.832335927	0.523809007	120/22--18/2	NA	NA	NA	NA	0.725666003	NA
	CESC	histological_grade	G4 (vs G1)	5.24E-07	0	Inf	0.995695801	1/0--18/2	NA	NA	NA	NA	0.99999651	NA
	CESC	histological_grade	GX (vs G1)	3.806203939	0.821988748	17.62455809	0.08739854	24/9--18/2	NA	NA	NA	NA	0.918068405	NA
	CESC	histological_grade	Global	NA	NA	NA	NA	NA	8(2.61%)	0.190699721	0.219869301	0.159032813	0.967716368	0.568287565
	CESC	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	0.873063463	0.517060719	1.474178528	0.611527591	121/22--154/39	NA	NA	NA	NA	0.806380264	NA
	CESC	histological_grade_v2	GX (vs G_1/2/Low)	2.120846641	1.018786889	4.415045508	0.04446101	24/9--154/39	NA	NA	NA	NA	0.537576494	NA
	CESC	histological_grade_v2	Global	NA	NA	NA	NA	NA	8(2.61%)	0.113227216	0.074765751	0.064975955	0.823833513	0.556792263
	CESC	histological_type	Adenocarcinoma (vs Cervical_Squamous_Cell_Carcinoma)	0.947380322	0.483945659	1.854607967	0.874677152	47/10--254/60	NA	NA	NA	NA	0.695952208	NA
	CESC	histological_type	Adenosquamous (vs Cervical_Squamous_Cell_Carcinoma)	1.605381988	0.219323778	11.75089791	0.641155349	6/1--254/60	NA	NA	NA	NA	0.742227503	NA
	CESC	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.895908698	0.882448871	0.880495584	0.883100031	0.510082452
	CESC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	21.72327464	11.35692009	41.55181661	0	80/53--200/14	27(8.79%)	0	0	0	0.78244473	0.812434393
	CESC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	13.61497811	7.305963304	25.37209965	2.22E-16	36/26--183/22	88(28.66%)	1.44E-15	2.22E-16	0	0.457046418	0.770143312
	CESC	new_tumor_event_type	Distant_Metastasis (vs No)	3.910426009	2.273636768	6.725538477	8.28E-07	31/20--260/40	NA	NA	NA	NA	0.17890766	NA
	CESC	new_tumor_event_type	Locoregional_Recurrence (vs No)	4.584600743	2.124946566	9.891337648	0.000103959	13/8--260/40	NA	NA	NA	NA	0.349026878	NA
	CESC	new_tumor_event_type	New_Primary_Tumor (vs No)	50.58409376	13.54208869	188.9479975	5.36E-09	3/3--260/40	NA	NA	NA	NA	0.639963887	NA
	CESC	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	3.82E-09	3.60E-12	0	0.523906638	0.641647249
	CESC	new_tumor_event_dx_days_to	Yes (vs No)	4.463667317	2.776890378	7.175049498	6.52E-10	48/32--259/39	0(0%)	5.54E-09	6.52E-10	1.42E-11	0.176672205	0.633984585
	CESC	number_of_lymphnodes_positive_by_he	Yes (vs No)	1.273486698	0.737278879	2.199667474	0.385960763	52/17--255/54	0(0%)	0.396107881	0.385960763	0.384819021	0.143040188	0.502106112
	CESC	performance_status_scale_timing	Pre-Adjuvant_Therapy (vs Preoperative)	1.877150114	0.933366233	3.7752518	0.077306911	52/18--96/14	NA	NA	NA	NA	0.496299495	NA
	CESC	performance_status_scale_timing	Post-Adjuvant_Therapy (vs Preoperative)	0.479206679	0.062676745	3.66386353	0.478449919	15/1--96/14	NA	NA	NA	NA	0.067358115	NA
	CESC	performance_status_scale_timing	Other (vs Preoperative)	4.624670058	1.318025361	16.2269815	0.016797184	9/3--96/14	NA	NA	NA	NA	0.053495764	NA
	CESC	performance_status_scale_timing	Global	NA	NA	NA	NA	NA	135(43.97%)	0.049581432	0.040920452	0.024395661	0.042761206	0.651416765
	CESC	lymphovascular_involvement	ABSENT (vs PRESENT)	0.100221998	0.023568989	0.42617224	0.001840257	72/2--80/23	155(50.49%)	2.63E-05	0.001840257	0.000124817	0.362972866	0.720306513
	CESC	corpus_involvement	PRESENT (vs ABSENT)	3.211246212	1.235186056	8.34862261	0.016699426	19/7--99/11	189(61.56%)	0.024581652	0.016699426	0.011478298	0.100027489	0.591002045
	CHOL	AR	(continuous)	0.978289495	0.800700369	1.195266511	0.829954272	36/18	9(20%)	0.829561413	0.829954272	0.829907471	0.2607616	0.472074468
	CHOL	AR	H (vs L)	0.729633364	0.282310998	1.885738958	0.515277356	18/11--18/7	9(20%)	0.511219581	0.515277356	0.51355809	0.176200545	0.503989362
	CHOL	ESR1	(continuous)	0.953361053	0.702996343	1.292890506	0.758628764	36/18	9(20%)	0.757181383	0.758628764	0.758505527	0.00816687	0.412234043
	CHOL	ESR1	H (vs L)	1.07711135	0.423585568	2.738924427	0.87603344	18/10--18/8	9(20%)	0.87621299	0.87603344	0.876005791	0.029197718	0.567819149
	CHOL	ESR2	(continuous)	0.921184988	0.66755677	1.271175458	0.617329033	36/18	9(20%)	0.613810398	0.617329033	0.617151794	0.754587759	0.496010638
	CHOL	ESR2	H (vs L)	1.298082115	0.497957314	3.383858672	0.593565354	18/9--18/9	9(20%)	0.593132686	0.593565354	0.592553897	0.394718942	0.555851064
	CHOL	PGR	(continuous)	0.898366461	0.628306852	1.284503416	0.556861955	36/18	9(20%)	0.557186554	0.556861955	0.556415362	0.424419151	0.533244681
	CHOL	PGR	H (vs L)	0.490884297	0.183972737	1.309799468	0.155314659	18/12--18/6	9(20%)	0.143145487	0.155314659	0.146808714	0.487529328	0.567819149
	CHOL	BMI	(continuous)	0.962383013	0.878511013	1.054262326	0.409847561	41/20	4(8.89%)	0.395694158	0.409847561	0.407721028	0.270295125	0.59832636
	CHOL	age_at_initial_pathologic_diagnosis	(continuous)	1.002721771	0.969475065	1.037108623	0.874461769	45/22	0(0%)	0.873713969	0.874461769	0.874450919	0.249194171	0.534280936
	CHOL	BMI_category	Over (vs Normal)	0.544793428	0.197210204	1.504992506	0.241406777	20/9--12/7	NA	NA	NA	NA	0.099742139	NA
	CHOL	BMI_category	Obesity (vs Normal)	0.532726317	0.154683824	1.834692996	0.318228004	9/4--12/7	NA	NA	NA	NA	0.45426913	NA
	CHOL	BMI_category	Global	NA	NA	NA	NA	NA	4(8.89%)	0.461454853	0.436601912	0.42621321	0.25793719	0.597280335
	CHOL	gender	MALE (vs FEMALE)	1.413676079	0.608426639	3.284668895	0.420920006	20/10--25/12	0(0%)	0.42441929	0.420920006	0.418662115	0.2679324	0.566889632
	CHOL	pathologic_stage_v2	StageIII/IV (vs StageI/II)	0.759894528	0.294363101	1.961657872	0.570402549	14/6--31/16	0(0%)	0.563290437	0.570402549	0.569202831	0.874083479	0.533444816
	CHOL	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	0.717440597	0.306346437	1.68019258	0.444382864	22/11--23/11	0(0%)	0.445243658	0.444382864	0.442498929	0.528566378	0.555183946
	CHOL	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.054060829	0.007194237	0.406238125	0.00457711	19/1--22/18	4(8.89%)	1.48E-05	0.00457711	8.50E-05	0.080046443	0.710084034
	CHOL	new_tumor_event_type	Yes (vs No)	2.956011807	1.153723582	7.573742911	0.023955059	21/16--24/6	0(0%)	0.01631208	0.023955059	0.017881764	0.086758478	0.596153846
	CHOL	new_tumor_event_after_initial_treatment	YES (vs NO)	2.673532345	1.088226719	6.568277616	0.032006775	19/15--26/7	0(0%)	0.025419455	0.032006775	0.025697167	0.047271324	0.581939799
	CHOL	perineural_invasion_present	YES (vs NO)	2.302875022	0.800508283	6.6248326	0.12180464	9/5--36/17	0(0%)	0.146019973	0.12180464	0.111618269	0.834493096	0.571906355
	CHOL	Smoking	Yes (vs No)	1.424527121	0.586250723	3.46144992	0.434733286	14/8--31/14	0(0%)	0.441835572	0.434733286	0.432399643	0.323380912	0.522575251
	CHOL	vascular_invasion	Micro (vs None)	1.425978288	0.472836702	4.300457364	0.528650002	7/4--38/18	0(0%)	0.543026506	0.528650002	0.526517727	0.592307239	0.52090301
	COAD	AR	(continuous)	1.076124421	0.946235314	1.223843321	0.263611962	448/101	11(2.4%)	0.269786338	0.263611962	0.263384917	0.798428816	0.525791063
	COAD	AR	H (vs L)	1.167238313	0.788684939	1.727489914	0.439444554	224/47--224/54	11(2.4%)	0.438840197	0.439444554	0.438995146	0.117167553	0.500726771
	COAD	ESR1	(continuous)	1.139781544	0.983960108	1.320279102	0.081093102	448/101	11(2.4%)	0.080600595	0.081093102	0.081009172	0.136397424	0.531251165
	COAD	ESR1	H (vs L)	1.143228898	0.771279593	1.694550622	0.505017231	226/51--222/50	11(2.4%)	0.50517781	0.505017231	0.504710001	0.197784636	0.504137006
	COAD	ESR2	(continuous)	1.050834874	0.847480913	1.302983838	0.651361982	448/101	11(2.4%)	0.650385062	0.651361982	0.651442958	0.580678197	0.545674779
	COAD	ESR2	H (vs L)	1.388484396	0.937230161	2.057006913	0.101694222	224/45--224/56	11(2.4%)	0.100423568	0.101694222	0.100180742	0.251077011	0.564104953
	COAD	PGR	(continuous)	1.051246525	0.923670821	1.196442748	0.448982066	448/101	11(2.4%)	0.450173786	0.448982066	0.449036264	0.044042061	0.504901047
	COAD	PGR	H (vs L)	1.014373541	0.685917206	1.500113529	0.943009376	225/52--223/49	11(2.4%)	0.943013518	0.943009376	0.943008901	0.159960524	0.487887145
	COAD	BMI	(continuous)	0.949362832	0.900469757	1.000910669	0.054076603	233/47	226(49.24%)	0.036637781	0.054076603	0.240405951	0.406750682	0.570586253
	COAD	cea_level_pretreatment	(continuous)	1.001062559	1.000494558	1.001630882	0.000245018	287/52	172(37.47%)	0.008366133	0.000245018	2.85E-06	0.830323175	0.7096812
	COAD	age_at_initial_pathologic_diagnosis	(continuous)	1.021032655	1.004566143	1.037769079	0.012102174	458/102	1(0.22%)	0.010146226	0.012102174	0.011701921	0.653608575	0.570507742
	COAD	gender	FEMALE (vs MALE)	0.889995181	0.601566896	1.316713779	0.559782885	216/46--243/56	1(0.22%)	0.559138079	0.559782885	0.559566025	0.045378665	0.49342816
	COAD	BMI_category	Over (vs Normal)	0.792855262	0.431099344	1.458177738	0.455274054	81/19--78/23	NA	NA	NA	NA	0.493020831	NA
	COAD	BMI_category	Obesity (vs Normal)	0.272978672	0.103612072	0.719195683	0.008617727	74/5--78/23	NA	NA	NA	NA	0.643890403	NA
	COAD	BMI_category	Global	NA	NA	NA	NA	NA	226(49.24%)	0.010937826	0.031739482	0.020946308	0.760539621	0.604278976
	COAD	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.936443931	0.746996128	5.019858817	0.173902165	178/29--76/5	NA	NA	NA	NA	0.20628991	NA
	COAD	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	3.41890033	1.330464809	8.785560795	0.010682436	129/32--76/5	NA	NA	NA	NA	0.978723169	NA
	COAD	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	9.100037919	3.533883284	23.43334045	4.74E-06	65/31--76/5	NA	NA	NA	NA	0.799104579	NA
	COAD	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	12(2.61%)	2.73E-09	9.17E-10	8.76E-12	0.083083362	0.696714666
	COAD	pathologic_stage_v2	StageIII/IV (vs StageI/II)	2.896918438	1.906232917	4.402471684	6.32E-07	194/63--254/34	12(2.61%)	2.81E-07	6.32E-07	1.85E-07	0.008813582	0.656719299
	COAD	histological_type	Colon_Mucinous_Adenocarcinoma (vs Colon_Adenocarcinoma)	1.42663377	0.845761383	2.406451696	0.182864775	62/17--392/82	6(1.31%)	0.200327293	0.182864775	0.180575606	0.667702736	0.519250995
	COAD	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	8.332156216	5.121339515	13.55598999	0	145/64--285/22	30(6.54%)	0	0	0	0.080274845	0.764529192
	COAD	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	8.892179752	4.61381138	17.13786157	6.68E-11	41/20--197/17	221(48.15%)	6.07E-10	6.68E-11	4.77E-15	0.237715957	0.757913998
	COAD	residual_tumor	R1 (vs R0)	1.458855721	0.34588374	6.153108029	0.607066293	4/2--331/50	NA	NA	NA	NA	0.562875446	NA
	COAD	residual_tumor	R2 (vs R0)	5.829493716	3.072672763	11.05975143	6.83E-08	26/12--331/50	NA	NA	NA	NA	0.850105452	NA
	COAD	residual_tumor	RX (vs R0)	1.229806195	0.487954624	3.099516233	0.660955901	25/5--331/50	NA	NA	NA	NA	0.645281297	NA
	COAD	residual_tumor	Global	NA	NA	NA	NA	NA	74(16.12%)	0.000136096	2.03E-06	4.14E-08	0.89989878	0.587058388
	COAD	new_tumor_event_dx_days_to	Yes (vs No)	2.041333471	1.368811067	3.044278674	0.000466027	88/40--371/62	1(0.22%)	0.000716659	0.000466027	0.000353869	0.000990052	0.539377026
	COAD	number_of_lymphnodes_positive_by_he	Yes (vs No)	2.371255226	1.59777762	3.519170175	1.82E-05	182/60--277/42	1(0.22%)	1.49E-05	1.82E-05	9.88E-06	0.014918353	0.632319049
	COAD	perineural_invasion_present	YES (vs NO)	1.489187061	0.830629016	2.669877958	0.181237512	46/13--413/89	1(0.22%)	0.202981042	0.181237512	0.178380347	0.292489306	0.517446885
	COAD	vascular_invasion_indicator	YES (vs NO)	2.395792764	1.588381832	3.613629199	3.09E-05	96/35--363/67	1(0.22%)	8.09E-05	3.09E-05	1.72E-05	0.3014618	0.609038531
	COAD	lymphovascular_invasion_indicator	YES (vs NO)	2.089160002	1.40770009	3.10051093	0.000254616	164/48--295/54	1(0.22%)	0.000318037	0.000254616	0.000186986	0.59333837	0.603060857
	COAD	mismatch_rep_proteins_tested_by_ihc	YES (vs NO)	0.161704698	0.039202157	0.667014562	0.011733577	56/2--287/53	117(25.49%)	0.000700259	0.011733577	0.00407191	0.651910664	0.568187433
	DLBC	AR	(continuous)	0.852048489	0.429243294	1.691317344	0.64716236	Sep-48	0(0%)	0.637379799	0.64716236	0.646640721	0.633042834	0.479338843
	DLBC	AR	H (vs L)	1.365565394	0.332942944	5.600866081	0.665247748	24/5--24/4	0(0%)	0.665586746	0.665247748	0.664072568	0.708156206	0.574380165
	DLBC	ESR1	(continuous)	1.420550544	0.667449095	3.023397388	0.362349166	Sep-48	0(0%)	0.363194425	0.362349166	0.359774687	0.934393867	0.55785124
	DLBC	ESR1	H (vs L)	0.762764722	0.178450119	3.260350986	0.71482595	24/6--24/3	0(0%)	0.71242034	0.71482595	0.714043507	0.941647934	0.54338843
	DLBC	ESR2	(continuous)	0.584369399	0.335552266	1.017688239	0.057693803	Sep-48	0(0%)	0.047669225	0.057693803	0.049663264	0.627008964	0.743801653
	DLBC	ESR2	H (vs L)	0.130593145	0.016013036	1.06504286	0.057287065	24/7--24/2	0(0%)	0.018203868	0.057287065	0.024981321	0.908374619	0.704545455
	DLBC	PGR	(continuous)	1.150173565	0.593093456	2.230507211	0.678846159	Sep-48	0(0%)	0.67502244	0.678846159	0.67838584	0.913696085	0.535123967
	DLBC	PGR	H (vs L)	0.942839221	0.234536167	3.790229061	0.933916817	24/4--24/5	0(0%)	0.933922401	0.933916817	0.933907514	0.99511591	0.506198347
	DLBC	BMI	(continuous)	0.963663613	0.845099465	1.098861848	0.580566497	Sep-48	0(0%)	0.565354818	0.580566497	0.579823563	0.890633727	0.57231405
	DLBC	age_at_initial_pathologic_diagnosis	(continuous)	0.989346495	0.941192401	1.039964289	0.673962075	Sep-48	0(0%)	0.675924347	0.673962075	0.673542049	0.606949028	0.506198347
	DLBC	gender	MALE (vs FEMALE)	1.039136627	0.249712116	4.324199182	0.957914043	22/5--26/4	0(0%)	0.957923039	0.957914043	0.957911768	0.854802278	0.516528926
	DLBC	clinical_stage_v2	StageIII/IV (vs StageI/II)	1.916660058	0.421513072	8.7152357	0.39981677	17/4--25/3	6(12.5%)	0.396858819	0.39981677	0.392103652	0.348815679	0.538674033
	DLBC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	6.251518384	1.387633528	28.16412353	0.01700803	9/4--37/5	2(4.17%)	0.019455879	0.01700803	0.006402223	0.524975146	0.672916667
	DLBC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	6.393793755	1.404258006	29.11188572	0.016442092	11/4--35/5	2(4.17%)	0.018795971	0.016442092	0.006202099	0.70791875	0.725206612
	DLBC	new_tumor_event_dx_days_to	Yes (vs No)	2.830576974	0.697301609	11.49024454	0.1455066	12/5--36/4	0(0%)	0.153885451	0.1455066	0.128975869	0.966755562	0.634297521
	ESCA	AR	(continuous)	0.908446965	0.784726218	1.051673654	0.198631818	184/77	1(0.54%)	0.195153009	0.198631818	0.198252204	0.216522258	0.561154405
	ESCA	AR	H (vs L)	0.889611387	0.568516631	1.39205852	0.608638588	92/40--92/37	1(0.54%)	0.608470908	0.608638588	0.608436168	0.058666897	0.542662792
	ESCA	ESR1	(continuous)	1.034170432	0.91679154	1.16657761	0.584639375	184/77	1(0.54%)	0.584905185	0.584639375	0.584572227	0.274619177	0.484084005
	ESCA	ESR1	H (vs L)	0.849581989	0.541213402	1.333650561	0.478619828	93/43--91/34	1(0.54%)	0.477467159	0.478619828	0.478139984	0.487194747	0.528794083
	ESCA	ESR2	(continuous)	0.92769444	0.7462778	1.153212616	0.49903983	184/77	1(0.54%)	0.499534712	0.49903983	0.49896539	0.253751877	0.539228636
	ESCA	ESR2	H (vs L)	0.816055592	0.521540346	1.276884396	0.373516186	92/40--92/37	1(0.54%)	0.373293656	0.373516186	0.372700488	0.087400311	0.552172764
	ESCA	PGR	(continuous)	0.967283572	0.859001175	1.089215633	0.582905119	184/77	1(0.54%)	0.582182067	0.582905119	0.582818913	0.497495734	0.539096553
	ESCA	PGR	H (vs L)	0.791651279	0.503157006	1.245559019	0.312322088	93/44--91/33	1(0.54%)	0.310199726	0.312322088	0.311248306	0.378339922	0.545568617
	ESCA	BMI	(continuous)	1.014320632	0.980766249	1.049022992	0.407421869	175/70	10(5.41%)	0.422506981	0.407421869	0.407818625	0.680542042	0.548126758
	ESCA	tobacco_smoking_history	(continuous)	1.142258794	0.914695846	1.426436075	0.240645529	166/61	19(10.27%)	0.241388446	0.240645529	0.239366189	0.322830636	0.526659697
	ESCA	age_at_initial_pathologic_diagnosis	(continuous)	1.001477372	0.983148317	1.020148139	0.875525496	185/77	0(0%)	0.875584442	0.875525496	0.875522721	0.047910643	0.550850785
	ESCA	tobacco_smoking_history_v2	No (vs Yes)	1.756862426	1.010313368	3.05505765	0.045899958	19/16--166/61	0(0%)	0.059082854	0.045899958	0.043117613	0.033222778	0.510274869
	ESCA	gender	FEMALE (vs MALE)	0.440333785	0.190895018	1.015709282	0.054428298	27/6--158/71	0(0%)	0.030932657	0.054428298	0.048024319	0.376073613	0.528992147
	ESCA	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	2.091737603	0.714922017	6.120060788	0.177879538	79/25--18/4	NA	NA	NA	NA	0.464429382	NA
	ESCA	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	5.247451364	1.745838224	15.77222072	0.003153358	56/27--18/4	NA	NA	NA	NA	0.509226803	NA
	ESCA	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	11.09260563	3.158336247	38.95908794	0.000173858	9/8--18/4	NA	NA	NA	NA	0.361624683	NA
	ESCA	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	23(12.43%)	2.39E-05	2.26E-05	3.09E-06	0.834607863	0.644438346
	ESCA	pathologic_stage_v2	StageIII/IV (vs StageI/II)	3.177406957	1.884421663	5.357566815	1.44E-05	65/35--97/29	23(12.43%)	1.29E-05	1.44E-05	5.20E-06	0.838838918	0.629345042
	ESCA	histological_grade	G2 (vs G1)	2.175937349	0.758625722	6.241158464	0.148141693	77/30--19/4	NA	NA	NA	NA	0.049354717	NA
	ESCA	histological_grade	G3 (vs G1)	2.946374196	1.024434891	8.474058215	0.04498955	49/26--19/4	NA	NA	NA	NA	0.290104332	NA
	ESCA	histological_grade	GX (vs G1)	2.88229112	0.958366598	8.668501298	0.059528444	40/17--19/4	NA	NA	NA	NA	0.351293461	NA
	ESCA	histological_grade	Global	NA	NA	NA	NA	NA	0(0%)	0.113291789	0.176541953	0.154942735	0.085945774	0.583573298
	ESCA	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	1.546793496	0.926969879	2.581065655	0.094983314	49/26--96/34	NA	NA	NA	NA	0.23152029	NA
	ESCA	histological_grade_v2	GX (vs G_1/2/Low)	1.500447092	0.836288832	2.692062107	0.173667148	40/17--96/34	NA	NA	NA	NA	0.189383955	NA
	ESCA	histological_grade_v2	Global	NA	NA	NA	NA	NA	0(0%)	0.179048616	0.181678014	0.177101	0.317191515	0.580039267
	ESCA	histological_type	Esophagus_Adenocarcinoma_NOS (vs Esophagus_Squamous_Cell_Carcinoma)	1.139781845	0.715455702	1.815769517	0.581854449	89/45--96/32	0(0%)	0.580858407	0.581854449	0.581614643	0.342243594	0.530628272
	ESCA	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	2.911439923	1.773510689	4.779493282	2.38E-05	78/51--100/24	7(3.78%)	9.64E-06	2.38E-05	9.76E-06	0.015194545	0.591815961
	ESCA	new_tumor_event_type	Distant_Metastasis (vs NO)	1.77567786	1.05954658	2.975831287	0.029292976	36/23--114/42	NA	NA	NA	NA	0.131928713	NA
	ESCA	new_tumor_event_type	Locoregional_Recurrence (vs NO)	0.858508412	0.450310637	1.636729476	0.643081218	33/12--114/42	NA	NA	NA	NA	0.000495732	NA
	ESCA	new_tumor_event_type	New_Primary_Tumor (vs NO)	1.16E-07	0	Inf	0.995350114	2/0--114/42	NA	NA	NA	NA	0.999895718	NA
	ESCA	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	0.042684595	0.109261061	0.053941812	0.006108976	0.595418848
	ESCA	new_tumor_event_dx_days_to	Yes (vs NO)	1.244095332	0.789843444	1.959594911	0.346085619	71/35--114/42	0(0%)	0.347808893	0.346085619	0.34515795	0.006463271	0.483769634
	ESCA	number_of_lymphnodes_positive_by_he	Yes (vs NO)	1.936694595	1.214112466	3.089323318	0.005532459	90/47--95/30	0(0%)	0.004746603	0.005532459	0.004758602	0.175088699	0.556675393
	ESCA	alcohol_history_documented	NO (vs YES)	1.291666472	0.807772407	2.065436083	0.285240016	53/27--129/50	3(1.62%)	0.291867658	0.285240016	0.283946756	0.105095692	0.503094141
	ESCA	esoph_non_ca_degree_of_dysplasia	Low_grade_dysplasia (vs Negative/no_dysplasia)	3.457426266	1.248634476	9.573495375	0.016973521	6/5--42/18	NA	NA	NA	NA	0.526010276	NA
	ESCA	esoph_non_ca_degree_of_dysplasia	High_grade_dysplasia (vs Negative/no_dysplasia)	1.10795024	0.573107587	2.141925466	0.760521927	30/18--42/18	NA	NA	NA	NA	0.605424322	NA
	ESCA	esoph_non_ca_degree_of_dysplasia	Global	NA	NA	NA	NA	NA	107(57.84%)	0.101975479	0.052836761	0.036842486	0.771120641	0.551925321
	GBM	AR	(continuous)	0.914552256	0.823692301	1.015434802	0.09431479	160/128	436(73.15%)	0.103406991	0.09431479	0.094099151	0.456113618	0.567148343
	GBM	AR	H (vs L)	0.776435768	0.547821621	1.100454014	0.155018538	80/68--80/60	436(73.15%)	0.154607003	0.155018538	0.153926592	0.162522582	0.550778092
	GBM	ESR1	(continuous)	1.096830761	0.915234647	1.314458236	0.316910234	160/128	436(73.15%)	0.318030152	0.316910234	0.316899279	0.350353228	0.514753436
	GBM	ESR1	H (vs L)	1.338954779	0.936721256	1.913909703	0.109301842	80/64--80/64	436(73.15%)	0.109147346	0.109301842	0.108112038	0.520604898	0.527687955
	GBM	ESR2	(continuous)	1.106150674	0.973935871	1.256314045	0.120343257	160/128	436(73.15%)	0.126461489	0.120343257	0.120044161	0.050264257	0.539561439
	GBM	ESR2	H (vs L)	1.065544676	0.750387665	1.513065191	0.72269809	81/68--79/60	436(73.15%)	0.722877277	0.72269809	0.722655065	0.160150439	0.52607114
	GBM	PGR	(continuous)	1.007705083	0.88507701	1.147323367	0.907700873	160/128	436(73.15%)	0.907721712	0.907700873	0.90770021	0.535259105	0.512075586
	GBM	PGR	H (vs L)	0.938231214	0.661748009	1.330231142	0.720379475	80/64--80/64	436(73.15%)	0.720426448	0.720379475	0.720335031	0.844679001	0.510610348
1	GBM	karnofsky_performance_score	(continuous)	0.974452839	0.967270497	0.981688513	7.07E-12	439/359	157(26.34%)	1.01E-10	7.07E-12	1.76E-11	0.02390047	0.602189734
	GBM	age_at_initial_pathologic_diagnosis	(continuous)	1.034097065	1.026857853	1.041387313	0	596/491	0(0%)	0	0	0	1.89E-05	0.653538256
	GBM	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	0.746548635	0.523244037	1.065152825	0.106985645	51/33--507/431	NA	NA	NA	NA	0.044411228	NA
	GBM	race	ASIAN (vs WHITE)	0.442731918	0.209608788	0.935130406	0.032698227	13/7--507/431	NA	NA	NA	NA	0.745178411	NA
	GBM	race	Global	NA	NA	NA	NA	NA	25(4.19%)	0.014755789	0.03141447	0.027603628	0.122522353	0.511003912
	GBM	gender	FEMALE (vs MALE)	0.828435982	0.688858659	0.996294621	0.045565199	230/184--366/307	0(0%)	0.044003055	0.045565199	0.045256958	0.090030856	0.511122423
	GBM	histological_type	Glioblastoma_Multiforme_(GBM) (vs Untreated_primary_(de_novo)_GBM)	0.980034942	0.63846005	1.504351742	0.926508896	31/22--545/450	NA	NA	NA	NA	0.207645255	NA
	GBM	histological_type	Treated_primary_GBM (vs Untreated_primary_(de_novo)_GBM)	0.527195389	0.332006493	0.837137178	0.006658964	20/19--545/450	NA	NA	NA	NA	0.029403238	NA
	GBM	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.011330907	0.025184957	0.022250729	0.037569789	0.514445204
	GBM	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.278784174	0.132053619	0.588553469	0.000807039	27/7--514/445	55(9.23%)	2.79E-05	0.000807039	0.000340371	0.105636562	0.514425863
	GBM	new_tumor_event_type	Progression_of_Disease (vs No)	0.692630694	0.56570875	0.84802874	0.00037643	256/227--230/166	NA	NA	NA	NA	2.37E-12	NA
	GBM	new_tumor_event_type	Recurrence (vs No)	0.563964928	0.437288775	0.727337307	1.02E-05	107/95--230/166	NA	NA	NA	NA	1.88E-11	NA
	GBM	new_tumor_event_type	Locoregional_Disease (vs No)	0.539003385	0.171858386	1.690488645	0.28926834	3/3--230/166	NA	NA	NA	NA	0.0443579	NA
	GBM	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	6.11E-05	4.75E-05	3.93E-05	3.75E-14	0.612054057
	GBM	new_tumor_event_dx_days_to	No (vs Yes)	1.856185615	1.531367489	2.249900865	2.94E-10	215/160--381/331	0(0%)	1.41E-09	2.94E-10	1.59E-10	8.10E-15	0.610847675
	GBM	history_of_neoadjuvant_treatment	Yes (vs No)	0.473496665	0.300817475	0.745299426	0.001237631	21/20--575/471	0(0%)	0.00030413	0.001237631	0.000960762	0.066992535	0.51876168
	HNSC	AR	(continuous)	0.952245332	0.885623785	1.023878521	0.186072612	519/220	9(1.7%)	0.180990666	0.186072612	0.185917672	0.829096438	0.524985628
	HNSC	AR	H (vs L)	0.819089713	0.627839914	1.068597176	0.141309004	260/114--259/106	9(1.7%)	0.141095271	0.141309004	0.140661259	0.606759585	0.520702788
	HNSC	ESR1	(continuous)	0.896660307	0.829840743	0.968860245	0.005769669	519/220	9(1.7%)	0.005248244	0.005769669	0.005790169	0.790083628	0.554771486
	HNSC	ESR1	H (vs L)	0.752708832	0.576202636	0.983283572	0.037195671	261/121--258/99	9(1.7%)	0.036588639	0.037195671	0.036573238	0.815707542	0.537927565
	HNSC	ESR2	(continuous)	0.961416846	0.845328031	1.093448128	0.548977094	519/220	9(1.7%)	0.548241764	0.548977094	0.549009323	0.094844528	0.541283415
	HNSC	ESR2	H (vs L)	0.771038463	0.589612924	1.008289145	0.057478531	261/124--258/96	9(1.7%)	0.056438866	0.057478531	0.056792939	0.215906881	0.544071572
	HNSC	PGR	(continuous)	0.998251744	0.926328177	1.075759724	0.963419192	519/220	9(1.7%)	0.963410142	0.963419192	0.963419205	0.903321861	0.511353837
	HNSC	PGR	H (vs L)	0.862394896	0.661286057	1.124664505	0.274499272	261/111--258/109	9(1.7%)	0.27454478	0.274499272	0.274066715	0.812029704	0.517555332
	HNSC	tobacco_smoking_history	(continuous)	0.966142403	0.857764039	1.088214359	0.570450538	514/214	14(2.65%)	0.570094194	0.570450538	0.570383455	0.820659754	0.50696066
	HNSC	age_at_initial_pathologic_diagnosis	(continuous)	1.020482894	1.008142718	1.03297412	0.0010891	527/223	1(0.19%)	0.001003645	0.0010891	0.001091723	0.984555162	0.556422268
	HNSC	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	1.60074496	1.035892682	2.473600278	0.034109516	48/23--452/189	NA	NA	NA	NA	0.886325191	NA
	HNSC	race	ASIAN (vs WHITE)	1.133893061	0.420509249	3.057515328	0.803915654	11/4--452/189	NA	NA	NA	NA	0.796505363	NA
	HNSC	race	AMERICAN_INDIAN_OR_ALASKA_NATIVE (vs WHITE)	0.653679878	0.091343672	4.677908962	0.672000547	2/1--452/189	NA	NA	NA	NA	0.102097166	NA
	HNSC	race	Global	NA	NA	NA	NA	NA	15(2.84%)	0.2344416	0.192260972	0.18509518	0.42757078	0.526216731
	HNSC	tobacco_smoking_history_v2	No (vs Yes)	1.898762236	0.961165083	3.750966501	0.064901685	13/9--515/214	1(0.19%)	0.091342792	0.064901685	0.060706044	0.076313007	0.512387246
	HNSC	gender	FEMALE (vs MALE)	1.376460131	1.038315805	1.824726622	0.026325837	142/72--386/151	1(0.19%)	0.029477204	0.026325837	0.025703645	0.899758512	0.53447098
	HNSC	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	2.072438805	0.722246672	5.946725356	0.175432201	74/26--27/4	NA	NA	NA	NA	0.724960898	NA
	HNSC	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	2.25321465	0.789432219	6.431174379	0.128986747	82/29--27/4	NA	NA	NA	NA	0.951008979	NA
	HNSC	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	3.745698434	1.385139023	10.12913255	0.009272126	270/133--27/4	NA	NA	NA	NA	0.739052447	NA
	HNSC	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	76(14.39%)	0.000206191	0.000827217	0.000499454	0.781124818	0.574237199
	HNSC	pathologic_stage_v2	StageIII/IV (vs StageI/II)	1.847054851	1.24937126	2.7306628	0.002097065	352/162--101/30	76(14.39%)	0.001005358	0.002097065	0.001785629	0.685190728	0.549197841
	HNSC	histological_grade	G2 (vs G1)	1.691077774	1.07833909	2.651989588	0.022108223	311/136--63/23	NA	NA	NA	NA	0.619286353	NA
	HNSC	histological_grade	G3 (vs G1)	1.403732124	0.86054491	2.289786219	0.174340868	125/56--63/23	NA	NA	NA	NA	0.175814554	NA
	HNSC	histological_grade	G4 (vs G1)	1.60E-07	0	Inf	0.992071369	7/0--63/23	NA	NA	NA	NA	0.999994661	NA
	HNSC	histological_grade	GX (vs G1)	0.933323183	0.379355524	2.296242201	0.880586542	18/7--63/23	NA	NA	NA	NA	0.826218075	NA
	HNSC	histological_grade	Global	NA	NA	NA	NA	NA	5(0.95%)	0.004572134	0.136692139	0.026705469	0.561825731	0.548673566
	HNSC	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	0.860866738	0.63296714	1.170821505	0.339659342	132/56--374/159	NA	NA	NA	NA	0.244870862	NA
	HNSC	histological_grade_v2	GX (vs G_1/2/Low)	0.615135663	0.271376103	1.394344898	0.244509963	18/7--374/159	NA	NA	NA	NA	0.520259359	NA
	HNSC	histological_grade_v2	Global	NA	NA	NA	NA	NA	5(0.95%)	0.322603579	0.354071136	0.349982068	0.382454811	0.515269169
	HNSC	laterality	Left (vs Right)	1.449620689	0.990940188	2.120612492	0.055738828	146/56--168/52	NA	NA	NA	NA	0.967773351	NA
	HNSC	laterality	Midline (vs Right)	1.829454456	0.989415159	3.382709042	0.054100354	34/13--168/52	NA	NA	NA	NA	0.936512625	NA
	HNSC	laterality	Global	NA	NA	NA	NA	NA	181(34.28%)	0.063636392	0.062198057	0.059247969	0.996717297	0.557881147
	HNSC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	7.049309954	5.209088932	9.539628039	0	163/130--335/67	31(5.87%)	0	0	0	0.839210667	0.717827812
	HNSC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	5.2147255	3.561745797	7.634840776	0	55/38--386/121	88(16.67%)	1.33E-13	0	0	0.789237746	0.610393339
	HNSC	margin_status	Positive (vs Negative)	1.737767968	1.21488894	2.485690182	0.002479821	60/38--357/148	NA	NA	NA	NA	0.477879322	NA
	HNSC	margin_status	Close (vs Negative)	1.368977229	0.854455834	2.193324194	0.191577708	50/20--357/148	NA	NA	NA	NA	0.70877372	NA
	HNSC	margin_status	Global	NA	NA	NA	NA	NA	62(11.74%)	0.011101907	0.007290371	0.006523166	0.751036947	0.538712605
	HNSC	new_tumor_event_after_initial_treatment	YES (vs NO)	2.133684428	1.454543929	3.129922135	0.000105916	49/31--150/36	1(0.19%)	0.000386721	0.000105916	7.21E-05	0.359766736	0.534735874
	HNSC	new_tumor_event_type	Locoregional_Recurrence (vs No)	1.815722967	1.117277298	2.950789297	0.016059341	29/18--458/188	NA	NA	NA	NA	0.365863971	NA
	HNSC	new_tumor_event_type	Distant_Metastasis (vs No)	1.805785855	1.003970554	3.247966325	0.04847341	20/12--458/188	NA	NA	NA	NA	0.185293129	NA
	HNSC	new_tumor_event_type	Locoregional_Disease (vs No)	0.602393235	0.192369219	1.886360047	0.384157791	11/3--458/188	NA	NA	NA	NA	0.804291199	NA
	HNSC	new_tumor_event_type	New_Primary_Tumor (vs No)	0.386586674	0.095917009	1.558110061	0.181424051	10/2--458/188	NA	NA	NA	NA	0.0152977	NA
	HNSC	new_tumor_event_type	Global	NA	NA	NA	NA	NA	1(0.19%)	0.018766618	0.016628102	0.01298774	0.089660264	0.53821434
	HNSC	new_tumor_event_dx_days_to	Yes (vs No)	2.211739424	1.690523206	2.89365521	7.08E-09	145/93--383/130	1(0.19%)	2.02E-08	7.08E-09	2.86E-09	0.003861493	0.567338659
	HNSC	postoperative_rx_tx	YES (vs NO)	1.43816499	0.961530615	2.151068833	0.076896228	66/28--462/195	1(0.19%)	0.090002351	0.076896228	0.075304052	0.256493021	0.51504315
	HNSC	number_of_lymphnodes_positive_by_he	Yes (vs No)	1.409188563	1.0823136	1.834784674	0.010852541	241/118--287/105	1(0.19%)	0.010806011	0.010852541	0.010473025	0.518003493	0.547597139
	HNSC	perineural_invasion_present	YES (vs NO)	1.583318475	1.212620095	2.067339478	0.000734121	172/94--356/129	1(0.19%)	0.000887021	0.000734121	0.0006592	0.153155971	0.566495183
	HNSC	extracapsular_spread_pathologic	Microscopic_Extension (vs No_Extranodal_Extension)	2.734619041	1.900608224	3.934604306	5.98E-08	77/47--248/82	NA	NA	NA	NA	0.87745506	NA
	HNSC	extracapsular_spread_pathologic	Gross_Extension (vs No_Extranodal_Extension)	2.588804825	1.620619293	4.13540086	6.88E-05	38/24--248/82	NA	NA	NA	NA	0.192029331	NA
	HNSC	extracapsular_spread_pathologic	Global	NA	NA	NA	NA	NA	166(31.44%)	4.43E-08	1.59E-08	3.81E-09	0.368441163	0.616202993
	HNSC	lymphovascular_invasion	YES (vs NO)	1.652644757	1.182775218	2.30917477	0.003245219	124/63--232/78	173(32.77%)	0.003717555	0.003245219	0.002939457	0.996812573	0.558703951
	KICH	AR	(continuous)	1.177282952	0.888310144	1.56026041	0.256050046	Sep-65	48(42.48%)	0.242996722	0.256050046	0.249901484	0.908689285	0.605381166
	KICH	AR	H (vs L)	1.561148742	0.389951416	6.249971913	0.529117632	32/3--33/6	48(42.48%)	0.520381399	0.529117632	0.52572792	0.885291326	0.552690583
	KICH	ESR1	(continuous)	1.036659277	0.695439856	1.545298918	0.859696687	Sep-65	48(42.48%)	0.860371589	0.859696687	0.859690144	0.664945397	0.542600897
	KICH	ESR1	H (vs L)	2.096301275	0.523946239	8.387270883	0.295429927	32/3--33/6	48(42.48%)	0.280582433	0.295429927	0.284501521	0.884480372	0.585201794
	KICH	ESR2	(continuous)	2.184408856	1.242205679	3.841265686	0.006666371	Sep-65	48(42.48%)	0.012633436	0.006666371	0.00535419	0.268140697	0.725336323
	KICH	ESR2	H (vs L)	4.539791313	0.941919604	21.88053533	0.059376466	34/2--31/7	48(42.48%)	0.036258692	0.059376466	0.038515758	0.240945257	0.689461883
	KICH	PGR	(continuous)	0.875900282	0.675759094	1.135317764	0.316778096	Sep-65	48(42.48%)	0.327606177	0.316778096	0.310707378	0.25022045	0.562780269
	KICH	PGR	H (vs L)	1.449913475	0.388871964	5.406018637	0.580065055	33/4--32/5	48(42.48%)	0.578541399	0.580065055	0.577897101	0.97092563	0.544843049
	KICH	age_at_initial_pathologic_diagnosis	(continuous)	1.068433385	1.018329962	1.121001976	0.006909147	112/12	1(0.88%)	0.004337062	0.006909147	0.00480083	0.786473304	0.70398773
	KICH	gender	FEMALE (vs MALE)	0.835517141	0.265031198	2.63398761	0.759031803	51/5--62/8	1(0.88%)	0.758017805	0.759031803	0.758718425	0.387813006	0.507668712
	KICH	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.31294332	0.184602992	9.337986018	0.78561129	33/2--54/3	NA	NA	NA	NA	0.073453417	NA
	KICH	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	4.620815018	0.844049787	25.29700469	0.077646698	19/4--54/3	NA	NA	NA	NA	0.06475292	NA
	KICH	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	23.64507525	4.288700728	130.3633942	0.000281729	7/4--54/3	NA	NA	NA	NA	0.05733174	NA
	KICH	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	1(0.88%)	0.001584013	0.000446555	6.31E-07	0.199646329	0.737218814
	KICH	pathologic_stage_v2	StageIII/IV (vs StageI/II)	6.816540658	2.051190308	22.65281108	0.001733529	26/8--87/5	1(0.88%)	0.001190489	0.001733529	0.000279095	0.337602778	0.711145194
	KICH	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	25.64444811	6.88945394	95.45571023	1.31E-06	16/10--96/3	2(1.77%)	1.58E-07	1.31E-06	7.22E-13	0.097323525	0.803480041
	KIRC	AR	(continuous)	0.802530827	0.750347059	0.858343776	1.43E-10	533/175	4(0.74%)	1.75E-09	1.43E-10	7.57E-11	0.691081731	0.657657895
	KIRC	AR	H (vs L)	0.400415438	0.29042011	0.552071009	2.33E-08	269/121--264/54	4(0.74%)	5.51E-09	2.33E-08	7.44E-09	0.976050607	0.608403509
	KIRC	ESR1	(continuous)	0.955382126	0.834483902	1.093795823	0.508477539	533/175	4(0.74%)	0.508240195	0.508477539	0.508769686	0.901861766	0.513789474
	KIRC	ESR1	H (vs L)	0.829322451	0.615472104	1.117476687	0.21870967	268/96--265/79	4(0.74%)	0.217661403	0.21870967	0.218044255	0.378130275	0.530026316
	KIRC	ESR2	(continuous)	1.25358884	1.133542955	1.386347974	1.08E-05	533/175	4(0.74%)	3.31E-05	1.08E-05	1.18E-05	0.213478691	0.588885965
	KIRC	ESR2	H (vs L)	1.897499881	1.399821117	2.572118504	3.67E-05	267/70--266/105	4(0.74%)	2.90E-05	3.67E-05	2.72E-05	0.778021347	0.576131579
	KIRC	PGR	(continuous)	0.898366143	0.806602646	1.000569154	0.051222176	533/175	4(0.74%)	0.049365136	0.051222176	0.051667602	0.85299205	0.52622807
	KIRC	PGR	H (vs L)	1.014756053	0.753755877	1.366131764	0.923077532	269/92--264/83	4(0.74%)	0.923087319	0.923077532	0.923076855	0.348963453	0.508824561
	KIRC	age_at_initial_pathologic_diagnosis	(continuous)	1.028105296	1.01548959	1.040877729	1.08E-05	537/177	0(0%)	9.94E-06	1.08E-05	9.54E-06	0.39001313	0.592342226
	KIRC	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	0.880529758	0.477290444	1.624446215	0.683860397	56/11--466/163	NA	NA	NA	NA	0.265923254	NA
	KIRC	race	ASIAN (vs WHITE)	0.52923379	0.073944607	3.78781384	0.526283186	8/1--466/163	NA	NA	NA	NA	0.282670801	NA
	KIRC	race	Global	NA	NA	NA	NA	NA	7(1.3%)	0.720519752	0.757230411	0.752183738	0.310387771	0.512943651
	KIRC	tobacco_smoking_history_v2	Yes (vs No)	0.36748374	0.207779298	0.649941067	0.000579546	87/13--450/164	0(0%)	7.71E-05	0.000579546	0.000345755	0.320126238	0.549254347
	KIRC	gender	FEMALE (vs MALE)	1.040646397	0.766464423	1.412909577	0.798451135	191/65--346/112	0(0%)	0.798803406	0.798451135	0.798438138	0.919643568	0.505719249
	KIRC	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.199876966	0.647138502	2.224724271	0.562960765	57/13--269/45	NA	NA	NA	NA	0.821838971	NA
	KIRC	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	2.705635246	1.811691885	4.040677193	1.15E-06	125/51--269/45	NA	NA	NA	NA	0.000592007	NA
	KIRC	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	6.574349316	4.502293068	9.600012322	0	83/67--269/45	NA	NA	NA	NA	4.80E-05	NA
	KIRC	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	3(0.56%)	0	0	0	0.00010016	0.730388238
	KIRC	pathologic_stage_v2	StageIII/IV (vs StageI/II)	3.908176163	2.852975682	5.353652685	0	208/118--326/58	3(0.56%)	0	0	0	3.54E-06	0.698185673
	KIRC	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	2.676754232	1.907089535	3.757040814	1.25E-08	285/131--244/45	NA	NA	NA	NA	0.025624924	NA
	KIRC	histological_grade_v2	GX (vs G_1/2/Low)	0.944073155	0.129895573	6.861466501	0.954649152	5/1--244/45	NA	NA	NA	NA	0.04344708	NA
	KIRC	histological_grade_v2	Global	NA	NA	NA	NA	NA	3(0.56%)	7.34E-09	6.75E-08	1.71E-08	0.017949052	0.6252675
	KIRC	laterality	Left (vs Right)	1.444324884	1.073610389	1.943046	0.015128198	253/98--283/79	NA	NA	NA	NA	0.537201611	NA
	KIRC	laterality	Bilateral (vs Right)	2.68E-06	0	Inf	0.993620185	1/0--283/79	NA	NA	NA	NA	0.999540133	NA
	KIRC	laterality	Global	NA	NA	NA	NA	NA	0(0%)	0.042921865	0.052299355	0.046207855	0.826648565	0.542055834
	KIRC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	5.029585667	3.637210636	6.954981307	0	159/110--353/55	25(4.66%)	0	0	0	0.171538018	0.702141504
	KIRC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	6.241780807	1.963224477	19.84481556	0.001915445	19/6--120/6	398(74.12%)	0.003243481	0.001915445	0.000414888	0.07714182	0.748720573
	KIRC	new_tumor_event_dx_days_to	Yes (vs NO)	2.319295734	1.722469292	3.122919362	2.99E-08	127/78--410/99	0(0%)	7.45E-08	2.99E-08	1.16E-08	0.527133262	0.598061475
	KIRC	history_of_neoadjuvant_treatment	Yes (vs No)	2.007557969	1.059730686	3.803125692	0.032521956	18/10--519/167	0(0%)	0.052831071	0.032521956	0.029150572	0.345833949	0.511292292
	KIRC	lymph_nodes_examined_positive	Yes (vs NO)	3.216385658	1.787398595	5.787817408	9.72E-05	18/12--519/165	0(0%)	0.000876731	9.72E-05	3.75E-05	0.35023382	0.52797702
	KIRC	serum_calcium_level	Low (vs Normal)	0.789860716	0.558358081	1.1173474	0.182537824	204/66--151/62	NA	NA	NA	NA	0.261673957	NA
	KIRC	serum_calcium_level	Elevated (vs Normal)	3.836577354	1.89585953	7.763932696	0.00018509	10/9--151/62	NA	NA	NA	NA	0.514206013	NA
	KIRC	serum_calcium_level	Global	NA	NA	NA	NA	NA	172(32.03%)	0.000919824	5.52E-05	9.17E-06	0.496176003	0.563076973
	KIRC	hemoglobin_level	Low (vs Normal)	2.239392434	1.57647113	3.181078536	6.74E-06	263/118--186/43	NA	NA	NA	NA	0.115563101	NA
	KIRC	hemoglobin_level	Elevated (vs Normal)	5.887674916	1.819640046	19.05031492	0.003084517	5/3--186/43	NA	NA	NA	NA	0.83018427	NA
	KIRC	hemoglobin_level	Global	NA	NA	NA	NA	NA	83(15.46%)	2.73E-06	5.28E-06	2.03E-06	0.287137186	0.58230931
	KIRC	platelet_count	Low (vs Normal)	1.637163486	1.014890072	2.640979898	0.043326901	46/20--360/108	NA	NA	NA	NA	0.74118268	NA
	KIRC	platelet_count	Elevated (vs Normal)	3.815628355	2.54084287	5.729996104	1.08E-10	38/30--360/108	NA	NA	NA	NA	0.373744497	NA
	KIRC	platelet_count	Global	NA	NA	NA	NA	NA	93(17.32%)	5.34E-08	6.41E-10	3.27E-11	0.592113048	0.593997562
	KIRC	white_cell_count	Low (vs Normal)	2.032371221	0.891899189	4.63116553	0.091465579	9/6--268/104	NA	NA	NA	NA	0.574139451	NA
	KIRC	white_cell_count	Elevated (vs Normal)	0.760290616	0.536802864	1.076823279	0.122785289	164/46--268/104	NA	NA	NA	NA	0.091537612	NA
	KIRC	white_cell_count	Global	NA	NA	NA	NA	NA	96(17.88%)	0.067436655	0.049430464	0.043782014	0.176356203	0.554950176
	KIRP	AR	(continuous)	0.932693036	0.812148114	1.071130111	0.323733652	289/44	2(0.69%)	0.331184045	0.323733652	0.323667548	0.341579168	0.565474409
	KIRP	AR	H (vs L)	0.815863758	0.450284372	1.478251773	0.502169952	145/24--144/20	2(0.69%)	0.501227557	0.502169952	0.501439226	0.503698934	0.548338821
	KIRP	ESR1	(continuous)	0.92276275	0.769778336	1.106151022	0.384772392	289/44	2(0.69%)	0.38858638	0.384772392	0.384413294	0.876132784	0.536366357
	KIRP	ESR1	H (vs L)	0.956649041	0.52915566	1.729505053	0.883376766	146/23--143/21	2(0.69%)	0.883342746	0.883376766	0.883367345	0.446823828	0.485483388
	KIRP	ESR2	(continuous)	1.34887042	1.040975213	1.74783356	0.02359084	289/44	2(0.69%)	0.025468325	0.02359084	0.023688162	0.886252317	0.562256809
	KIRP	ESR2	H (vs L)	0.961019915	0.529990459	1.742596044	0.895821002	145/24--144/20	2(0.69%)	0.895762903	0.895821002	0.895814294	0.530354332	0.502544148
	KIRP	PGR	(continuous)	1.128594548	0.981106419	1.298254327	0.090451944	289/44	2(0.69%)	0.09509804	0.090451944	0.089384513	0.453519422	0.613663574
	KIRP	PGR	H (vs L)	1.508802244	0.827512139	2.750997966	0.179544356	147/19--142/25	2(0.69%)	0.176924055	0.179544356	0.176598347	0.652681297	0.569814427
	KIRP	BMI	(continuous)	1.003955885	0.997983778	1.00996373	0.194645264	212/30	79(27.15%)	0.285080333	0.194645264	0.164863382	0.406598586	0.415591256
	KIRP	tobacco_smoking_history	(continuous)	0.742846237	0.558531407	0.987984783	0.041048291	247/39	44(15.12%)	0.03169146	0.041048291	0.038142053	0.232703367	0.568711542
	KIRP	age_at_initial_pathologic_diagnosis	(continuous)	1.005439443	0.979776316	1.03177476	0.680915579	288/44	3(1.03%)	0.680165215	0.680915579	0.680886392	0.044804701	0.48315201
	KIRP	BMI_category	Over (vs Normal)	0.7990426	0.341135218	1.871601179	0.605432293	86/13--51/9	NA	NA	NA	NA	0.600430283	NA
	KIRP	BMI_category	Obesity (vs Normal)	0.699075908	0.268799043	1.818113337	0.462881515	76/8--51/9	NA	NA	NA	NA	0.857214263	NA
	KIRP	BMI_category	Global	NA	NA	NA	NA	NA	79(27.15%)	0.758884038	0.75498858	0.753437699	0.754757879	0.537002897
	KIRP	tobacco_smoking_history_v2	No (vs Yes)	0.593296556	0.233114897	1.509988455	0.273370253	43/5--248/39	1(0.34%)	0.242070749	0.273370253	0.268010388	0.032531248	0.556460045
	KIRP	gender	FEMALE (vs MALE)	1.634379142	0.847625116	3.151387481	0.14251897	77/13--214/31	1(0.34%)	0.156440538	0.14251897	0.138623055	0.521151142	0.562658701
	KIRP	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	0.975297097	0.217433382	4.374693613	0.973941947	21/2--173/12	NA	NA	NA	NA	0.361061816	NA
	KIRP	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	4.597585171	2.173968231	9.723136293	6.55E-05	52/16--173/12	NA	NA	NA	NA	0.04049146	NA
	KIRP	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	16.34751691	6.794363478	39.33279548	4.45E-10	15/9--173/12	NA	NA	NA	NA	3.56E-05	NA
	KIRP	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	31(10.65%)	2.00E-08	1.79E-09	1.54E-14	9.00E-05	0.823720326
	KIRP	pathologic_stage_v2	StageIII/IV (vs StageI/II)	6.203392408	3.222581748	11.94138129	4.71E-08	67/25--194/14	31(10.65%)	2.56E-08	4.71E-08	4.18E-10	0.000279109	0.784959199
	KIRP	clinical_stage	Stage_II (vs Stage_I)	0.564874883	0.072850692	4.379967091	0.584689282	21/1--139/11	NA	NA	NA	NA	0.471179838	NA
	KIRP	clinical_stage	Stage_III (vs Stage_I)	6.588594017	2.904200474	14.94716756	6.46E-06	29/12--139/11	NA	NA	NA	NA	0.003368857	NA
	KIRP	clinical_stage	Stage_IV (vs Stage_I)	19.66624435	7.472345845	51.75900244	1.60E-09	11/7--139/11	NA	NA	NA	NA	0.001892333	NA
	KIRP	clinical_stage	Global	NA	NA	NA	NA	NA	91(31.27%)	1.01E-08	1.22E-09	3.33E-16	0.001733836	0.849078341
	KIRP	clinical_stage_v2	StageIII/IV (vs StageI/II)	9.226109792	4.469888211	19.04322835	1.86E-09	40/19--160/12	91(31.27%)	2.89E-09	1.86E-09	2.76E-13	1.00E-04	0.8234447
	KIRP	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	15.2679421	7.748135927	30.08595333	3.33E-15	47/28--229/12	16(5.5%)	2.22E-16	3.33E-15	0	0.002892627	0.844822006
	KIRP	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	7.093691596	3.056211223	16.46498124	5.11E-06	14/8--185/17	92(31.62%)	9.44E-05	5.11E-06	1.02E-07	0.935934659	0.640286449
	KIRP	new_tumor_event_dx_days_to	Yes (vs No)	4.737756617	2.612847878	8.590755686	3.01E-07	53/24--238/20	1(0.34%)	5.65E-07	3.01E-07	1.63E-08	0.008044558	0.727557879
	KIRP	lymph_nodes_examined_positive	Yes (vs NO)	8.950097552	4.909039536	16.31770239	8.53E-13	29/19--262/25	1(0.34%)	2.08E-10	8.53E-13	0	0.000486725	0.749439881
	KIRP	hemoglobin_level	Low (vs Normal)	4.340036625	1.860069508	10.12645916	0.000684751	97/23--112/7	NA	NA	NA	NA	0.568548652	NA
	KIRP	hemoglobin_level	Elevated (vs Normal)	1.64E-06	0	Inf	0.99807807	1/0--112/7	NA	NA	NA	NA	0.99984067	NA
	KIRP	hemoglobin_level	Global	NA	NA	NA	NA	NA	81(27.84%)	0.0008809	0.00313509	0.001006261	0.849966376	0.67325228
	LAML	AR	(continuous)	0.924964567	0.869401126	0.984079069	0.013597896	161/103	39(19.5%)	0.012545715	0.013597896	0.012891343	0.801033513	0.563734763
	LAML	AR	H (vs L)	0.620741017	0.419694548	0.918094866	0.016945028	78/59--83/44	39(19.5%)	0.016197223	0.016945028	0.015941363	0.609357616	0.554802438
	LAML	ESR1	(continuous)	1.063582314	0.957415086	1.181522367	0.250604652	161/103	39(19.5%)	0.253533603	0.250604652	0.250134832	0.346869724	0.526586801
	LAML	ESR1	H (vs L)	1.721907806	1.162901277	2.549628719	0.006656648	82/45--79/58	39(19.5%)	0.006367362	0.006656648	0.006041425	0.650256597	0.563629676
	LAML	ESR2	(continuous)	1.006370902	0.865315783	1.170419415	0.934308697	161/103	39(19.5%)	0.934375591	0.934308697	0.934308801	0.698881499	0.489754098
	LAML	ESR2	H (vs L)	0.975318812	0.662274236	1.43633367	0.89930547	80/50--81/53	39(19.5%)	0.899318972	0.89930547	0.899302891	0.238523055	0.51550021
	LAML	PGR	(continuous)	0.924071384	0.751776651	1.13585321	0.453231676	161/103	39(19.5%)	0.445369738	0.453231676	0.452898323	0.047105157	0.545187053
	LAML	PGR	H (vs L)	0.788644186	0.531884123	1.169351792	0.237410865	97/61--64/42	39(19.5%)	0.234544632	0.237410865	0.236325001	0.191418394	0.543505675
	LAML	wbc_24hr_of_banking	(continuous)	1.003717436	0.99973894	1.007711765	0.067083109	185/120	15(7.5%)	0.081353682	0.067083109	0.066642219	0.485856919	0.560974656
	LAML	metamyelocytes_24hr_of_banking	(continuous)	1.145219103	0.983592756	1.333404283	0.08066487	186/120	14(7%)	0.103797425	0.08066487	0.0783032	0.2454865	0.527084625
	LAML	basophils_count	(continuous)	0.971761721	0.868890943	1.086811699	0.615842382	186/120	14(7%)	0.603099202	0.615842382	0.61544042	0.658746076	0.486089585
	LAML	basophils_count.1	(continuous)	1.119755937	0.991107431	1.265103377	0.069291553	186/120	14(7%)	0.104033344	0.069291553	0.064721678	0.611769823	0.513484191
	LAML	age_at_initial_pathologic_diagnosis	(continuous)	1.043541125	1.02911422	1.058170277	1.97E-09	186/120	14(7%)	1.90E-10	1.97E-09	9.75E-10	0.078523823	0.691723497
	LAML	gender	FEMALE (vs MALE)	1.087806962	0.759394457	1.558246806	0.646245515	91/63--109/70	14(7%)	0.646594543	0.646245515	0.646149329	0.529235729	0.503913515
	LAML	history_neoadjuvant_hydroxyurea_tx	YES (vs NO)	1.497615044	0.990604024	2.264124481	0.055467386	49/35--151/98	14(7%)	0.063743955	0.055467386	0.05384128	0.123578879	0.523984811
	LAML	fab_category	M1 (vs M0_Undifferentiated)	1.041733929	0.523032811	2.074840345	0.907408152	44/31--19/14	NA	NA	NA	NA	0.774003764	NA
	LAML	fab_category	M2 (vs M0_Undifferentiated)	1.046929344	0.527319071	2.078553784	0.895722765	44/29--19/14	NA	NA	NA	NA	0.876355867	NA
	LAML	fab_category	M3 (vs M0_Undifferentiated)	0.298801921	0.111621453	0.79986943	0.01619672	21/7--19/14	NA	NA	NA	NA	0.123229851	NA
	LAML	fab_category	M4 (vs M0_Undifferentiated)	1.025259401	0.522709065	2.010978784	0.942143664	42/30--19/14	NA	NA	NA	NA	0.314530038	NA
	LAML	fab_category	M5 (vs M0_Undifferentiated)	1.466192045	0.683745474	3.144034139	0.325512753	22/15--19/14	NA	NA	NA	NA	0.181344878	NA
	LAML	fab_category	M6 (vs M0_Undifferentiated)	2.464739271	0.685453036	8.862663605	0.167109466	3/3--19/14	NA	NA	NA	NA	0.236545074	NA
	LAML	fab_category	M7 (vs M0_Undifferentiated)	2.312517471	0.646243795	8.275107773	0.197467866	3/3--19/14	NA	NA	NA	NA	0.301048743	NA
	LAML	fab_category	Global	NA	NA	NA	NA	NA	16(8%)	0.010513411	0.039703926	0.020163491	0.047631704	0.586000786
	LAML	cyto_risk_group	Poor (vs Intermediate/Normal)	1.41200188	0.916103677	2.176335887	0.118054274	43/34--116/82	NA	NA	NA	NA	0.662313634	NA
	LAML	cyto_risk_group	Favorable (vs Intermediate/Normal)	0.369840074	0.204831572	0.667776352	0.000968989	38/14--116/82	NA	NA	NA	NA	0.877111796	NA
	LAML	cyto_risk_group	Global	NA	NA	NA	NA	NA	17(8.5%)	5.81E-05	0.000360548	0.000170085	0.906616448	0.599628763
	LGG	AR	(continuous)	1.175158772	1.05676997	1.306810544	0.002890497	514/125	1(0.19%)	0.002250647	0.002890497	0.002743817	0.673226081	0.585711728
	LGG	AR	H (vs L)	1.345353913	0.939700682	1.926120929	0.105173236	257/50--257/75	1(0.19%)	0.102397113	0.105173236	0.103923286	0.302291195	0.545353626
	LGG	ESR1	(continuous)	1.249773573	1.036571993	1.506826341	0.019473096	514/125	1(0.19%)	0.020870258	0.019473096	0.019656373	0.039749834	0.589525515
	LGG	ESR1	H (vs L)	1.661837303	1.159726798	2.38133949	0.005651998	260/49--254/76	1(0.19%)	0.005054696	0.005651998	0.005160526	0.325069824	0.57652641
	LGG	ESR2	(continuous)	1.443317468	1.145083534	1.81922563	0.001889119	514/125	1(0.19%)	0.001954958	0.001889119	0.002197787	0.028237238	0.578549687
	LGG	ESR2	H (vs L)	1.196593397	0.836833255	1.711016799	0.325274517	259/56--255/69	1(0.19%)	0.324371721	0.325274517	0.32465647	0.043783236	0.545496867
	LGG	PGR	(continuous)	0.851059353	0.74597556	0.970946048	0.016464397	514/125	1(0.19%)	0.019124785	0.016464397	0.016863905	0.022480281	0.58431513
	LGG	PGR	H (vs L)	0.724293499	0.508794881	1.031065941	0.073425882	260/68--254/57	1(0.19%)	0.072690023	0.073425882	0.072210043	0.212100972	0.551101164
	LGG	eastern_cancer_oncology_group	(continuous)	1.898980171	1.324444952	2.722744864	0.000485892	149/30	366(71.07%)	0.003472937	0.000485892	0.000437874	0.395528937	0.713576159
	LGG	karnofsky_performance_score	(continuous)	0.959643191	0.943815233	0.975736588	1.21E-06	295/87	220(42.72%)	7.38E-06	1.21E-06	8.24E-07	0.005409177	0.69544685
	LGG	age_at_initial_pathologic_diagnosis	(continuous)	1.058336933	1.043359313	1.073529559	6.33E-15	514/125	1(0.19%)	7.66E-15	6.33E-15	8.88E-16	0.008291532	0.747663384
	LGG	gender	FEMALE (vs MALE)	0.916038609	0.642069737	1.306909024	0.628610578	230/54--285/71	1(0.19%)	0.627979526	0.628610578	0.628503063	0.784210788	0.516293644
	LGG	histological_grade_v2	G_1/2/Low (vs G_3/4/High)	0.299426054	0.202418233	0.442924339	1.57E-09	249/37--265/88	2(0.39%)	1.82E-10	1.57E-09	1.87E-10	0.033479013	0.663239305
	LGG	histological_type	Oligodendroglioma (vs Astrocytoma)	0.560924944	0.375405746	0.838124606	0.004775077	191/42--194/58	NA	NA	NA	NA	0.141419247	NA
	LGG	histological_type	Oligoastrocytoma (vs Astrocytoma)	0.606070926	0.378969895	0.969264241	0.036593121	130/25--194/58	NA	NA	NA	NA	0.447427519	NA
	LGG	histological_type	Global	NA	NA	NA	NA	NA	1(0.19%)	0.010470661	0.009486998	0.008450115	0.328451811	0.594592659
	LGG	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.061325532	0.022608399	0.166346184	4.18E-08	212/4--269/113	35(6.8%)	0	4.18E-08	1.10E-13	0.873910382	0.677022552
	LGG	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	1.182591314	0.374680375	3.732573978	0.774893972	63/5--135/7	NA	NA	NA	NA	0.856187783	NA
	LGG	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	3.188330654	1.401183945	7.254902113	0.005708307	146/31--135/7	NA	NA	NA	NA	0.631692857	NA
	LGG	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	8.504572801	3.885910912	18.61281953	8.48E-08	101/68--135/7	NA	NA	NA	NA	0.161806533	NA
	LGG	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	71(13.79%)	7.56E-14	2.10E-11	2.72E-14	0.00363138	0.756386694
	LGG	treatment_outcome_first_course_v2	Complete_Remission/Response (vs Uncomplete_Remission/Response)	0.21511645	0.099751789	0.463902328	8.90E-05	135/7--310/104	71(13.79%)	9.80E-07	8.90E-05	1.64E-05	0.545071184	0.610710347
	LGG	new_tumor_event_dx_days_to	Yes (vs NO)	2.602768849	1.751139334	3.868570336	2.24E-06	165/89--350/36	1(0.19%)	7.43E-07	2.24E-06	1.01E-06	0.144759155	0.585138765
	LGG	radiation_therapy	YES (vs NO)	1.429900901	0.970897745	2.105903116	0.070227267	142/38--373/87	1(0.19%)	0.077013801	0.070227267	0.06883334	0.774573105	0.536007162
	LGG	targeted_molecular_therapy	YES (vs NO)	1.261193264	0.841036009	1.891248925	0.26163693	138/33--377/92	1(0.19%)	0.269904653	0.26163693	0.260616144	0.963865916	0.520483438
	LGG	history_neoadjuvant_steroid_tx	YES (vs NO)	1.27058065	0.883657836	1.826923411	0.196206013	151/48--364/77	1(0.19%)	0.200654218	0.196206013	0.195167776	0.445429583	0.519015219
	LGG	history_neoadjuvant_medication	NO (vs YES)	0.863507862	0.604319522	1.233860235	0.420294823	250/56--265/69	1(0.19%)	0.41920221	0.420294823	0.419892846	0.115425746	0.503115488
	LGG	firstsymptomlongestduration	31-90Days (vs 0-30Days)	1.056898202	0.637510776	1.752180279	0.830116007	77/21--219/56	NA	NA	NA	NA	0.529242074	NA
	LGG	firstsymptomlongestduration	91-180Days (vs 0-30Days)	1.300902335	0.69611838	2.431119379	0.409628429	37/12--219/56	NA	NA	NA	NA	0.623186613	NA
	LGG	firstsymptomlongestduration	>181Days (vs 0-30Days)	0.59112216	0.361847041	0.965671593	0.035776438	111/23--219/56	NA	NA	NA	NA	0.493238419	NA
	LGG	firstsymptomlongestduration	Global	NA	NA	NA	NA	NA	71(13.79%)	0.06848743	0.086266105	0.079467665	0.745135124	0.554955587
	LGG	histor_hay_fever	YES (vs NO)	0.409067773	0.150744453	1.110066998	0.079267136	37/4--478/121	1(0.19%)	0.042566075	0.079267136	0.069686662	0.657320001	0.526589078
	LGG	idh1_mutation_found	NO (vs YES)	4.950025086	1.891587409	12.95353746	0.001119404	38/14--91/7	386(74.95%)	0.000563596	0.001119404	0.000316434	0.744011222	0.717817164
	LIHC	AR	(continuous)	0.932889027	0.876568098	0.992828666	0.028779774	370/130	7(1.86%)	0.032229718	0.028779774	0.028360002	0.146631722	0.579314974
	LIHC	AR	H (vs L)	0.68538083	0.484098004	0.970354926	0.033204261	187/73--183/57	7(1.86%)	0.032377493	0.033204261	0.032191823	0.380069978	0.558089329
	LIHC	ESR1	(continuous)	0.883203128	0.821175188	0.949916384	0.000829001	370/130	7(1.86%)	0.000853304	0.000829001	0.000792929	0.01119083	0.623888828
	LIHC	ESR1	H (vs L)	0.512745769	0.360167904	0.729960169	0.000210061	185/79--185/51	7(1.86%)	0.000168473	0.000210061	0.000160312	0.023103654	0.605293712
	LIHC	ESR2	(continuous)	1.009083778	0.866007268	1.175798527	0.907722259	370/130	7(1.86%)	0.907903419	0.907722259	0.907723949	0.920977528	0.51001415
	LIHC	ESR2	H (vs L)	0.898857984	0.634874227	1.272607457	0.547792433	187/68--183/62	7(1.86%)	0.547487993	0.547792433	0.547610624	0.665875086	0.508544683
	LIHC	PGR	(continuous)	0.979559931	0.89939183	1.066873889	0.635461635	370/130	7(1.86%)	0.634393774	0.635461635	0.63544013	0.30578049	0.530495991
	LIHC	PGR	H (vs L)	0.884725361	0.626835389	1.248715336	0.486037181	185/65--185/65	7(1.86%)	0.486169936	0.486037181	0.485768278	0.091162993	0.532001742
	LIHC	BMI	(continuous)	1.001854729	0.973016248	1.031547932	0.901041373	340/114	37(9.81%)	0.901360271	0.901041373	0.901044513	0.513181169	0.436687677
	LIHC	age_at_initial_pathologic_diagnosis	(continuous)	1.012617609	0.999000321	1.026420513	0.069497467	376/132	1(0.27%)	0.064182107	0.069497467	0.069262498	0.182147774	0.527982639
	LIHC	BMI_category	Over (vs Normal)	0.807565245	0.518215404	1.258475953	0.345035486	92/29--180/61	NA	NA	NA	NA	0.322032411	NA
	LIHC	BMI_category	Obesity (vs Normal)	0.89643513	0.558128011	1.439805789	0.651106317	69/24--180/61	NA	NA	NA	NA	0.445139036	NA
	LIHC	BMI_category	Global	NA	NA	NA	NA	NA	37(9.81%)	0.625707343	0.630131391	0.629233849	0.542950167	0.543055857
	LIHC	gender	FEMALE (vs MALE)	1.21660051	0.855206751	1.730712252	0.27561759	122/51--255/81	1(0.27%)	0.279503755	0.27561759	0.274875126	0.207041164	0.506916264
	LIHC	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.366487094	0.840713223	2.221074829	0.207711574	87/26--175/44	NA	NA	NA	NA	0.80698758	NA
	LIHC	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	2.590011463	1.706191219	3.931657426	7.87E-06	86/45--175/44	NA	NA	NA	NA	0.862083522	NA
	LIHC	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	5.44522576	1.682263329	17.62535215	0.004685706	5/3--175/44	NA	NA	NA	NA	0.390703625	NA
	LIHC	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	25(6.63%)	4.19E-05	1.52E-05	4.93E-06	0.820385343	0.608957055
	LIHC	pathologic_stage_v2	StageIII/IV (vs StageI/II)	2.408895203	1.665632576	3.483827216	3.01E-06	91/48--262/70	25(6.63%)	7.24E-06	3.01E-06	1.44E-06	0.678548511	0.590777096
	LIHC	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	1.082825075	0.756338459	1.550245303	0.663833945	137/48--235/80	6(1.59%)	0.664899768	0.663833945	0.663751799	0.062032412	0.527946337
	LIHC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	2.33573004	1.604077951	3.401103303	9.66E-06	154/80--202/43	22(5.84%)	5.10E-06	9.66E-06	5.25E-06	1.11E-06	0.549662431
	LIHC	residual_tumor	R1 (vs R0)	1.448369704	0.70576541	2.972340056	0.312531139	17/8--330/112	NA	NA	NA	NA	0.11971559	NA
	LIHC	residual_tumor	R2 (vs R0)	10.73051031	1.464996094	78.5966952	0.019500669	1/1--330/112	NA	NA	NA	NA	0.768632189	NA
	LIHC	residual_tumor	RX (vs R0)	3.146056368	1.512561033	6.543650444	0.002159142	22/8--330/112	NA	NA	NA	NA	0.603283215	NA
	LIHC	residual_tumor	Global	NA	NA	NA	NA	NA	8(2.12%)	0.015195471	0.001990088	0.000353219	0.407904787	0.535776068
	LIHC	new_tumor_event_type	Intrahepatic_Recurrence (vs NO)	0.91482425	0.57595061	1.453081902	0.706108099	76/28--199/51	NA	NA	NA	NA	0.000326184	NA
	LIHC	new_tumor_event_type	Locoregional_Recurrence (vs NO)	1.706138773	1.09462948	2.659264679	0.018311681	62/32--199/51	NA	NA	NA	NA	0.018013937	NA
	LIHC	new_tumor_event_type	Extrahepatic_Recurrence (vs NO)	1.356601485	0.761964783	2.415292188	0.30007981	29/15--199/51	NA	NA	NA	NA	0.001171429	NA
	LIHC	new_tumor_event_type	New_Primary_Tumor (vs NO)	1.558238357	0.663921463	3.657219887	0.308204915	11/6--199/51	NA	NA	NA	NA	0.268889463	NA
	LIHC	new_tumor_event_type	Global	NA	NA	NA	NA	NA	1(0.27%)	0.097513345	0.083069102	0.076794413	0.000896019	0.56212287
	LIHC	new_tumor_event_dx_days_to	YES (vs NO)	1.250013278	0.879454662	1.776706933	0.213526268	179/81--198/51	1(0.27%)	0.210160507	0.213526268	0.212596016	9.43E-05	0.482903419
	LIHC	eastern_cancer_oncology_group	1 (vs 0)	1.805660756	1.124382368	2.899734878	0.014483845	86/33--166/36	NA	NA	NA	NA	0.978504793	NA
	LIHC	eastern_cancer_oncology_group	2 (vs 0)	4.034037022	2.163175455	7.522947181	1.15E-05	26/14--166/36	NA	NA	NA	NA	0.841951079	NA
	LIHC	eastern_cancer_oncology_group	3 (vs 0)	10.06220016	4.481441335	22.59270275	2.21E-08	12/8--166/36	NA	NA	NA	NA	0.407661055	NA
	LIHC	eastern_cancer_oncology_group	4 (vs 0)	39.92436304	8.788425833	181.3697691	1.80E-06	3/2--166/36	NA	NA	NA	NA	0.728794616	NA
	LIHC	eastern_cancer_oncology_group	Global	NA	NA	NA	NA	NA	85(22.55%)	2.12E-08	5.19E-11	0	0.940002202	0.656285939
	LIHC	risk_factors_Non.Alcoholic_Fatty_Liver_Disease	Yes (vs NO)	0.577951559	0.213400571	1.565262932	0.280788296	20/4--357/128	1(0.27%)	0.238813303	0.280788296	0.27478698	0.641358206	0.512809203
	LIHC	risk_factors_Hepatitis_C_risk	Hepatitis_C (vs NO)	1.10921708	0.680485636	1.808065395	0.67755961	56/19--321/113	1(0.27%)	0.681211632	0.67755961	0.6774249	0.570048131	0.499206041
	LIHC	risk_factors_Hepatitis_B	Hepatitis_B (vs NO)	0.356706211	0.221240048	0.575118845	2.34E-05	107/20--270/112	1(0.27%)	2.36E-06	2.34E-05	1.01E-05	0.09629861	0.572814849
	LIHC	alcohol	Yes (vs NO)	1.039382249	0.71825226	1.50408919	0.837684942	118/41--259/91	1(0.27%)	0.838074379	0.837684942	0.837675105	0.006674946	0.47731042
	LIHC	viral_hepatitis_serology	Yes (vs NO)	1.850626817	1.309534011	2.615296422	0.000486279	166/73--211/59	1(0.27%)	0.000470607	0.000486279	0.000398392	0.020165148	0.605243657
	LIHC	viral_hepatitis_serology_HC	Yes (vs NO)	1.82779262	1.294440995	2.580902394	0.000612548	147/67--230/65	1(0.27%)	0.000663358	0.000612548	0.000510703	0.009959815	0.606249338
	LIHC	viral_hepatitis_serology_HB	Yes (vs NO)	2.492283907	1.729611327	3.591257166	9.60E-07	104/48--273/84	1(0.27%)	2.95E-06	9.60E-07	4.22E-07	0.523857126	0.606178764
	LIHC	vascular_invasion	Micro (vs None)	1.198561155	0.765731883	1.876046791	0.428177761	94/28--210/62	NA	NA	NA	NA	0.88214606	NA
	LIHC	vascular_invasion	Macro (vs None)	2.069249711	0.984248403	4.350318836	0.05510016	17/8--210/62	NA	NA	NA	NA	0.77155668	NA
	LIHC	vascular_invasion	Global	NA	NA	NA	NA	NA	57(15.12%)	0.187575496	0.145067367	0.135629334	0.938047386	0.542280838
	LIHC	alpha_fetoprotien_norm_range_lower	NO (vs Yes)	0.595908865	0.369309105	0.961545141	0.033955361	119/25--150/53	109(28.91%)	0.029625525	0.033955361	0.032059691	0.756323412	0.566759113
	LIHC	platelet_count_preresection	Low (vs Normal)	1.342136222	0.824777511	2.184018859	0.236210312	69/22--221/64	NA	NA	NA	NA	0.483101958	NA
	LIHC	platelet_count_preresection	High (vs Normal)	2.159339701	1.160564285	4.0176559	0.015098319	20/12--221/64	NA	NA	NA	NA	0.750368729	NA
	LIHC	platelet_count_preresection	Global	NA	NA	NA	NA	NA	68(18.04%)	0.059172344	0.040386476	0.035677401	0.769045789	0.554853052
	LIHC	bilirubin_total	H (vs Normal)	1.494343833	0.878789207	2.541068408	0.138088638	49/17--252/73	NA	NA	NA	NA	0.811095144	NA
	LIHC	bilirubin_total	L (vs Normal)	5.451754506	0.749782405	39.64033696	0.09384253	1/1--252/73	NA	NA	NA	NA	0.591082706	NA
	LIHC	bilirubin_total	Global	NA	NA	NA	NA	NA	76(20.16%)	0.161165555	0.093533822	0.067063524	0.834614154	0.537609642
	LUAD	AR	(continuous)	0.969349609	0.894692218	1.050236769	0.446487329	506/183	16(3.07%)	0.446102244	0.446487329	0.446434103	0.25098702	0.501748605
	LUAD	AR	H (vs L)	0.859577483	0.642280871	1.150389936	0.308824989	254/98--252/85	16(3.07%)	0.308177196	0.308824989	0.308371487	0.088239264	0.502820005
	LUAD	ESR1	(continuous)	0.986430213	0.905417908	1.074691098	0.754674699	506/183	16(3.07%)	0.754531577	0.754674699	0.754676515	0.388532602	0.507044958
	LUAD	ESR1	H (vs L)	1.02810246	0.769011499	1.374484868	0.851601314	252/92--254/91	16(3.07%)	0.851606884	0.851601314	0.851596674	0.474387114	0.498423223
	LUAD	ESR2	(continuous)	0.930798549	0.80468672	1.076674831	0.334340017	506/183	16(3.07%)	0.335103759	0.334340017	0.334351781	0.410941847	0.536963289
	LUAD	ESR2	H (vs L)	0.808531768	0.603570816	1.083093487	0.154203279	254/103--252/80	16(3.07%)	0.152758293	0.154203279	0.153433218	0.386501368	0.536286084
	LUAD	PGR	(continuous)	0.948766802	0.85567298	1.051988863	0.318229222	506/183	16(3.07%)	0.318385537	0.318229222	0.318214886	0.128638897	0.532344142
	LUAD	PGR	H (vs L)	0.85565063	0.63962665	1.144633359	0.293688822	255/98--251/85	16(3.07%)	0.293059433	0.293688822	0.293203885	0.709904079	0.522277028
	LUAD	tobacco_smoking_history	(continuous)	1.036652014	0.901505533	1.192058573	0.613506896	499/174	23(4.41%)	0.612851244	0.613506896	0.613450512	0.276374784	0.522436722
	LUAD	age_at_initial_pathologic_diagnosis	(continuous)	1.008352259	0.993157632	1.023779353	0.282967057	503/181	19(3.64%)	0.280079035	0.282967057	0.282887497	0.268675917	0.519693586
	LUAD	tobacco_smoking_history_v2	No (vs Yes)	1.209782855	0.637255457	2.296684226	0.560377135	14/10--508/178	9(1.72%)	0.571038729	0.560377135	0.559788748	0.338859356	0.500516929
	LUAD	gender	MALE (vs FEMALE)	1.073431907	0.803220076	1.43454589	0.631985639	242/90--280/98	9(1.72%)	0.632196961	0.631985639	0.631915415	0.041086926	0.531671869
	LUAD	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	2.416053305	1.68202298	3.470412497	1.80E-06	124/54--279/69	NA	NA	NA	NA	0.173194568	NA
	LUAD	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	3.55365231	2.431985271	5.192648531	5.65E-11	85/47--279/69	NA	NA	NA	NA	0.019993779	NA
	LUAD	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	3.848854654	2.219925976	6.673052304	1.58E-06	26/16--279/69	NA	NA	NA	NA	0.915477216	NA
	LUAD	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	17(3.26%)	6.20E-12	9.10E-12	4.71E-13	0.109460722	0.667085171
	LUAD	pathologic_stage_v2	StageIII/IV (vs StageI/II)	2.647497405	1.943544769	3.606421948	6.68E-10	111/63--403/123	17(3.26%)	6.75E-09	6.68E-10	1.41E-10	0.236867083	0.607014535
	LUAD	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	6.37428129	4.371870895	9.293838482	0	171/116--294/36	65(12.45%)	0	0	0	0.280815686	0.698471539
	LUAD	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	2.572788878	0.630052587	10.50585736	0.188028322	6/2--320/89	NA	NA	NA	NA	0.578881647	NA
	LUAD	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	1.122360781	0.563440232	2.235718449	0.742677982	37/9--320/89	NA	NA	NA	NA	0.998409558	NA
	LUAD	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	4.126500907	2.867829893	5.93759406	2.26E-14	68/46--320/89	NA	NA	NA	NA	0.018764909	NA
	LUAD	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	98(18.77%)	1.02E-10	6.08E-13	4.22E-15	0.096391559	0.654505649
	LUAD	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	2.852079511	2.029672658	4.007718934	1.56E-09	111/57--320/89	98(18.77%)	8.96E-09	1.56E-09	2.78E-10	0.033972962	0.638491687
	LUAD	residual_tumor	R1 (vs R0)	3.400568764	1.767236083	6.543476579	0.00024727	13/10--348/134	NA	NA	NA	NA	0.363029206	NA
	LUAD	residual_tumor	R2 (vs R0)	5.775877651	1.814288012	18.38779864	0.002995471	5/3--348/134	NA	NA	NA	NA	0.982984299	NA
	LUAD	residual_tumor	RX (vs R0)	1.183813968	0.54965958	2.549606269	0.666406833	26/7--348/134	NA	NA	NA	NA	0.592742223	NA
	LUAD	residual_tumor	Global	NA	NA	NA	NA	NA	139(26.63%)	0.001862103	0.000104321	1.63E-05	0.790692079	0.536896452
	LUAD	new_tumor_event_type	Distant_Metastasis (vs NO)	2.430994528	1.674643855	3.52894998	2.99E-06	63/38--391/118	NA	NA	NA	NA	0.059073021	NA
	LUAD	new_tumor_event_type	Locoregional_Recurrence (vs NO)	1.162803615	0.74209763	1.822013969	0.510372413	48/23--391/118	NA	NA	NA	NA	0.060284698	NA
	LUAD	new_tumor_event_type	New_Primary_Tumor (vs NO)	0.152813089	0.021286272	1.097037588	0.061779321	11/1--391/118	NA	NA	NA	NA	0.322602119	NA
	LUAD	new_tumor_event_type	Locoregional_Recurrence|Distant_Metastasis (vs NO)	1.726647527	0.802118824	3.716795557	0.16263169	8/7--391/118	NA	NA	NA	NA	0.563711824	NA
	LUAD	new_tumor_event_type	Distant_Metastasis|New_Primary_Tumor (vs NO)	8.263887995	1.142074975	59.79628859	0.036480609	1/1--391/118	NA	NA	NA	NA	0.615443334	NA
	LUAD	new_tumor_event_type	Global	NA	NA	NA	NA	NA	9(1.72%)	1.10E-05	1.24E-05	1.31E-06	0.231682781	0.564327892
	LUAD	new_tumor_event	Yes (vs NO)	1.989491105	1.482859936	2.669216936	4.49E-06	187/108--335/80	9(1.72%)	3.58E-06	4.49E-06	2.91E-06	0.017926464	0.556723065
	LUAD	other_dx	Yes (vs No)	1.426885385	0.974238883	2.089838476	0.067863255	93/33--429/155	9(1.72%)	0.078386071	0.067863255	0.066465637	0.86255571	0.52362964
	LUAD	targeted_molecular_therapy	YES (vs No)	1.386331486	0.8011449	2.398960525	0.242996249	38/14--484/174	9(1.72%)	0.264152241	0.242996249	0.240912375	0.791415277	0.514762312
	LUAD	egfr_mutation_status	YES (vs NO)	1.330463009	0.843840183	2.097709799	0.219042661	80/26--197/84	247(47.32%)	0.229260231	0.219042661	0.217596623	0.874701091	0.526993994
	LUAD	eml4_alk_translocation_status	YES (vs NO)	1.846562042	1.029422008	3.312335803	0.03966431	34/14--213/87	277(53.07%)	0.053777551	0.03966431	0.036692019	0.516388829	0.54771561
	LUSC	AR	(continuous)	1.036437345	0.964509876	1.113728741	0.329427524	495/212	9(1.79%)	0.33218115	0.329427524	0.329306619	0.480107961	0.523093333
	LUSC	AR	H (vs L)	1.176294784	0.895591595	1.544978119	0.243110913	247/105--248/107	9(1.79%)	0.243046878	0.243110913	0.242611186	0.299719716	0.512711111
	LUSC	ESR1	(continuous)	1.067556658	0.984742622	1.157335117	0.112564467	495/212	9(1.79%)	0.114211641	0.112564467	0.112352143	0.82747866	0.539724444
	LUSC	ESR1	H (vs L)	1.385182876	1.05503114	1.818649259	0.018996138	247/96--248/116	9(1.79%)	0.018670087	0.018996138	0.018486986	0.864252379	0.542133333
	LUSC	ESR2	(continuous)	0.973005553	0.851204007	1.112236078	0.688384614	495/212	9(1.79%)	0.687807249	0.688384614	0.688396683	0.204819433	0.526284444
	LUSC	ESR2	H (vs L)	0.975735752	0.74359531	1.280347313	0.859353612	252/113--243/99	9(1.79%)	0.859323543	0.859353612	0.859350168	0.423686833	0.51168
	LUSC	PGR	(continuous)	1.068532976	0.968672579	1.178687976	0.185452837	495/212	9(1.79%)	0.185236928	0.185452837	0.185320521	0.331493564	0.538266667
	LUSC	PGR	H (vs L)	1.200126544	0.915056651	1.574004975	0.187363429	247/97--248/115	9(1.79%)	0.186469851	0.187363429	0.186754963	0.612886027	0.528791111
	LUSC	tobacco_smoking_history	(continuous)	0.801318666	0.695690763	0.922984233	0.002131973	486/212	18(3.57%)	0.002446715	0.002131973	0.002011287	0.399389689	0.563293567
	LUSC	age_at_initial_pathologic_diagnosis	(continuous)	1.016865966	1.000539208	1.033459142	0.042842914	492/215	12(2.38%)	0.03971849	0.042842914	0.042798896	0.416620761	0.532092734
	LUSC	tobacco_smoking_history_v2	No (vs Yes)	0.447892466	0.143237447	1.400525255	0.167322413	12/3--492/216	6(1.19%)	0.113106448	0.167322413	0.156112756	0.554656251	0.506596421
	LUSC	gender	FEMALE (vs MALE)	0.838625904	0.610371088	1.152239057	0.277596621	131/51--373/168	6(1.19%)	0.270391397	0.277596621	0.276983121	0.635750998	0.519885371
	LUSC	pathologic_stage_v2	StageIII/IV (vs StageI/II)	1.565411626	1.139503686	2.150509551	0.005675094	92/50--408/167	10(1.98%)	0.007940353	0.005675094	0.005284894	0.292132426	0.543917963
	LUSC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	3.951019541	2.889225625	5.403024008	0	114/91--319/76	77(15.28%)	0	0	0	0.000301016	0.622993187
	LUSC	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	9.104966217	2.831621503	29.27665641	0.000210054	4/3--311/102	NA	NA	NA	NA	0.683742971	NA
	LUSC	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	2.367207306	1.147676315	4.882622703	0.019655643	17/8--311/102	NA	NA	NA	NA	0.740869945	NA
	LUSC	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	4.523919839	2.850864989	7.178821442	1.49E-10	31/24--311/102	NA	NA	NA	NA	0.863450191	NA
	LUSC	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	145(28.77%)	1.35E-08	2.32E-11	5.80E-14	0.956060339	0.604360552
	LUSC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	3.843374068	2.585745031	5.71267625	2.78E-11	52/35--311/102	145(28.77%)	3.15E-09	2.78E-11	8.23E-13	0.641856932	0.602221555
	LUSC	residual_tumor	R1 (vs R0)	4.357462752	1.890044314	10.04605104	0.000552924	12/6--401/177	NA	NA	NA	NA	0.981095886	NA
	LUSC	residual_tumor	R2 (vs R0)	1.90E-07	0	Inf	0.993329032	4/0--401/177	NA	NA	NA	NA	0.999847737	NA
	LUSC	residual_tumor	RX (vs R0)	1.815919856	0.955821744	3.449978976	0.068458942	23/11--401/177	NA	NA	NA	NA	0.377935656	NA
	LUSC	residual_tumor	Global	NA	NA	NA	NA	NA	69(13.69%)	0.003138308	0.002297254	0.000339209	0.854605097	0.53303653
	LUSC	new_tumor_event_dx_days_to	Yes (vs NO)	1.813055495	1.383404028	2.376146202	1.62E-05	133/94--371/125	6(1.19%)	2.36E-05	1.62E-05	1.21E-05	0.0071629	0.540399804
	LUSC	other_dx	Yes (vs No)	1.366991697	0.958557075	1.949457521	0.084304293	70/37--433/182	7(1.39%)	0.095316966	0.084304293	0.083051607	0.984939807	0.519107779
	LUSC	targeted_molecular_therapy	YES (vs NO)	0.725932052	0.428877076	1.228737495	0.232932676	51/16--453/203	6(1.19%)	0.211796521	0.232932676	0.230943253	0.937464702	0.51377822
	LUSC	eastern_cancer_oncology_group	1 (vs 0)	1.146479744	0.716711534	1.833953747	0.568466808	93/46--70/30	NA	NA	NA	NA	0.565742445	NA
	LUSC	eastern_cancer_oncology_group	2 (vs 0)	0.763190088	0.333903607	1.744392987	0.521687024	26/7--70/30	NA	NA	NA	NA	0.84131492	NA
	LUSC	eastern_cancer_oncology_group	3 (vs 0)	5.356475973	1.831554158	15.66529426	0.002175063	5/4--70/30	NA	NA	NA	NA	0.788800061	NA
	LUSC	eastern_cancer_oncology_group	Global	NA	NA	NA	NA	NA	312(61.9%)	0.055253377	0.013461102	0.004343408	0.881457016	0.568965517
	MESO	AR	(continuous)	0.931923182	0.808501743	1.074185459	0.330709641	86/73	1(1.15%)	0.324199957	0.330709641	0.330385226	0.049148012	0.553381862
	MESO	AR	H (vs L)	1.012576597	0.636079646	1.611922925	0.957980936	43/36--43/37	1(1.15%)	0.957978442	0.957980936	0.957980672	0.333930423	0.487564453
	MESO	ESR1	(continuous)	0.746203802	0.577694754	0.963865623	0.024975184	86/73	1(1.15%)	0.014093817	0.024975184	0.029503839	0.139462241	0.581286018
	MESO	ESR1	H (vs L)	0.873775007	0.549255643	1.390031712	0.568918791	44/36--42/37	1(1.15%)	0.569307989	0.568918791	0.568633307	0.046096327	0.54670913
	MESO	ESR2	(continuous)	0.990274356	0.822845919	1.191770268	0.917627599	86/73	1(1.15%)	0.917426444	0.917627599	0.917626642	0.204187499	0.515468608
	MESO	ESR2	H (vs L)	1.134753722	0.712890341	1.806260986	0.594020743	44/35--42/38	1(1.15%)	0.593694794	0.594020743	0.593781124	0.19547418	0.49696694
	MESO	PGR	(continuous)	1.131939189	0.967267133	1.324645783	0.122332511	86/73	1(1.15%)	0.12096299	0.122332511	0.121943201	0.310144005	0.540339703
	MESO	PGR	H (vs L)	1.56938049	0.984703694	2.501214466	0.058073204	45/35--41/38	1(1.15%)	0.058038666	0.058073204	0.056059244	0.943451657	0.555808311
	MESO	age_at_initial_pathologic_diagnosis	(continuous)	1.020936473	0.991467051	1.051281816	0.165587435	86/73	1(1.15%)	0.161342042	0.165587435	0.165332898	0.811286617	0.553078556
	MESO	gender	FEMALE (vs MALE)	1.126450698	0.626813926	2.024350644	0.690532453	16/14--71/60	1(1.15%)	0.694041638	0.690532453	0.690361142	0.398054384	0.519714892
	MESO	pathologic_stage_v2	StageIII/IV (vs StageI/II)	0.992724724	0.588276352	1.675237114	0.978180068	61/52--26/22	1(1.15%)	0.978191423	0.978180068	0.978180022	0.189406401	0.518198362
	MESO	histological_type	Biphasic_mesothelioma (vs Epithelioid_mesothelioma)	2.011369338	1.18727571	3.407470209	0.009371329	23/21--57/46	NA	NA	NA	NA	0.238773092	NA
	MESO	histological_type	Diffuse_malignant_mesothelioma_-_NOS (vs Epithelioid_mesothelioma)	1.157495263	0.458040014	2.925061662	0.757156959	5/5--57/46	NA	NA	NA	NA	0.643489439	NA
	MESO	histological_type	Sarcomatoid_mesothelioma (vs Epithelioid_mesothelioma)	6.87491368	0.893220081	52.91466134	0.064095552	2/2--57/46	NA	NA	NA	NA	0.834781132	NA
	MESO	histological_type	Global	NA	NA	NA	NA	NA	1(1.15%)	0.048304957	0.025464689	0.015798296	0.584021547	0.589323628
	MESO	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.62207837	0.302486135	1.279336319	0.19693309	16/10--50/43	21(24.14%)	0.175251817	0.19693309	0.192824269	0.599189175	0.53166578
	MESO	new_tumor_event_type	Intrapleural_Progression (vs NO)	0.673783818	0.387910813	1.170332506	0.161027669	25/20--43/36	NA	NA	NA	NA	0.589417098	NA
	MESO	new_tumor_event_type	Distant_Metastasis (vs NO)	0.626577976	0.295203335	1.329930643	0.223440959	10/9--43/36	NA	NA	NA	NA	0.792214266	NA
	MESO	new_tumor_event_type	Locoregional_Recurrence (vs NO)	0.759015918	0.346404181	1.663101066	0.490853065	9/9--43/36	NA	NA	NA	NA	0.507523689	NA
	MESO	new_tumor_event_type	Global	NA	NA	NA	NA	NA	1(1.15%)	0.429847491	0.430654363	0.424793015	0.784937012	0.554595086
	MESO	new_tumor_event_dx_days_to	NO (vs Yes)	1.368684512	0.854935731	2.191155691	0.191149199	40/33--47/41	1(1.15%)	0.194191986	0.191149199	0.189391099	0.781908289	0.54322111
	OV	AR	(continuous)	0.954853256	0.887549823	1.027260349	0.215429578	304/184	283(48.21%)	0.221716185	0.215429578	0.215232617	0.780371653	0.543836141
	OV	AR	H (vs L)	0.755455665	0.565022243	1.010072203	0.058445973	152/95--152/89	283(48.21%)	0.058464793	0.058445973	0.057646138	0.075963495	0.553464778
	OV	ESR1	(continuous)	1.029950448	0.929316228	1.141482192	0.573739695	304/184	283(48.21%)	0.567982666	0.573739695	0.57375693	0.370984231	0.530321593
	OV	ESR1	H (vs L)	1.197754472	0.893202364	1.606148653	0.228023224	153/90--151/94	283(48.21%)	0.227809427	0.228023224	0.227424787	0.206184897	0.51479709
	OV	ESR2	(continuous)	0.926712089	0.826936483	1.038526313	0.190348093	304/184	283(48.21%)	0.186941634	0.190348093	0.190215959	0.744427347	0.512366003
	OV	ESR2	H (vs L)	0.807470684	0.603550964	1.080288068	0.149881401	153/102--151/82	283(48.21%)	0.148691607	0.149881401	0.149112055	0.724436627	0.528924196
	OV	PGR	(continuous)	0.978206085	0.923017023	1.036695013	0.457068718	304/184	283(48.21%)	0.457006715	0.457068718	0.457000299	0.751813064	0.521401225
	OV	PGR	H (vs L)	0.886014084	0.662682452	1.184611053	0.414100344	153/96--151/88	283(48.21%)	0.413880644	0.414100344	0.413818076	0.856590787	0.515754211
	OV	age_at_initial_pathologic_diagnosis	(continuous)	1.024166115	1.014301079	1.034127098	1.33E-06	582/348	5(0.85%)	1.44E-06	1.33E-06	1.22E-06	0.004797967	0.598338837
	OV	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	1.431652916	0.927157912	2.210659097	0.105496406	34/22--498/311	NA	NA	NA	NA	0.775953738	NA
	OV	race	ASIAN (vs WHITE)	0.84482181	0.375956658	1.898420671	0.683119638	20/6--498/311	NA	NA	NA	NA	0.125253424	NA
	OV	race	AMERICAN_INDIAN_OR_ALASKA_NATIVE (vs WHITE)	6.925612048	2.200513293	21.79677914	0.000938964	3/3--498/311	NA	NA	NA	NA	0.875110034	NA
	OV	race	NATIVE_HAWAIIAN_OR_OTHER_PACIFIC_ISLANDER (vs WHITE)	6.244285629	0.867945739	44.92343387	0.068866507	1/1--498/311	NA	NA	NA	NA	0.747427052	NA
	OV	race	Global	NA	NA	NA	NA	NA	32(5.45%)	0.028535135	0.002319462	0.00027506	0.629726765	0.52464487
	OV	clinical_stage_v2	StageIII/IV (vs StageI/II)	2.159790954	1.213479333	3.844067912	0.008850704	535/335--47/12	9(1.53%)	0.003051651	0.008850704	0.007299078	0.296222958	0.522491296
	OV	histological_grade_v2	G_1/2/Low (vs G_3/4/High)	0.818095549	0.597101538	1.120881935	0.211416671	75/45--496/295	NA	NA	NA	NA	0.013414415	NA
	OV	histological_grade_v2	GX (vs G_3/4/High)	0.928133178	0.413434469	2.083597912	0.856558007	10/6--496/295	NA	NA	NA	NA	0.733205836	NA
	OV	histological_grade_v2	GB (vs G_3/4/High)	2.956833841	0.733997839	11.91129715	0.127268457	2/2--496/295	NA	NA	NA	NA	0.982400645	NA
	OV	histological_grade_v2	Global	NA	NA	NA	NA	NA	8(1.36%)	0.33240128	0.258953145	0.231013036	0.10370643	0.527035864
	OV	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.091371276	0.048430364	0.172385863	1.49E-13	120/10--398/302	70(11.93%)	0	1.49E-13	0	0.035662491	0.603201008
	OV	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	3.818033658	2.774703206	5.253672169	2.22E-16	65/57--331/168	NA	NA	NA	NA	0.555015446	NA
	OV	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	3.364067227	2.074200376	5.456053542	8.79E-07	31/19--331/168	NA	NA	NA	NA	0.986990513	NA
	OV	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	5.86079127	4.026461622	8.530783983	0	42/36--331/168	NA	NA	NA	NA	0.15063403	NA
	OV	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	119(20.27%)	0	0	0	0.371748455	0.660693796
	OV	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	4.187014697	3.228964967	5.429322477	0	138/112--331/168	119(20.27%)	0	0	0	0.714175558	0.652190315
	OV	new_tumor_event_type	Progression_of_Disease (vs NO)	2.115808414	1.389424366	3.221942379	0.000478064	34/28--259/102	NA	NA	NA	NA	0.119444532	NA
	OV	new_tumor_event_type	Recurrence (vs NO)	1.363040806	1.075353364	1.727692776	0.010449412	294/219--259/102	NA	NA	NA	NA	6.77E-10	NA
	OV	new_tumor_event_type	Global	NA	NA	NA	NA	NA	5(0.85%)	0.001259365	0.0009631	0.000825011	3.50E-09	0.509225298
	OV	new_tumor_event_dx_days_to	NO (vs Yes)	0.929719648	0.726773618	1.18933682	0.561938159	225/86--362/263	5(0.85%)	0.559572402	0.561938159	0.561854859	1.90E-09	0.46485141
	OV	anatomic_neoplasm_subdivision	Left (vs Bilateral)	0.740540506	0.531463364	1.03186838	0.075960218	82/42--400/247	NA	NA	NA	NA	0.598414977	NA
	OV	anatomic_neoplasm_subdivision	Right (vs Bilateral)	1.277797945	0.914211823	1.785983892	0.151304698	71/40--400/247	NA	NA	NA	NA	0.647171016	NA
	OV	anatomic_neoplasm_subdivision	Global	NA	NA	NA	NA	NA	36(6.13%)	0.045518293	0.048653725	0.047071312	0.807579076	0.531347463
	OV	vascular_invasion_indicator	YES (vs NO)	0.863107038	0.618101095	1.205229638	0.387487419	91/39--496/310	5(0.85%)	0.378528476	0.387487419	0.387061298	0.208601606	0.502717805
	OV	lymphovascular_invasion_indicator	YES (vs NO)	1.242227641	0.94750103	1.628630961	0.116483988	138/67--449/282	5(0.85%)	0.124573196	0.116483988	0.115789115	0.493093669	0.520472441
	PAAD	AR	(continuous)	1.075741289	0.950682367	1.217251272	0.246912838	178/93	7(3.78%)	0.241298877	0.246912838	0.246475175	0.055718762	0.495779013
	PAAD	AR	H (vs L)	1.049804562	0.698290722	1.578267593	0.815261544	89/46--89/47	7(3.78%)	0.815254601	0.815261544	0.815243994	0.238055448	0.491718316
	PAAD	ESR1	(continuous)	0.953790997	0.819743916	1.109757874	0.540370378	178/93	7(3.78%)	0.541482918	0.540370378	0.540363187	0.065464007	0.555193417
	PAAD	ESR1	H (vs L)	0.766445175	0.508035656	1.156293261	0.204868537	89/53--89/40	7(3.78%)	0.202746453	0.204868537	0.20354845	0.071499409	0.555139987
	PAAD	ESR2	(continuous)	0.782855391	0.62620802	0.978688461	0.03162866	178/93	7(3.78%)	0.032270284	0.03162866	0.032002841	0.372504262	0.560055567
	PAAD	ESR2	H (vs L)	0.782247022	0.517581997	1.182248237	0.243833679	89/49--89/44	7(3.78%)	0.242939782	0.243833679	0.24266456	0.820172274	0.533019876
	PAAD	PGR	(continuous)	0.948940356	0.841784336	1.06973694	0.391293326	178/93	7(3.78%)	0.398982781	0.391293326	0.391843525	0.76969917	0.555567429
	PAAD	PGR	H (vs L)	0.793455584	0.525752828	1.197467193	0.27056029	89/50--89/43	7(3.78%)	0.269448062	0.27056029	0.269508413	0.175067846	0.545629408
	PAAD	tobacco_smoking_history	(continuous)	0.921543922	0.787468615	1.078447044	0.308431575	149/80	36(19.46%)	0.302787869	0.308431575	0.307527099	0.52163221	0.527869344
	PAAD	age_at_initial_pathologic_diagnosis	(continuous)	1.028177123	1.008263352	1.048484202	0.005358494	185/100	0(0%)	0.004353321	0.005358494	0.005148483	0.267443603	0.562982998
	PAAD	tobacco_smoking_history_v2	No (vs Yes)	1.093535916	0.668688417	1.788307932	0.721607474	36/20--149/80	0(0%)	0.723957202	0.721607474	0.721518924	0.731932477	0.504057187
	PAAD	gender	FEMALE (vs MALE)	1.19876627	0.809154288	1.775978441	0.365991851	83/49--102/51	0(0%)	0.366603164	0.365991851	0.365345082	0.180461051	0.506472179
	PAAD	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	2.447471526	1.124608161	5.32640352	0.024073533	152/88--21/7	NA	NA	NA	NA	0.011224036	NA
	PAAD	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	1.960263982	0.403121351	9.532203817	0.404224277	4/2--21/7	NA	NA	NA	NA	0.068429738	NA
	PAAD	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	2.439138787	0.621488429	9.572821866	0.201196709	5/3--21/7	NA	NA	NA	NA	0.00888042	NA
	PAAD	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	3(1.62%)	0.086893843	0.161002415	0.139855987	0.027639861	0.527849228
	PAAD	pathologic_stage_v2	StageIII/IV (vs StageI/II)	0.985532612	0.398993406	2.434312233	0.974800944	9/5--173/95	3(1.62%)	0.974747028	0.974800944	0.974800715	0.106740471	0.509200633
	PAAD	histological_grade	G2 (vs G1)	1.930189382	1.020261699	3.651642567	0.043214669	97/52--32/12	NA	NA	NA	NA	0.395116798	NA
	PAAD	histological_grade	G3 (vs G1)	2.614812242	1.339180518	5.10554251	0.004871175	51/33--32/12	NA	NA	NA	NA	0.122112315	NA
	PAAD	histological_grade	G4 (vs G1)	1.627731234	0.210060515	12.6130747	0.640966444	2/1--32/12	NA	NA	NA	NA	0.336251239	NA
	PAAD	histological_grade	GX (vs G1)	3.063990816	0.680263896	13.80058501	0.14478047	3/2--32/12	NA	NA	NA	NA	0.058181487	NA
	PAAD	histological_grade	Global	NA	NA	NA	NA	NA	0(0%)	0.052549678	0.077561102	0.066052281	0.136202222	0.599690881
	PAAD	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	1.554781119	1.024297954	2.36000113	0.038198885	53/34--129/64	NA	NA	NA	NA	0.319079924	NA
	PAAD	histological_grade_v2	GX (vs G_1/2/Low)	1.852251059	0.451578352	7.597427938	0.392013535	3/2--129/64	NA	NA	NA	NA	0.097955391	NA
	PAAD	histological_grade_v2	Global	NA	NA	NA	NA	NA	0(0%)	0.106618184	0.094748686	0.090883968	0.180175549	0.564625193
	PAAD	histological_type	Pancreas-Adenocarcinoma-Other_Subtype (vs Pancreas-Adenocarcinoma_Ductal_Type)	0.227994952	0.099289469	0.523536877	0.000490704	25/6--154/92	NA	NA	NA	NA	0.164155792	NA
	PAAD	histological_type	Pancreas-Colloid_(mucinous_non-cystic)_Carcinoma (vs Pancreas-Adenocarcinoma_Ductal_Type)	0.928583082	0.22779939	3.785201265	0.9176866	4/2--154/92	NA	NA	NA	NA	0.247001746	NA
	PAAD	histological_type	Pancreas-Undifferentiated_Carcinoma (vs Pancreas-Adenocarcinoma_Ductal_Type)	2.49E-07	0	Inf	0.995895561	1/0--154/92	NA	NA	NA	NA	0.999825454	NA
	PAAD	histological_type	Global	NA	NA	NA	NA	NA	1(0.54%)	0.000218712	0.006881707	0.001925982	0.367903965	0.55939441
	PAAD	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.25516179	0.140837836	0.462287272	6.65E-06	58/13--105/77	22(11.89%)	2.12E-07	6.65E-06	1.33E-06	0.004310693	0.593957303
	PAAD	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	3.178776037	1.198505432	8.431014852	0.020135786	10/5--70/26	NA	NA	NA	NA	0.878543471	NA
	PAAD	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	1.437793818	0.548293916	3.770333761	0.460381672	8/5--70/26	NA	NA	NA	NA	0.211274866	NA
	PAAD	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	2.939909981	1.791428355	4.824681193	1.98E-05	56/46--70/26	NA	NA	NA	NA	0.019939226	NA
	PAAD	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	41(22.16%)	0.000117146	0.000215721	9.55E-05	0.100515752	0.610270585
	PAAD	treatment_outcome_first_course_v2	Complete_Remission/Response (vs Uncomplete_Remission/Response)	0.372830398	0.231305541	0.600947581	5.11E-05	70/26--74/56	41(22.16%)	2.26E-05	5.11E-05	2.59E-05	0.042465841	0.593322665
	PAAD	residual_tumor	R1 (vs R0)	1.629052575	1.050383946	2.526516424	0.029294255	53/32--111/56	NA	NA	NA	NA	0.198147322	NA
	PAAD	residual_tumor	R2 (vs R0)	1.002257609	0.243938775	4.117919806	0.997504397	5/2--111/56	NA	NA	NA	NA	0.838717621	NA
	PAAD	residual_tumor	RX (vs R0)	2.174282351	0.677009648	6.982919312	0.191989578	4/3--111/56	NA	NA	NA	NA	0.317542955	NA
	PAAD	residual_tumor	Global	NA	NA	NA	NA	NA	12(6.49%)	0.139293132	0.120308912	0.112982409	0.362208401	0.568889623
	PAAD	new_tumor_event_type	Distant_Metastasis (vs NO)	1.102111145	0.712961209	1.703667692	0.661737377	59/38--101/44	NA	NA	NA	NA	0.005250234	NA
	PAAD	new_tumor_event_type	Locoregional_Recurrence (vs NO)	2.106245642	1.182295649	3.752251568	0.011460133	21/16--101/44	NA	NA	NA	NA	0.271771549	NA
	PAAD	new_tumor_event_type	Locoregional_Recurrence|Distant_Metastasis (vs NO)	1.09461732	0.149892218	7.993657659	0.928987372	2/1--101/44	NA	NA	NA	NA	0.270257486	NA
	PAAD	new_tumor_event_type	New_Primary_Tumor (vs NO)	0.466280179	0.061646633	3.526830187	0.459870407	2/1--101/44	NA	NA	NA	NA	0.081548745	NA
	PAAD	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	0.155469333	0.118159193	0.103351906	0.031211151	0.532167697
	PAAD	new_tumor_event_dx_days_to	Yes (vs NO)	1.243069756	0.836537846	1.847163791	0.281602074	84/56--101/44	0(0%)	0.279984282	0.281602074	0.280670138	0.013614836	0.499227202
	PAAD	radiation_therapy	YES (vs NO)	0.409494546	0.218614853	0.767037466	0.00529992	33/11--152/89	0(0%)	0.001798714	0.00529992	0.003961826	0.050343726	0.573560665
	PAAD	targeted_molecular_therapy	NO (vs YES)	1.819236233	1.224722962	2.702342142	0.003036327	91/56--94/44	0(0%)	0.002905472	0.003036327	0.00263073	0.004581439	0.606694359
	PAAD	number_of_lymphnodes_positive_by_he	NO (vs Yes)	0.439867399	0.268616008	0.72029709	0.001099223	53/20--132/80	0(0%)	0.000448111	0.001099223	0.000800537	0.377208485	0.567668083
	PAAD	alcohol_history_documented	NO (vs YES)	0.96269776	0.649461594	1.427008132	0.849854006	83/47--102/53	0(0%)	0.849801853	0.849854006	0.849845189	0.07027144	0.526758114
	PAAD	diabetes_diagnosis_indicator	YES (vs NO)	0.893492105	0.522543256	1.52777427	0.680725129	38/16--147/84	0(0%)	0.676936546	0.680725129	0.680566341	0.849771438	0.510142968
	PCPG	AR	(continuous)	0.772759198	0.420029532	1.421701885	0.407233255	179/6	0(0%)	0.383085704	0.407233255	0.411710884	0.094970835	0.507763975
	PCPG	AR	H (vs L)	0.601400157	0.106652489	3.391220885	0.564485069	90/4--89/2	0(0%)	0.556448276	0.564485069	0.560622914	0.236847766	0.522515528
	PCPG	ESR1	(continuous)	0.848742161	0.452439523	1.59217579	0.609392254	179/6	0(0%)	0.608485334	0.609392254	0.611724491	0.128864427	0.48447205
	PCPG	ESR1	H (vs L)	0.439644177	0.080233036	2.409070041	0.343698036	90/4--89/2	0(0%)	0.327888971	0.343698036	0.330359314	0.215535935	0.534161491
	PCPG	ESR2	(continuous)	1.301361105	0.660492427	2.564057751	0.446498301	179/6	0(0%)	0.465927313	0.446498301	0.448245494	0.873083312	0.662267081
	PCPG	ESR2	H (vs L)	1.715514847	0.286162886	10.28432174	0.554747812	90/3--89/3	0(0%)	0.549950589	0.554747812	0.549964468	0.573528244	0.559782609
	PCPG	PGR	(continuous)	0.928559034	0.57272668	1.505468332	0.763691793	179/6	0(0%)	0.765170408	0.763691793	0.763527385	0.893471555	0.513975155
	PCPG	PGR	H (vs L)	0.539291088	0.09839905	2.955667549	0.476826792	90/4--89/2	0(0%)	0.46486318	0.476826792	0.469915775	0.316171621	0.523291925
	PCPG	age_at_initial_pathologic_diagnosis	(continuous)	1.021539184	0.971093791	1.074605062	0.409511078	179/6	0(0%)	0.409169658	0.409511078	0.406070101	0.425750359	0.650621118
	PCPG	gender	MALE (vs FEMALE)	3.131482468	0.550497008	17.8133256	0.198106512	78/4--101/2	0(0%)	0.180850902	0.198106512	0.177094259	0.243447506	0.696428571
	PCPG	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	14.52122628	2.436195854	86.55544351	0.003307779	13/4--166/2	0(0%)	0.004241093	0.003307779	0.00041398	0.69741656	0.75
	PCPG	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	30.44602977	3.172362531	292.1988642	0.003071219	12/4--160/1	7(3.91%)	0.001198767	0.003071219	5.45E-05	0.718246288	0.846153846
	PCPG	other_dx	Yes (vs No)	4.599044894	0.927067532	22.81518142	0.061861213	27/3--152/3	0(0%)	0.073894383	0.061861213	0.040063882	0.111298855	0.590838509
	PRAD	AR	(continuous)	1.220846604	0.709286762	2.101359436	0.471398708	497/10	3(0.6%)	0.463467439	0.471398708	0.470442648	0.576043201	0.503100775
	PRAD	AR	H (vs L)	0.894886004	0.243382439	3.290381024	0.867232806	252/6--245/4	3(0.6%)	0.866868741	0.867232806	0.867173834	0.911525633	0.528940568
	PRAD	ESR1	(continuous)	0.690944261	0.44701416	1.067984003	0.096125802	497/10	3(0.6%)	0.120060871	0.096125802	0.10490529	0.432268042	0.583204134
	PRAD	ESR1	H (vs L)	0.491260701	0.126016481	1.915123121	0.305874119	250/7--247/3	3(0.6%)	0.287728727	0.305874119	0.296098329	0.551873305	0.575452196
	PRAD	ESR2	(continuous)	1.052315278	0.539600709	2.052197905	0.881052617	497/10	3(0.6%)	0.881363596	0.881052617	0.881055045	0.98893392	0.618863049
	PRAD	ESR2	H (vs L)	1.584187964	0.393458555	6.378439282	0.517376627	249/3--248/7	3(0.6%)	0.507902728	0.517376627	0.514094899	0.988589988	0.619379845
	PRAD	PGR	(continuous)	0.731456301	0.486581311	1.099566111	0.132685681	497/10	3(0.6%)	0.165364553	0.132685681	0.137439712	0.825589282	0.636692506
	PRAD	PGR	H (vs L)	0.500717263	0.127551823	1.965615009	0.321498971	250/7--247/3	3(0.6%)	0.304285916	0.321498971	0.312451785	0.601227992	0.581653747
	PRAD	gleason_pattern_primary	(continuous)	2.644391784	1.10445295	6.331467451	0.029036486	500/10	0(0%)	0.029931551	0.029036486	0.021880909	0.067912087	0.752434649
	PRAD	gleason_pattern_secondary	(continuous)	2.765618498	1.024116609	7.468530054	0.044751855	500/10	0(0%)	0.031489155	0.044751855	0.034657416	0.677459128	0.694515633
	PRAD	gleason_score	(continuous)	2.995697195	1.353800848	6.628893535	0.006780082	500/10	0(0%)	0.001895867	0.006780082	0.001971714	0.682126752	0.781906715
	PRAD	psa_most_recent_results	(continuous)	1.062560134	1.004236579	1.124270976	0.03514017	443/10	57(11.4%)	9.32E-05	0.03514017	0	0.762495618	0.661572052
	PRAD	age_at_initial_pathologic_diagnosis	(continuous)	1.052751868	0.955320068	1.160120605	0.299509138	500/10	0(0%)	0.293642957	0.299509138	0.297329469	0.125605727	0.554074833
	PRAD	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	5.692338884	1.349885174	24.00405797	0.017856938	89/5--347/3	64(12.8%)	0.016501014	0.017856938	0.007608269	0.308998034	0.705753824
	PRAD	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	5.494702234	0.489099809	61.72922593	0.167437368	39/1--340/3	NA	NA	NA	NA	0.660694677	NA
	PRAD	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	4.217539997	0.379643713	46.85351817	0.241368697	30/1--340/3	NA	NA	NA	NA	0.967335437	NA
	PRAD	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	15.95348356	2.883071124	88.2786538	0.001508628	29/4--340/3	NA	NA	NA	NA	0.802229071	NA
	PRAD	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	62(12.4%)	0.012951793	0.016830811	0.000817045	0.975020336	0.731821214
	PRAD	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	8.906005803	1.794507496	44.1998373	0.007465045	98/6--340/3	62(12.4%)	0.003212652	0.007465045	0.001209557	0.748827288	0.698465644
	PRAD	new_tumor_event_type	Biochemical_evidence_of_disease (vs NO)	0.871936282	0.101117204	7.518729244	0.90078561	70/1--409/6	NA	NA	NA	NA	0.295391896	NA
	PRAD	new_tumor_event_type	Locoregional_Recurrence (vs NO)	5.402671441	0.588403561	49.60686952	0.135919814	8/1--409/6	NA	NA	NA	NA	0.576110276	NA
	PRAD	new_tumor_event_type	New_Primary_Tumor (vs NO)	8.36E-08	0	Inf	0.998770193	7/0--409/6	NA	NA	NA	NA	0.999947718	NA
	PRAD	new_tumor_event_type	Distant_Metastasis (vs NO)	21.36048205	3.800327867	120.0607446	0.000509662	6/2--409/6	NA	NA	NA	NA	0.653978496	NA
	PRAD	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	0.054174253	0.00860795	2.21E-05	0.868201218	0.657355202
	PRAD	new_tumor_event_dx_days_to	Yes (vs NO)	2.556658584	0.675117624	9.68202115	0.167065937	91/4--409/6	0(0%)	0.180648363	0.167065937	0.152595565	0.427871942	0.487442337
	PRAD	radiation_therapy	YES (vs NO)	4.310239793	0.856412519	21.69301202	0.07639983	40/2--460/8	0(0%)	0.12073556	0.07639983	0.05338946	0.877909854	0.554587391
	PRAD	targeted_molecular_therapy	YES (vs NO)	2.604041554	0.533638607	12.70716235	0.236649746	43/2--457/8	0(0%)	0.280309311	0.236649746	0.219200269	0.67349925	0.640697078
	PRAD	number_of_lymphnodes_positive_by_he	Yes (vs NO)	3.345909042	0.794399367	14.0925431	0.099716768	80/3--420/7	0(0%)	0.125218441	0.099716768	0.080656504	0.975863353	0.604561763
	PRAD	biochemical_recurrence_indicator	YES (vs NO)	7.356927423	1.97298206	27.43277915	0.002959039	58/5--373/5	69(13.8%)	0.00425364	0.002959039	0.000486687	0.765439518	0.681431005
	READ	AR	(continuous)	0.748093135	0.528691854	1.058543523	0.101271157	159/23	11(6.47%)	0.090339817	0.101271157	0.099729174	0.032871961	0.523755656
	READ	AR	H (vs L)	0.663208978	0.286183195	1.536939119	0.338224702	80/14--79/9	11(6.47%)	0.33275821	0.338224702	0.334906518	0.162600647	0.496323529
	READ	ESR1	(continuous)	0.953178678	0.685148492	1.326062309	0.775903045	159/23	11(6.47%)	0.775394696	0.775903045	0.775901817	0.064158216	0.441742081
	READ	ESR1	H (vs L)	0.773909452	0.339019163	1.766672522	0.542787854	80/13--79/10	11(6.47%)	0.541089642	0.542787854	0.541691092	0.025760918	0.447115385
	READ	ESR2	(continuous)	1.205732127	0.766939797	1.895572466	0.417670645	159/23	11(6.47%)	0.411874395	0.417670645	0.418211849	0.384769814	0.49321267
	READ	ESR2	H (vs L)	0.941402347	0.414730626	2.136901218	0.885202829	80/12--79/11	11(6.47%)	0.885162078	0.885202829	0.88518571	0.346162276	0.530825792
	READ	PGR	(continuous)	1.15127958	0.867936317	1.527122031	0.328403079	159/23	11(6.47%)	0.325549223	0.328403079	0.328539187	0.378653362	0.610859729
	READ	PGR	H (vs L)	0.940920885	0.408219479	2.168764981	0.886345357	80/10--79/13	11(6.47%)	0.886483311	0.886345357	0.886328746	0.389023669	0.458427602
	READ	age_at_initial_pathologic_diagnosis	(continuous)	1.069218001	1.025608661	1.11468163	0.001631966	170/26	0(0%)	0.000903082	0.001631966	0.001537626	0.436418226	0.725736359
	READ	gender	FEMALE (vs MALE)	1.223011551	0.565080082	2.646982796	0.609326122	78/13--92/13	0(0%)	0.609639834	0.609326122	0.60873686	0.938503336	0.527281507
	READ	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.067890755	0.193776304	5.885088314	0.939871664	51/4--33/2	NA	NA	NA	NA	0.858453783	NA
	READ	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	2.460432175	0.512669365	11.80824698	0.260559503	52/8--33/2	NA	NA	NA	NA	0.497068497	NA
	READ	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	6.663257048	1.428443769	31.08207368	0.015787771	25/9--33/2	NA	NA	NA	NA	0.16826522	NA
	READ	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	9(5.29%)	0.007036513	0.006309439	0.001718837	0.321185739	0.624854482
	READ	pathologic_stage_v2	StageIII/IV (vs StageI/II)	3.556398676	1.392629094	9.082081938	0.007993941	77/17--84/6	9(5.29%)	0.004353797	0.007993941	0.004731459	0.179425745	0.601280559
	READ	histological_type	Rectal_Mucinous_Adenocarcinoma (vs Rectal_Adenocarcinoma)	1.830004518	0.418134251	8.009189705	0.422367683	13/2--151/24	6(3.53%)	0.457359335	0.422367683	0.415332663	0.92985734	0.525360517
	READ	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	6.983554461	2.528952062	19.28468065	0.000176675	55/15--103/5	12(7.06%)	3.76E-05	0.000176675	1.35E-05	0.674758295	0.709637046
	READ	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	10.07409788	0.838843182	120.9850069	0.068546017	12/2--51/2	107(62.94%)	0.060921575	0.068546017	0.029372703	0.53192741	0.605263158
	READ	residual_tumor	R1 (vs R0)	2.797146799	0.339847625	23.02217125	0.338854963	2/1--127/12	NA	NA	NA	NA	0.039503546	NA
	READ	residual_tumor	R2 (vs R0)	5.17823317	1.922037599	13.95087108	0.001145536	12/6--127/12	NA	NA	NA	NA	0.361589477	NA
	READ	residual_tumor	RX (vs R0)	1.95E-08	0	Inf	0.998195454	5/0--127/12	NA	NA	NA	NA	0.999923871	NA
	READ	residual_tumor	Global	NA	NA	NA	NA	NA	24(14.12%)	0.011567277	0.013277157	0.001588228	0.11600424	0.625
	READ	new_tumor_event_dx_days_to	Yes (vs NO)	1.560140619	0.701685488	3.46884579	0.275280746	32/10--138/16	0(0%)	0.284782608	0.275280746	0.271558862	0.262288014	0.517865765
	READ	number_of_lymphnodes_positive_by_he	Yes (vs NO)	3.438199036	1.486567372	7.952019422	0.00389278	75/18--95/8	0(0%)	0.002411134	0.00389278	0.002172866	0.194119709	0.60140029
	READ	vascular_invasion_indicator	YES (vs NO)	1.695604831	0.734412934	3.91479454	0.216126285	38/8--132/18	0(0%)	0.233253374	0.216126285	0.210894044	0.708594321	0.570497344
	READ	lymphovascular_invasion_indicator	YES (vs NO)	1.249263509	0.565171145	2.761392422	0.582363726	68/10--102/16	0(0%)	0.585855946	0.582363726	0.581599342	0.632838666	0.535007243
	SARC	AR	(continuous)	0.961776431	0.894828193	1.033733526	0.289732203	259/98	2(0.77%)	0.288563129	0.289732203	0.289299814	0.328841351	0.543540447
	SARC	AR	H (vs L)	0.897940169	0.604161064	1.334572178	0.594407897	130/49--129/49	2(0.77%)	0.594496405	0.594407897	0.594230631	0.222605452	0.528273018
	SARC	ESR1	(continuous)	0.917129629	0.836779256	1.005195516	0.064430318	259/98	2(0.77%)	0.058084171	0.064430318	0.064690041	0.719621531	0.565061203
	SARC	ESR1	H (vs L)	0.70495515	0.472046645	1.052781051	0.087525149	130/54--129/44	2(0.77%)	0.086373945	0.087525149	0.08598055	0.961663326	0.54413917
	SARC	ESR2	(continuous)	1.084597041	0.937302305	1.255038781	0.275497028	259/98	2(0.77%)	0.283089743	0.275497028	0.275956273	0.042169016	0.496840075
	SARC	ESR2	H (vs L)	0.986845156	0.663809736	1.46708207	0.947811633	130/49--129/49	2(0.77%)	0.947811875	0.947811633	0.947811255	0.0409591	0.525512241
	SARC	PGR	(continuous)	0.930109103	0.874862474	0.988844497	0.020393609	259/98	2(0.77%)	0.018294755	0.020393609	0.019926578	0.328326954	0.575771687
	SARC	PGR	H (vs L)	0.766713956	0.51459136	1.142363311	0.191644328	130/54--129/44	2(0.77%)	0.190287913	0.191644328	0.190353661	0.796408401	0.536389037
	SARC	age_at_initial_pathologic_diagnosis	(continuous)	1.020469997	1.005223585	1.035947655	0.008331979	261/99	0(0%)	0.007212881	0.008331979	0.008343545	0.954101807	0.58271436
	SARC	gender	MALE (vs FEMALE)	0.831675941	0.557303543	1.241127711	0.366863859	119/41--142/58	0(0%)	0.364671847	0.366863859	0.366189945	0.717034923	0.52814699
	SARC	histological_type	Dedifferentiated_liposarcoma (vs Leiomyosarcoma_(LMS))	1.245350395	0.761209952	2.037411103	0.382326912	59/26--105/41	NA	NA	NA	NA	0.968083255	NA
	SARC	histological_type	Pleomorphic_'MFH'_/_Undifferentiated_pleomorphic_sarcoma (vs Leiomyosarcoma_(LMS))	1.065241888	0.547182222	2.073788648	0.852486153	29/11--105/41	NA	NA	NA	NA	0.381952752	NA
	SARC	histological_type	Myxofibrosarcoma (vs Leiomyosarcoma_(LMS))	0.844042537	0.409966395	1.737722441	0.645379227	25/9--105/41	NA	NA	NA	NA	0.635852512	NA
	SARC	histological_type	Undifferentiated_Pleomorphic_Sarcoma_(UPS) (vs Leiomyosarcoma_(LMS))	1.152634655	0.451552608	2.94221897	0.766392578	21/5--105/41	NA	NA	NA	NA	0.646769104	NA
	SARC	histological_type	Malignant_Peripheral_Nerve_Sheath_Tumors_(MPNST) (vs Leiomyosarcoma_(LMS))	1.050305522	0.324869728	3.395643219	0.934662039	9/3--105/41	NA	NA	NA	NA	0.705694513	NA
	SARC	histological_type	Synovial_Sarcoma_-_Monophasic (vs Leiomyosarcoma_(LMS))	1.149114211	0.355000668	3.719608414	0.816601055	6/3--105/41	NA	NA	NA	NA	0.193874528	NA
	SARC	histological_type	Desmoid_Tumor (vs Leiomyosarcoma_(LMS))	6.75E-08	0	Inf	0.996616289	2/0--105/41	NA	NA	NA	NA	0.999843896	NA
	SARC	histological_type	Sarcoma;_synovial;_poorly_differentiated (vs Leiomyosarcoma_(LMS))	4.69553021	0.632498547	34.85858437	0.130506825	2/1--105/41	NA	NA	NA	NA	0.976407144	NA
	SARC	histological_type	Synovial_Sarcoma_-_Biphasic (vs Leiomyosarcoma_(LMS))	6.82E-08	0	Inf	0.99617896	2/0--105/41	NA	NA	NA	NA	0.999886706	NA
	SARC	histological_type	Giant_cell_'MFH'_/_Undifferentiated_pleomorphic_sarcoma_with_giant_cells (vs Leiomyosarcoma_(LMS))	7.09E-08	0	Inf	0.999579807	1/0--105/41	NA	NA	NA	NA	0.999963475	NA
	SARC	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.691746897	0.968993832	0.789767343	0.970239842	0.546716185
	SARC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	8.860932297	4.824133463	16.27569423	2.03E-12	123/81--129/12	9(3.45%)	0	2.03E-12	0	0.070966138	0.699491022
	SARC	margin_status	Positive (vs Negative)	1.906644689	1.184412423	3.069280513	0.007890821	74/31--137/38	50(19.16%)	0.009119278	0.007890821	0.006888348	0.363583803	0.589618195
	SARC	residual_tumor	R1 (vs R0)	2.219326749	1.420769831	3.466720021	0.000459526	70/35--155/44	NA	NA	NA	NA	0.26307725	NA
	SARC	residual_tumor	RX (vs R0)	2.247075207	1.184010804	4.264612255	0.013262134	26/12--155/44	NA	NA	NA	NA	0.561242003	NA
	SARC	residual_tumor	R2 (vs R0)	10.87810554	5.042148896	23.46879923	1.17E-09	9/8--155/44	NA	NA	NA	NA	0.368940251	NA
	SARC	residual_tumor	Global	NA	NA	NA	NA	NA	1(0.38%)	5.09E-07	5.08E-09	7.22E-12	0.318222503	0.633507511
	SARC	new_tumor_event_type	Distant_Metastasis (vs NO)	3.058865261	1.89743664	4.931209026	4.46E-06	68/41--136/29	NA	NA	NA	NA	0.061248894	NA
	SARC	new_tumor_event_type	Locoregional_Recurrence (vs NO)	2.338021835	1.390476718	3.931274814	0.001358757	48/28--136/29	NA	NA	NA	NA	0.097462881	NA
	SARC	new_tumor_event_type	New_Primary_Tumor (vs NO)	0.501451664	0.068296267	3.681808422	0.497401194	8/1--136/29	NA	NA	NA	NA	0.06768988	NA
	SARC	new_tumor_event_type	Locoregional_Disease (vs NO)	4.46E-07	0	Inf	0.994275658	1/0--136/29	NA	NA	NA	NA	0.999832385	NA
	SARC	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	1.21E-05	8.79E-05	1.61E-05	0.166836595	0.62223091
	SARC	new_tumor_event_dx_days_to	Yes (vs NO)	2.4050895	1.559886311	3.708254546	7.11E-05	126/70--135/29	0(0%)	3.12E-05	7.11E-05	4.11E-05	0.071389466	0.583984884
	SARC	histologic_subtype	Poorly_differentiated_or_pleomorphic_or_epithelioid_leiomyosarcoma (vs Conventional_leiomyosarcoma)	1.860778688	0.997207842	3.472192236	0.051035792	34/18--66/22	NA	NA	NA	NA	0.975974099	NA
	SARC	histologic_subtype	Well-differentiated_leiomyosarcoma_(resembling_leiomyoma) (vs Conventional_leiomyosarcoma)	0.410920686	0.054436047	3.101911668	0.388502479	4/1--66/22	NA	NA	NA	NA	0.275747787	NA
	SARC	histologic_subtype	Global	NA	NA	NA	NA	NA	157(60.15%)	0.06755066	0.077989418	0.065996484	0.548230152	0.582880435
	SARC	tumor_total_depth	Superficial (vs Deep)	0.3415398	0.107580686	1.084297179	0.068355834	21/3--187/74	53(20.31%)	0.030279564	0.068355834	0.055961982	0.647016938	0.530055774
	SARC	disease_multifocal_indicator	YES (vs NO)	2.387880134	1.493791156	3.81711427	0.000276086	40/24--199/66	22(8.43%)	0.000734734	0.000276086	0.000175849	0.917755947	0.574432131
	SARC	locoregional_recurrence_indicator	YES (vs NO)	2.269228766	1.344960063	3.828663272	0.002137431	29/21--144/43	88(33.72%)	0.003688627	0.002137431	0.001597307	0.226125563	0.55826926
	SARC	metastatic_disease_confirmed	YES (vs NO)	2.914911267	1.782616468	4.766424996	2.01E-05	56/37--121/28	84(32.18%)	1.96E-05	2.01E-05	7.88E-06	0.347769866	0.61481318
	SKCM	AR	(continuous)	0.982208505	0.904494484	1.066599702	0.669484332	454/213	16(3.4%)	0.66822609	0.669484332	0.669468903	0.069989493	0.521483445
	SKCM	AR	H (vs L)	0.958533605	0.730676045	1.257447371	0.759753801	227/96--227/117	16(3.4%)	0.759919485	0.759753801	0.759736958	0.508295483	0.511606237
	SKCM	ESR1	(continuous)	0.887682992	0.8078728	0.975377677	0.013189053	454/213	16(3.4%)	0.014391917	0.013189053	0.013046114	0.358268502	0.55583625
	SKCM	ESR1	H (vs L)	0.716505433	0.54600396	0.940249654	0.016203387	225/116--229/97	16(3.4%)	0.015948933	0.016203387	0.0157314	0.733865701	0.536361377
	SKCM	ESR2	(continuous)	1.010544057	0.931446042	1.096359043	0.80086752	454/213	16(3.4%)	0.801292182	0.80086752	0.800864523	0.398785063	0.4964177
	SKCM	ESR2	H (vs L)	0.924449414	0.702118204	1.217183536	0.575690921	225/116--229/97	16(3.4%)	0.575448682	0.575690921	0.575597561	0.226355111	0.519733709
	SKCM	PGR	(continuous)	0.986196205	0.889450943	1.093464414	0.791890729	454/213	16(3.4%)	0.791479304	0.791890729	0.791892589	0.107643301	0.523543785
	SKCM	PGR	H (vs L)	0.928819853	0.709493202	1.215947268	0.591072071	226/102--228/111	16(3.4%)	0.591306248	0.591072071	0.590988739	0.111847585	0.524941503
	SKCM	breslow_thickness_at_diagnosis	(continuous)	1.026997339	1.013584461	1.040587711	7.14E-05	354/172	116(24.68%)	0.0012153	7.14E-05	2.64E-05	0.659468427	0.676776629
	SKCM	age_at_initial_pathologic_diagnosis	(continuous)	1.025245597	1.015747215	1.034832799	1.52E-07	455/214	15(3.19%)	7.23E-08	1.52E-07	1.22E-07	0.753116532	0.606211397
	SKCM	race	ASIAN (vs WHITE)	4.427496983	2.043865397	9.59100808	0.000161627	12/7--447/207	NA	NA	NA	NA	0.621528556	NA
	SKCM	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	NA	NA	NA	NA	1/0--447/207	NA	NA	NA	NA	NA	NA
	SKCM	race	Global	NA	NA	NA	NA	NA	25(5.32%)	0.001911541	0.000161627	3.64E-05	0.885270074	0.517704621
	SKCM	gender	FEMALE (vs MALE)	0.846792816	0.634692664	1.129772115	0.258265318	180/71--290/145	15(3.19%)	0.253974666	0.258265318	0.257744564	0.031651303	0.502175117
	SKCM	pathologic_stage_v2	StageIII/IV (vs StageI/II)	1.600967469	1.195518764	2.143920209	0.001585744	194/93--224/98	NA	NA	NA	NA	0.0526006	NA
	SKCM	pathologic_stage_v2	I/II_NOS (vs StageI/II)	0.407546871	0.147951135	1.122630471	0.082525648	14/6--224/98	NA	NA	NA	NA	0.949925861	NA
	SKCM	pathologic_stage_v2	Global	NA	NA	NA	NA	NA	51(10.85%)	0.000351869	0.000752264	0.000536061	0.146993134	0.587850808
	SKCM	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.125973542	0.079410947	0.199838108	0	214/20--247/190	23(4.89%)	0	0	0	0.17294422	0.673387703
	SKCM	new_tumor_event_dx_days_to	NO (vs Yes)	0.65153849	0.471918405	0.899525002	0.009229597	190/49--280/167	15(3.19%)	0.006925639	0.009229597	0.008716878	0.903859201	0.54338949
	SKCM	clark_level_at_diagnosis	IV (vs V)	0.549304028	0.361445743	0.834800023	0.005023621	168/90--52/30	NA	NA	NA	NA	0.564065786	NA
	SKCM	clark_level_at_diagnosis	III (vs V)	0.314848549	0.190233128	0.521095403	6.94E-06	77/36--52/30	NA	NA	NA	NA	0.534194136	NA
	SKCM	clark_level_at_diagnosis	II (vs V)	0.190110844	0.07841011	0.460937151	0.00023885	18/6--52/30	NA	NA	NA	NA	0.14026183	NA
	SKCM	clark_level_at_diagnosis	I (vs V)	3.79E-07	0	Inf	0.994441528	6/0--52/30	NA	NA	NA	NA	0.99963844	NA
	SKCM	clark_level_at_diagnosis	Global	NA	NA	NA	NA	NA	156(33.19%)	1.34E-05	2.81E-05	8.97E-06	0.697822987	0.622511246
	SKCM	primary_melanoma_tumor_ulceration	YES (vs NO)	2.364855079	1.764636147	3.169230978	8.31E-09	167/78--303/138	15(3.19%)	3.06E-08	8.31E-09	3.34E-09	0.431077008	0.598875505
	SKCM	submitted_tumor_site.1	Regional_Lymph_Node (vs Primary_Tumor)	0.339106913	0.215866982	0.532705361	2.69E-06	222/107--103/30	NA	NA	NA	NA	0.523621034	NA
	SKCM	submitted_tumor_site.1	Regional_Cutaneous_or_Subcutaneous_Tissue_(includes_satellite_and_in-transit_metastasis) (vs Primary_Tumor)	0.356031581	0.21321378	0.594513575	7.89E-05	74/40--103/30	NA	NA	NA	NA	0.60865929	NA
	SKCM	submitted_tumor_site.1	Distant_Metastasis (vs Primary_Tumor)	0.335604213	0.197600089	0.569990572	5.35E-05	68/38--103/30	NA	NA	NA	NA	0.915184645	NA
	SKCM	submitted_tumor_site.1	Global	NA	NA	NA	NA	NA	18(3.83%)	0.000179405	3.43E-05	1.26E-05	0.492562213	0.557548812
	STAD	AR	(continuous)	1.118554424	1.034712615	1.209189858	0.004826834	409/157	34(7.67%)	0.005222773	0.004826834	0.004684645	0.792252165	0.568114074
	STAD	AR	H (vs L)	1.644760987	1.1949555	2.263882383	0.002268561	204/64--205/93	34(7.67%)	0.002042278	0.002268561	0.00204569	0.774321896	0.559628347
	STAD	ESR1	(continuous)	1.095144974	0.989001166	1.212680586	0.080579181	409/157	34(7.67%)	0.083899986	0.080579181	0.081219638	0.214575565	0.556714735
	STAD	ESR1	H (vs L)	1.410491205	1.028048571	1.935205685	0.033057164	205/68--204/89	34(7.67%)	0.032168344	0.033057164	0.032208467	0.586423897	0.547933618
	STAD	ESR2	(continuous)	1.01843362	0.883738115	1.173658825	0.800760591	409/157	34(7.67%)	0.800799412	0.800760591	0.800761837	0.477923598	0.513950428
	STAD	ESR2	H (vs L)	1.049805449	0.767333533	1.43626133	0.761180278	204/79--205/78	34(7.67%)	0.761202701	0.761180278	0.761157735	0.678532102	0.508512581
	STAD	PGR	(continuous)	1.111842469	1.020713185	1.211107775	0.015105485	409/157	34(7.67%)	0.016461696	0.015105485	0.015023794	0.582621471	0.55777545
	STAD	PGR	H (vs L)	1.466705324	1.068409013	2.01348405	0.017822585	205/67--204/90	34(7.67%)	0.017110904	0.017822585	0.017142788	0.850898002	0.54930315
	STAD	age_at_initial_pathologic_diagnosis	(continuous)	1.016829134	1.002332136	1.031535807	0.022732024	434/169	9(2.03%)	0.021217824	0.022732024	0.0226421	0.588038385	0.540059208
	STAD	gender	FEMALE (vs MALE)	0.931245732	0.677689425	1.279669687	0.660471929	158/58--285/114	6(1.35%)	0.659318029	0.660471929	0.660404964	0.513928186	0.503274349
	STAD	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.456369624	0.756600633	2.803344844	0.260513123	130/37--59/13	NA	NA	NA	NA	0.755175021	NA
	STAD	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	2.589644271	1.412041668	4.749333964	0.002104932	183/85--59/13	NA	NA	NA	NA	0.841953888	NA
	STAD	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	4.452002881	2.244432899	8.830885372	1.92E-05	44/26--59/13	NA	NA	NA	NA	0.152733712	NA
	STAD	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	33(7.45%)	2.19E-06	3.16E-06	9.85E-07	0.248485387	0.62290345
	STAD	pathologic_stage_v2	StageIII/IV (vs StageI/II)	2.199341115	1.566359228	3.088117498	5.33E-06	227/111--189/50	33(7.45%)	2.14E-06	5.33E-06	3.02E-06	0.699534051	0.595497393
	STAD	histological_grade	G2 (vs G3)	0.768060866	0.554415043	1.064035872	0.112570734	159/56--263/109	NA	NA	NA	NA	0.065919003	NA
	STAD	histological_grade	G1 (vs G3)	0.642342034	0.203793836	2.024611232	0.449831861	12/3--263/109	NA	NA	NA	NA	0.498486441	NA
	STAD	histological_grade	GX (vs G3)	1.271714091	0.468170201	3.454420479	0.637324251	9/4--263/109	NA	NA	NA	NA	0.739551424	NA
	STAD	histological_grade	Global	NA	NA	NA	NA	NA	6(1.35%)	0.335278813	0.344561823	0.340585821	0.26876573	0.550845293
	STAD	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	1.315194495	0.954717507	1.811778401	0.093654897	263/109--171/59	NA	NA	NA	NA	0.056918174	NA
	STAD	histological_grade_v2	GX (vs G_1/2/Low)	1.672790796	0.606315211	4.615139118	0.320400917	9/4--171/59	NA	NA	NA	NA	0.353542386	NA
	STAD	histological_grade_v2	Global	NA	NA	NA	NA	NA	6(1.35%)	0.192584136	0.196982202	0.194478557	0.140544698	0.550171845
	STAD	histological_type	Stomach_Intestinal_Adenocarcinoma_Not_Otherwise_Specified_(NOS) (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	0.870702763	0.5732138	1.322583828	0.51625043	82/37--164/61	NA	NA	NA	NA	0.77462359	NA
	STAD	histological_type	Stomach_Intestinal_Adenocarcinoma_Tubular_Type (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	0.81089732	0.524501111	1.253676017	0.345708795	79/31--164/61	NA	NA	NA	NA	0.690042093	NA
	STAD	histological_type	Stomach_Adenocarcinoma_Diffuse_Type (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	0.816552946	0.51986573	1.282559467	0.379009828	72/28--164/61	NA	NA	NA	NA	0.214913465	NA
	STAD	histological_type	Stomach_Intestinal_Adenocarcinoma_Mucinous_Type (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	0.208706425	0.065340104	0.666640686	0.008185205	22/3--164/61	NA	NA	NA	NA	0.500562336	NA
	STAD	histological_type	Stomach_Adenocarcinoma_Signet_Ring_Type (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	1.575836405	0.778631769	3.189261565	0.206107631	13/9--164/61	NA	NA	NA	NA	0.293855998	NA
	STAD	histological_type	Stomach_Intestinal_Adenocarcinoma_Papillary_Type (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	0.693706139	0.21732826	2.214291912	0.536861047	8/3--164/61	NA	NA	NA	NA	0.786520674	NA
	STAD	histological_type	Global	NA	NA	NA	NA	NA	9(2.03%)	0.024279159	0.098014639	0.057959703	0.695229011	0.557310448
	STAD	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	5.018866371	3.480630651	7.236912553	0	144/99--251/44	53(11.96%)	0	0	0	0.003286485	0.665716333
	STAD	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	3.045442845	1.104057606	8.400578078	0.031461772	7/4--274/68	NA	NA	NA	NA	0.308308497	NA
	STAD	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	2.474620384	1.131995737	5.409690024	0.023167271	18/8--274/68	NA	NA	NA	NA	0.435494501	NA
	STAD	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	4.646746989	3.226855934	6.691422865	1.11E-16	72/55--274/68	NA	NA	NA	NA	0.291211447	NA
	STAD	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	76(17.16%)	1.29E-13	7.33E-15	0	0.549750578	0.652913518
	STAD	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	4.129495158	2.915123718	5.849744954	1.44E-15	97/67--274/68	76(17.16%)	1.08E-14	1.44E-15	0	0.199920973	0.646532326
	STAD	residual_tumor	R1 (vs R0)	1.645740813	0.833786339	3.248389542	0.151002091	18/9--350/119	NA	NA	NA	NA	0.339241228	NA
	STAD	residual_tumor	R2 (vs R0)	7.732863832	4.373048101	13.6740282	2.02E-12	19/14--350/119	NA	NA	NA	NA	0.96373852	NA
	STAD	residual_tumor	RX (vs R0)	6.627966123	3.691797015	11.89933649	2.38E-10	25/13--350/119	NA	NA	NA	NA	0.88951421	NA
	STAD	residual_tumor	Global	NA	NA	NA	NA	NA	36(8.13%)	7.99E-12	0	0	0.808291804	0.602999277
	STAD	new_tumor_event_dx_days_to	Yes (vs NO)	1.950495296	1.435477259	2.650290611	1.95E-05	115/75--328/97	6(1.35%)	2.96E-05	1.95E-05	1.36E-05	4.37E-07	0.537933677
	STAD	radiation_therapy	YES (vs NO)	0.527007914	0.320814293	0.865726207	0.011428453	51/20--392/152	6(1.35%)	0.006208901	0.011428453	0.010190403	0.543660576	0.535715944
	STAD	targeted_molecular_therapy	YES (vs NO)	0.659782585	0.455746829	0.955164208	0.027596513	102/38--341/134	6(1.35%)	0.02221972	0.027596513	0.026522995	0.208693618	0.545666713
	STAD	number_of_lymphnodes_positive_by_he	NO (vs Yes)	0.621359562	0.442643215	0.872232289	0.005960134	165/48--278/124	6(1.35%)	0.00449714	0.005960134	0.005506673	0.84335192	0.549301008
	STAD	history_reflux_disease_indicator	YES (vs NO)	0.573720049	0.31128109	1.057419499	0.074912735	46/11--397/161	6(1.35%)	0.053277402	0.074912735	0.071235265	0.866596669	0.522711439
	TGCT	AR	(continuous)	0.812565581	0.419762015	1.572945621	0.53796035	134/4	0(0%)	0.532095282	0.53796035	0.537037073	0.647668795	0.626436782
	TGCT	AR	H (vs L)	0.398295583	0.039952183	3.970730963	0.432670334	67/3--67/1	0(0%)	0.405592256	0.432670334	0.417804696	0.443269022	0.607758621
	TGCT	ESR1	(continuous)	2.758617669	0.808777393	9.409228678	0.105029969	134/4	0(0%)	0.092402512	0.105029969	0.100522462	0.45304212	0.727011494
	TGCT	ESR1	H (vs L)	616264694.1	0	Inf	0.998852983	68/1--66/3	0(0%)	0.038862684	0.998852983	0.077863088	0.999974188	0.754310345
	TGCT	ESR2	(continuous)	0.744568188	0.209140243	2.65076571	0.648919843	134/4	0(0%)	0.651832308	0.648919843	0.648899632	0.818073888	0.650862069
	TGCT	ESR2	H (vs L)	0.427823577	0.043078556	4.248819597	0.468525697	67/3--67/1	0(0%)	0.443583261	0.468525697	0.45615666	0.221687376	0.558908046
	TGCT	PGR	(continuous)	0.558076671	0.246042516	1.26583639	0.162768315	134/4	0(0%)	0.152756718	0.162768315	0.153088611	0.504800445	0.702586207
	TGCT	PGR	H (vs L)	1.74E-09	0	Inf	0.998857013	67/4--67/0	0(0%)	0.044088409	0.998857013	0.088842741	0.999973483	0.745689655
	TGCT	age_at_initial_pathologic_diagnosis	(continuous)	0.890209452	0.763806552	1.037530859	0.136638554	134/4	0(0%)	0.102063907	0.136638554	0.141001397	0.843369749	0.698275862
	TGCT	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	27545521225	0	Inf	0.999043016	7/3--126/1	1(0.75%)	1.48E-05	0.999043016	2.00E-15	0.999989561	0.976811594
	TGCT	new_tumor_event_type	Yes (vs NO)	2.730991855	0.383944217	19.42552119	0.315541678	33/2--101/2	0(0%)	0.325220336	0.315541678	0.295476598	0.928491471	0.673850575
	TGCT	postoperative_rx_tx	YES (vs NO)	0.562514979	0.057072631	5.544217887	0.622132742	42/1--92/3	0(0%)	0.607379443	0.622132742	0.617637679	0.171597095	0.659482759
	TGCT	history_of_undescended_testis	Yes (vs No)	1.254025412	0.129734463	12.12152651	0.844953618	23/1--111/3	0(0%)	0.847875296	0.844953618	0.844629796	0.737227952	0.550287356
	TGCT	lymphovascular_invasion_present	YES (vs NO)	3.158139393	0.312525473	31.91370075	0.329839268	55/3--79/1	0(0%)	0.298330608	0.329839268	0.306653739	0.812560531	0.627873563
	THCA	AR	(continuous)	1.205747037	0.904186642	1.607882543	0.20263044	505/16	2(0.39%)	0.207430806	0.20263044	0.201492304	0.425357745	0.58500401
	THCA	AR	H (vs L)	2.476535643	0.858461107	7.144445737	0.093417892	254/5--251/11	2(0.39%)	0.080368441	0.093417892	0.082757376	0.841125089	0.613472334
	THCA	ESR1	(continuous)	1.025635429	0.791717325	1.328666179	0.848015883	505/16	2(0.39%)	0.848015412	0.848015883	0.848034963	0.128512398	0.414060412
	THCA	ESR1	H (vs L)	0.736266312	0.274079569	1.977849299	0.543684411	253/9--252/7	2(0.39%)	0.54189078	0.543684411	0.542114245	0.595293583	0.568430901
	THCA	ESR2	(continuous)	1.300186223	0.634795079	2.663039256	0.472991602	505/16	2(0.39%)	0.476100721	0.472991602	0.473604563	0.214027893	0.471130714
	THCA	ESR2	H (vs L)	1.353332871	0.503807725	3.635335007	0.548406137	255/7--250/9	2(0.39%)	0.546638014	0.548406137	0.546883636	0.399037638	0.499331729
	THCA	PGR	(continuous)	0.842737524	0.641029778	1.107915042	0.220280294	505/16	2(0.39%)	0.230436369	0.220280294	0.224242819	0.534899277	0.599438653
	THCA	PGR	H (vs L)	0.728772298	0.271216726	1.958245976	0.530415943	253/9--252/7	2(0.39%)	0.528554333	0.530415943	0.528707792	0.172754579	0.584202085
	THCA	tumor_size_width	(continuous)	1.345442813	1.044533696	1.733037785	0.021601834	478/15	29(5.72%)	0.032287658	0.021601834	0.020965681	0.327818555	0.651162791
	THCA	tumor_size_width.1	(continuous)	1.582355855	1.054018052	2.375528624	0.02684627	429/12	78(15.38%)	0.039228333	0.02684627	0.02648873	0.242476255	0.648840992
	THCA	tumor_size_width.2	(continuous)	1.864573921	1.060618507	3.277932529	0.030432375	407/12	100(19.72%)	0.040637627	0.030432375	0.027579694	0.307225313	0.637320977
	THCA	age_at_initial_pathologic_diagnosis	(continuous)	1.120456858	1.078573335	1.163966817	4.88E-09	507/16	0(0%)	3.40E-12	4.88E-09	4.29E-13	0.801849742	0.929027113
	THCA	gender	MALE (vs FEMALE)	1.998132742	0.722849698	5.523325894	0.182092522	136/6--371/10	0(0%)	0.19812698	0.182092522	0.17363774	0.685725644	0.569510898
	THCA	pathologic_stage_v2	StageIII/IV (vs StageI/II)	7.211180961	2.320548001	22.40898737	0.000637528	168/12--337/4	2(0.39%)	0.000171884	0.000637528	6.62E-05	0.334433684	0.735584624
	THCA	histological_type	Thyroid_Papillary_Carcinoma_-_Follicular_(>=_99%_follicular_patterned) (vs Thyroid_Papillary_Carcinoma_-_Classical/usual)	0.290217901	0.0382675	2.200991209	0.231391629	102/1--359/15	NA	NA	NA	NA	0.702432776	NA
	THCA	histological_type	Thyroid_Papillary_Carcinoma_-_Tall_Cell_(>=_50%_tall_cell_features) (vs Thyroid_Papillary_Carcinoma_-_Classical/usual)	2.97E-08	0	Inf	0.997393576	37/0--359/15	NA	NA	NA	NA	0.999958603	NA
	THCA	histological_type	"Other,_specify (vs Thyroid_Papillary_Carcinoma_-_Classical/usual)"	2.96E-08	0	Inf	0.998762502	9/0--359/15	NA	NA	NA	NA	0.999975218	NA
	THCA	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.212922545	0.697981311	0.389075087	0.985802764	0.606725146
	THCA	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	25.01368073	6.464919446	96.78144157	3.11E-06	44/7--451/3	12(2.37%)	1.83E-06	3.11E-06	3.64E-12	0.382411894	0.864006515
	THCA	residual_tumor	R1 (vs R0)	4.151940154	1.249673898	13.79448437	0.020136817	52/4--389/8	NA	NA	NA	NA	0.551208378	NA
	THCA	residual_tumor	RX (vs R0)	6.36933381	1.680154428	24.14564549	0.00646673	30/3--389/8	NA	NA	NA	NA	0.564450904	NA
	THCA	residual_tumor	R2 (vs R0)	1.78E-07	0	Inf	0.997554157	4/0--389/8	NA	NA	NA	NA	0.999878395	NA
	THCA	residual_tumor	Global	NA	NA	NA	NA	NA	32(6.31%)	0.026365838	0.019367097	0.004613047	0.805570492	0.70781054
	THCA	other_dx	Yes (vs No)	5.287656801	1.701959185	16.42772324	0.003984309	34/4--473/12	0(0%)	0.013808899	0.003984309	0.001269565	0.18096003	0.634370016
	THCA	number_of_lymphnodes_positive_by_he	Yes (vs NO)	0.724235923	0.262755938	1.996216247	0.532827972	219/6--288/10	0(0%)	0.528163434	0.532827972	0.531068461	0.095035661	0.574561404
	THCA	history_thyroid_disease	Nodular_Hyperplasia (vs Normal)	0.535221671	0.068531607	4.180001744	0.551138482	69/1--281/14	NA	NA	NA	NA	0.646227166	NA
	THCA	history_thyroid_disease	Lymphocytic_Thyroiditis (vs Normal)	9.96E-09	0	Inf	0.998204588	43/0--281/14	NA	NA	NA	NA	0.999984318	NA
	THCA	history_thyroid_disease	"Other,_specify (vs Normal)"	9.85E-09	0	Inf	0.998491787	26/0--281/14	NA	NA	NA	NA	0.999981853	NA
	THCA	history_thyroid_disease	Lymphocytic_Thyroiditis|Nodular_Hyperplasia (vs Normal)	9.37E-09	0	Inf	0.998796011	23/0--281/14	NA	NA	NA	NA	0.999958033	NA
	THCA	history_thyroid_disease	"Lymphocytic_Thyroiditis|Other,_specify (vs Normal)"	1.01E-08	0	Inf	0.999163212	5/0--281/14	NA	NA	NA	NA	0.999999775	NA
	THCA	history_thyroid_disease	"Lymphocytic_Thyroiditis|Nodular_Hyperplasia|Other,_specify (vs Normal)"	1.04E-08	0	Inf	0.999531074	1/0--281/14	NA	NA	NA	NA	0.999993143	NA
	THCA	history_thyroid_disease	"Normal|Other,_specify (vs Normal)"	9.12E-09	0	Inf	0.99983302	1/0--281/14	NA	NA	NA	NA	0.999991036	NA
	THCA	history_thyroid_disease	Global	NA	NA	NA	NA	NA	58(11.44%)	0.467834404	0.999822981	0.78789221	0.999969939	0.61464497
	THCA	tumor_focality	Multifocal (vs Unifocal)	0.255844066	0.057750815	1.133424454	0.072646782	228/2--269/14	10(1.97%)	0.035946499	0.072646782	0.053257832	0.274839516	0.628301887
	THCA	extrathyroidal_extension	Minimal_(T3) (vs None)	1.155182225	0.336215863	3.9690155	0.818808999	134/4--354/7	NA	NA	NA	NA	0.407559346	NA
	THCA	extrathyroidal_extension	Moderate/Advanced_(T4a) (vs None)	8.365897318	2.43495927	28.74308363	0.000743071	18/4--354/7	NA	NA	NA	NA	0.861442058	NA
	THCA	extrathyroidal_extension	Very_Advanced_(T4b) (vs None)	NA	NA	NA	NA	1/1--354/7	NA	NA	NA	NA	NA	NA
	THCA	extrathyroidal_extension	Global	NA	NA	NA	NA	NA	0(0%)	2.74E-05	0.001915716	0	0.814452431	0.710393408
	THYM	AR	(continuous)	1.091588988	0.722480712	1.649271045	0.67727253	119/9	5(4.03%)	0.681464105	0.67727253	0.676822965	0.386133776	0.480103806
	THYM	AR	H (vs L)	0.611261665	0.159392748	2.344151963	0.472917437	60/5--59/4	5(4.03%)	0.470837964	0.472917437	0.468966352	0.81070734	0.540657439
	THYM	ESR1	(continuous)	1.144825951	0.733406246	1.78704022	0.551645458	119/9	5(4.03%)	0.555857862	0.551645458	0.551552696	0.323022855	0.588235294
	THYM	ESR1	H (vs L)	0.947223632	0.238483249	3.762245827	0.938584212	60/4--59/5	5(4.03%)	0.938616603	0.938584212	0.938578085	0.119649525	0.462802768
	THYM	ESR2	(continuous)	0.477863115	0.265416055	0.860359244	0.013844085	119/9	5(4.03%)	0.011588711	0.013844085	0.008980821	0.706296866	0.807958478
	THYM	ESR2	H (vs L)	0.112299339	0.014019823	0.899522144	0.039426152	59/8--60/1	5(4.03%)	0.008395417	0.039426152	0.012720467	0.75542644	0.747404844
	THYM	PGR	(continuous)	1.190434343	0.802465297	1.765975337	0.386323136	119/9	5(4.03%)	0.394922362	0.386323136	0.385038897	0.121927166	0.611591696
	THYM	PGR	H (vs L)	0.729727042	0.191531216	2.780233775	0.644309508	61/5--58/4	5(4.03%)	0.642908242	0.644309508	0.643054923	0.090619814	0.474048443
	THYM	age_at_initial_pathologic_diagnosis	(continuous)	1.054387154	0.995307915	1.116973204	0.071844167	123/9	1(0.81%)	0.052147187	0.071844167	0.060890269	0.724112111	0.71869783
	THYM	gender	FEMALE (vs MALE)	1.552702635	0.415261284	5.805707311	0.513183068	60/5--64/4	1(0.81%)	0.511438219	0.513183068	0.509844432	0.321473918	0.519198664
	THYM	clinical_stage_v2	StageIII/IV (vs StageI/II)	1.529205063	0.31323633	7.465507361	0.59954832	23/2--99/7	3(2.42%)	0.613720384	0.59954832	0.596858018	0.454283949	0.578947368
	THYM	histological_type	Type_AB (vs Type_A)	0.27810414	0.025113929	3.079642082	0.296887985	38/1--17/2	NA	NA	NA	NA	0.405247649	NA
	THYM	histological_type	Type_B (vs Type_A)	0.411460762	0.071902384	2.354580611	0.318386629	58/4--17/2	NA	NA	NA	NA	0.853238577	NA
	THYM	histological_type	Type_C (vs Type_A)	1.507653585	0.204720252	11.1030507	0.686942354	11/2--17/2	NA	NA	NA	NA	0.308007105	NA
	THYM	histological_type	Global	NA	NA	NA	NA	NA	1(0.81%)	0.387635469	0.347006279	0.285558776	0.633437373	0.656928214
	THYM	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	6.727612569	1.748234601	25.88941488	0.00556448	10/4--113/5	2(1.61%)	0.011042447	0.00556448	0.001580012	0.695463177	0.640939597
	THYM	new_tumor_event_type	Yes (vs NO)	4.520417377	1.188792934	17.18900969	0.026847022	21/5--103/4	1(0.81%)	0.029427742	0.026847022	0.015986655	0.167678951	0.574290484
	UCEC	AR	(continuous)	0.986510951	0.892606344	1.090294577	0.790159673	531/87	17(3.1%)	0.790670985	0.790159673	0.790151331	0.17882626	0.524590464
	UCEC	AR	H (vs L)	0.907818716	0.595133882	1.384788946	0.653508099	265/47--266/40	17(3.1%)	0.653154404	0.653508099	0.653382989	0.081174053	0.528365156
	UCEC	ESR1	(continuous)	0.85510369	0.786209319	0.930035172	0.000259828	531/87	17(3.1%)	0.000678896	0.000259828	0.000204774	0.075213104	0.64800088
	UCEC	ESR1	H (vs L)	0.406335357	0.256575125	0.643509079	0.000123439	265/61--266/26	17(3.1%)	5.85E-05	0.000123439	7.22E-05	0.265327834	0.617638436
	UCEC	ESR2	(continuous)	1.056570485	0.852083754	1.310130823	0.616080058	531/87	17(3.1%)	0.616810558	0.616080058	0.616124386	0.812164677	0.523124565
	UCEC	ESR2	H (vs L)	1.296823356	0.849520608	1.979646875	0.228464975	267/39--264/48	17(3.1%)	0.227040217	0.228464975	0.227165421	0.607072028	0.524700407
	UCEC	PGR	(continuous)	0.87308073	0.818740117	0.931027986	3.48E-05	531/87	17(3.1%)	6.58E-05	3.48E-05	2.49E-05	0.057216051	0.660699234
	UCEC	PGR	H (vs L)	0.524145452	0.336724923	0.815883935	0.004219801	265/57--266/30	17(3.1%)	0.003337383	0.004219801	0.003603073	0.111300676	0.59519185
	UCEC	BMI	(continuous)	0.991430312	0.969523083	1.013832555	0.450285019	516/87	32(5.84%)	0.429562166	0.450285019	0.458952128	0.957969148	0.518278126
	UCEC	tumor_invasion_percent	(continuous)	1.012339979	1.00837359	1.016321968	9.17E-10	474/79	74(13.5%)	8.47E-07	9.17E-10	5.00E-09	0.716667329	0.702613813
	UCEC	age_at_initial_pathologic_diagnosis	(continuous)	1.034661707	1.01479825	1.054913967	0.000570563	545/91	3(0.55%)	0.000537554	0.000570563	0.000571527	0.929749147	0.599836668
	UCEC	clinical_stage_v2	StageIII/IV (vs StageI/II)	3.968803771	2.61840474	6.015648816	8.24E-11	154/50--394/41	1(0.18%)	1.50E-10	8.24E-11	2.43E-12	0.008881031	0.690273443
	UCEC	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	3.448590278	2.008859736	5.920161919	7.12E-06	327/75--221/16	1(0.18%)	4.53E-07	7.12E-06	1.75E-06	0.335685361	0.629902293
	UCEC	histological_type	Serous_endometrial_adenocarcinoma (vs Endometrioid_endometrial_adenocarcinoma)	2.910290745	1.888274104	4.48546755	1.30E-06	115/36--411/49	NA	NA	NA	NA	0.371237855	NA
	UCEC	histological_type	Mixed_serous_and_endometrioid (vs Endometrioid_endometrial_adenocarcinoma)	2.907862238	1.241815632	6.809112867	0.013938089	22/6--411/49	NA	NA	NA	NA	0.224618063	NA
	UCEC	histological_type	Global	NA	NA	NA	NA	NA	1(0.18%)	6.69E-06	2.87E-06	8.40E-07	0.38806415	0.602761569
	UCEC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	11.35357578	7.247553549	17.78582003	0	101/60--427/29	21(3.83%)	0	0	0	0.799714188	0.763543089
	UCEC	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	7.115690369	3.01938292	16.76933691	7.24E-06	12/6--441/53	NA	NA	NA	NA	0.734098462	NA
	UCEC	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	5.24378199	1.626999607	16.90058771	0.005518038	6/3--441/53	NA	NA	NA	NA	0.982366507	NA
	UCEC	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	9.006778015	4.865848738	16.6717164	2.63E-12	20/13--441/53	NA	NA	NA	NA	0.107717328	NA
	UCEC	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	69(12.59%)	6.82E-10	8.09E-14	0	0.453043486	0.656988996
	UCEC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	7.701606562	4.633806014	12.80043736	3.44E-15	38/22--441/53	69(12.59%)	2.20E-11	3.44E-15	0	0.197915239	0.654273004
	UCEC	residual_tumor	RX (vs R0)	1.959941611	0.990907327	3.876619955	0.053148131	41/10--376/51	NA	NA	NA	NA	0.292687482	NA
	UCEC	residual_tumor	R1 (vs R0)	1.72064492	0.684383916	4.325962181	0.248608081	22/5--376/51	NA	NA	NA	NA	0.818914822	NA
	UCEC	residual_tumor	R2 (vs R0)	6.058636015	3.141699778	11.68382498	7.60E-08	16/11--376/51	NA	NA	NA	NA	0.640269368	NA
	UCEC	residual_tumor	Global	NA	NA	NA	NA	NA	94(17.15%)	6.50E-05	1.34E-06	3.55E-08	0.665677493	0.595771506
	UCEC	new_tumor_event_type	Metastatic (vs NO)	3.334560288	1.742590049	6.380899697	0.000275557	27/11--463/54	NA	NA	NA	NA	0.733351924	NA
	UCEC	new_tumor_event_type	Locoregional_Recurrence (vs NO)	4.222782927	2.295994549	7.766523512	3.60E-06	25/13--463/54	NA	NA	NA	NA	0.002826853	NA
	UCEC	new_tumor_event_type	Locoregional_Disease (vs NO)	2.78289111	0.999596308	7.747610584	0.050090415	12/4--463/54	NA	NA	NA	NA	0.57163601	NA
	UCEC	new_tumor_event_type	New_Primary_Tumor (vs NO)	1.624310469	0.506988107	5.204036272	0.414188057	11/3--463/54	NA	NA	NA	NA	0.331788431	NA
	UCEC	new_tumor_event_type	Distant_Metastasis (vs NO)	6.766725901	2.890052722	15.84351007	1.06E-05	10/6--463/54	NA	NA	NA	NA	0.503429352	NA
	UCEC	new_tumor_event_type	Global	NA	NA	NA	NA	NA	1(0.18%)	1.34E-06	4.03E-08	6.53E-10	0.049800579	0.605628308
	UCEC	new_tumor_event_dx_days_to	Yes (vs NO)	4.678609816	3.09350757	7.0759128	2.67E-13	109/50--439/41	1(0.18%)	8.33E-13	2.67E-13	7.77E-16	0.136697264	0.648408875
	UCEC	peritoneal_washing	positive (vs negative)	4.651630184	2.83978597	7.619469776	1.03E-09	58/25--353/46	137(25%)	3.38E-08	1.03E-09	1.88E-11	0.96500679	0.633287053
	UCEC	lymph_nodes_pelvic_pos_by_he	Yes (vs NO)	4.010198511	2.460188454	6.536772447	2.53E-08	56/22--492/69	1(0.18%)	8.69E-07	2.53E-08	1.71E-09	0.248123584	0.607833492
	UCEC	lymph_nodes_pelvic_pos_total	Yes (vs NO)	3.653551476	2.311165758	5.775630044	2.93E-08	74/27--474/64	1(0.18%)	4.97E-07	2.93E-08	2.91E-09	0.252951725	0.61948704
	UCEC	lymph_nodes_aortic_pos_by_he	Yes (vs NO)	2.458548202	1.230843581	4.91082649	0.01082353	29/9--519/82	1(0.18%)	0.023183926	0.01082353	0.008413831	0.76241031	0.534061609
	UCEC	lymph_nodes_aortic_pos_total	Yes (vs NO)	2.967597123	1.64259681	5.361408613	0.00031278	38/13--510/78	1(0.18%)	0.001492756	0.00031278	0.000154113	0.76960906	0.552839598
	UCS	AR	(continuous)	0.951927746	0.80285349	1.128682187	0.570753307	57/35	0(0%)	0.56824457	0.570753307	0.570445045	0.571013078	0.535366932
	UCS	AR	H (vs L)	0.863866792	0.432566029	1.725206753	0.678389616	29/18--28/17	0(0%)	0.677785805	0.678389616	0.678128266	0.424708564	0.501768347
	UCS	ESR1	(continuous)	0.943336549	0.777229206	1.144943908	0.555006734	57/35	0(0%)	0.556335115	0.555006734	0.555202751	0.424068174	0.50132626
	UCS	ESR1	H (vs L)	0.850563143	0.435908108	1.659656353	0.635094896	29/19--28/16	0(0%)	0.634524556	0.635094896	0.634736209	0.931695093	0.524314766
	UCS	ESR2	(continuous)	0.756729834	0.479182617	1.195035091	0.231819375	57/35	0(0%)	0.232185392	0.231819375	0.233864455	0.70650127	0.534040672
	UCS	ESR2	H (vs L)	0.720027808	0.365083226	1.420059888	0.343180049	29/18--28/17	0(0%)	0.342521695	0.343180049	0.341088254	0.715003144	0.547745358
	UCS	PGR	(continuous)	0.93471411	0.8001626	1.091891156	0.394559279	57/35	0(0%)	0.38899915	0.394559279	0.394271896	0.823244652	0.543766578
	UCS	PGR	H (vs L)	0.77308021	0.39654054	1.507167491	0.449890139	29/19--28/16	0(0%)	0.448888109	0.449890139	0.448666645	0.522438841	0.546419098
	UCS	tumor_invasion_percent	(continuous)	1.025449784	1.010243499	1.040884955	0.000977347	45/27	12(21.05%)	0.000545705	0.000977347	0.00055172	0.359108453	0.690611664
	UCS	age_at_initial_pathologic_diagnosis	(continuous)	1.039726639	0.999343346	1.081741814	0.053921714	57/35	0(0%)	0.058107913	0.053921714	0.052593251	0.445076288	0.600353669
	UCS	clinical_stage_v2	StageIII/IV (vs StageI/II)	2.480851424	1.203012515	5.116009774	0.013875243	30/23--27/12	0(0%)	0.010644976	0.013875243	0.011016814	0.816627351	0.613174182
	UCS	histological_type	Uterine_Carcinosarcoma/_MMMT_Heterologous_Type (vs Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT)_NOS)	2.059700384	0.993290758	4.271020986	0.052152571	20/16--24/14	NA	NA	NA	NA	0.968205759	NA
	UCS	histological_type	Uterine_Carcinosarcoma/MMMT_Homologous_Type (vs Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT)_NOS)	0.534674576	0.191091686	1.496019573	0.233004931	13/5--24/14	NA	NA	NA	NA	0.305027987	NA
	UCS	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.015791276	0.01860972	0.012875036	0.553455717	0.653404067
	UCS	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.101402512	0.024170073	0.425421529	0.001759215	17/2--37/31	3(5.26%)	1.38E-05	0.001759215	0.000124909	0.828679316	0.656767283
	UCS	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	7.036390089	2.997823161	16.51557908	7.39E-06	18/16--31/12	8(14.04%)	4.57E-06	7.39E-06	3.57E-07	0.207455468	0.741792929
	UCS	new_tumor_event_type	NO (vs Yes)	0.383859249	0.177695355	0.829216514	0.014829122	26/10--31/25	0(0%)	0.00975791	0.014829122	0.011586638	0.055032311	0.574270557
	UCS	radiation_therapy	YES (vs NO)	0.471005243	0.235643472	0.94144742	0.033112102	25/14--32/21	0(0%)	0.030701475	0.033112102	0.02961079	0.216539725	0.616268789
	UCS	postoperative_rx_tx	NO (vs YES)	2.059618067	1.041192117	4.074201593	0.037899093	21/15--36/20	0(0%)	0.043218065	0.037899093	0.034279349	0.028371389	0.622015915
	UCS	lymph_nodes_pelvic_pos_by_he	Yes (vs NO)	0.923713626	0.415969963	2.051222298	0.845431689	13/8--44/27	0(0%)	0.844408892	0.845431689	0.845391997	0.488217428	0.519009726
	UCS	lymph_nodes_aortic_pos_by_he	Yes (vs NO)	1.981761186	0.886487603	4.430267703	0.095630751	9/8--48/27	0(0%)	0.116660365	0.095630751	0.089386628	0.203284914	0.534040672
	UVM	AR	(continuous)	1.157643259	0.781924799	1.713896167	0.464654855	80/23	0(0%)	0.46618604	0.464654855	0.463727612	0.446212459	0.500986193
	UVM	AR	H (vs L)	2.242566145	0.947150793	5.309717262	0.066284478	40/8--40/15	0(0%)	0.058911385	0.066284478	0.059370058	0.369972627	0.569033531
	UVM	ESR1	(continuous)	1.203982932	0.943303138	1.536701026	0.13592907	80/23	0(0%)	0.12019513	0.13592907	0.134560094	0.067995836	0.557199211
	UVM	ESR1	H (vs L)	1.603229175	0.692746484	3.710367135	0.270232972	40/9--40/14	0(0%)	0.264228345	0.270232972	0.265853183	0.298171088	0.533530572
	UVM	ESR2	(continuous)	1.493245666	1.048711299	2.126212067	0.02616515	80/23	0(0%)	0.026632815	0.02616515	0.027236496	0.596093517	0.596646943
	UVM	ESR2	H (vs L)	1.442083016	0.608578213	3.417150636	0.405579903	40/8--40/15	0(0%)	0.398199335	0.405579903	0.403037773	0.327977271	0.560157791
	UVM	PGR	(continuous)	1.66643921	1.252136041	2.217825819	0.000462223	80/23	0(0%)	0.001457199	0.000462223	0.000320757	0.852731861	0.687376726
	UVM	PGR	H (vs L)	3.365212958	1.380202516	8.205069994	0.007617319	40/7--40/16	0(0%)	0.004969333	0.007617319	0.004633075	0.264611259	0.669625247
	UVM	tumor_basal_diameter	(continuous)	1.167181203	1.01144096	1.346902107	0.034374647	79/22	1(1.25%)	0.032668932	0.034374647	0.033975098	0.902485559	0.611111111
	UVM	tumor_thickness	(continuous)	1.117613003	0.948710751	1.316585505	0.183472644	80/23	0(0%)	0.174650023	0.183472644	0.18072771	0.768340729	0.600591716
	UVM	BMI	(continuous)	1.057405483	1.005375788	1.112127792	0.030141671	53/17	27(33.75%)	0.059808548	0.030141671	0.026725868	0.681329165	0.564981949
	UVM	age_at_initial_pathologic_diagnosis	(continuous)	1.045723808	1.007515617	1.085380976	0.018561147	80/23	0(0%)	0.013339819	0.018561147	0.016772547	0.172377178	0.682445759
	UVM	gender	FEMALE (vs MALE)	0.648562649	0.273818346	1.536177235	0.325023777	35/8--45/15	0(0%)	0.316189946	0.325023777	0.321360492	0.511759459	0.57199211
	UVM	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_II)	1.180445182	0.473955237	2.940047331	0.721611181	36/11--39/8	NA	NA	NA	NA	0.47801147	NA
	UVM	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_II)	69.94549186	6.777528908	721.8518575	0.000361314	4/3--39/8	NA	NA	NA	NA	0.957535826	NA
	UVM	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	1(1.25%)	0.000815169	0.001579611	2.08E-10	0.760326825	0.626782077
	UVM	pathologic_stage_v2	StageIII/IV (vs StageI/II)	1.501880881	0.629197358	3.584958128	0.359542145	40/14--39/8	1(1.25%)	0.352217153	0.359542145	0.356264578	0.193425235	0.578411405
	UVM	clinical_stage	Stage_III (vs Stage_II)	1.399606018	0.555751837	3.524769286	0.475592703	40/13--36/7	NA	NA	NA	NA	0.949022957	NA
	UVM	clinical_stage	Stage_IV (vs Stage_II)	79.34226934	7.545712981	834.2744709	0.000268939	4/3--36/7	NA	NA	NA	NA	0.838648695	NA
	UVM	clinical_stage	Global	NA	NA	NA	NA	NA	0(0%)	0.000640909	0.001285059	1.24E-10	0.979388488	0.618343195
	UVM	clinical_stage_v2	StageIII/IV (vs StageI/II)	1.71846308	0.704268629	4.193166127	0.23419037	44/16--36/7	0(0%)	0.220279206	0.23419037	0.228648969	0.64250276	0.567061144
	UVM	histological_type	Epithelioid_Cell (vs Spindle_Cell)	9.334580201	2.21001495	39.42705796	0.00237554	13/6--30/3	NA	NA	NA	NA	0.647866682	NA
	UVM	histological_type	Epithelioid_Cell|Spindle_Cell (vs Spindle_Cell)	4.083882408	1.168146752	14.2773975	0.027570902	37/14--30/3	NA	NA	NA	NA	0.603994527	NA
	UVM	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.003395823	0.009879058	0.003192161	0.86783935	0.691814596
	UVM	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	10.75903242	3.649843714	31.71554392	1.65E-05	25/19--55/4	0(0%)	2.74E-07	1.65E-05	7.86E-08	0.812712588	0.760848126
	UVM	new_tumor_event_type	Yes (vs NO)	1.80341449	0.784440585	4.146016774	0.165030281	22/11--58/12	0(0%)	0.169834215	0.165030281	0.159583177	0.184824107	0.606508876
